#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Thalamic cortical error-related responses in adult social drinkers: sex differences and problem alcohol use
#Text=Background
#Text=Error-related brain activities are altered in individuals with substance use disorders.
1-1	0-8	Thalamic	_	
1-2	9-17	cortical	_	
1-3	18-31	error-related	_	
1-4	32-41	responses	_	
1-5	42-44	in	_	
1-6	45-50	adult	_	
1-7	51-57	social	_	
1-8	58-66	drinkers	_	
1-9	66-67	:	_	
1-10	68-71	sex	_	
1-11	72-83	differences	_	
1-12	84-87	and	_	
1-13	88-95	problem	_	
1-14	96-103	alcohol	_	
1-15	104-107	use	_	
1-16	108-118	Background	_	
1-17	119-132	Error-related	_	
1-18	133-138	brain	_	
1-19	139-149	activities	_	
1-20	150-153	are	_	
1-21	154-161	altered	_	
1-22	162-164	in	_	
1-23	165-176	individuals	_	
1-24	177-181	with	_	
1-25	182-191	substance	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[1]	
1-26	192-195	use	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[1]	
1-27	196-205	disorders	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[1]	
1-28	205-206	.	_	

#Text=Here we examined error-related activities in relation to problem drinking in nondependent alcohol drinkers.
2-1	207-211	Here	_	
2-2	212-214	we	_	
2-3	215-223	examined	_	
2-4	224-237	error-related	_	
2-5	238-248	activities	_	
2-6	249-251	in	_	
2-7	252-260	relation	_	
2-8	261-263	to	_	
2-9	264-271	problem	_	
2-10	272-280	drinking	_	
2-11	281-283	in	_	
2-12	284-296	nondependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[2]	
2-13	297-304	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[2]	
2-14	305-313	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[2]	
2-15	313-314	.	_	

#Text=In particular, we investigated sex differences and whether altered error responses are related to post-error behavioral control.
3-1	315-317	In	_	
3-2	318-328	particular	_	
3-3	328-329	,	_	
3-4	330-332	we	_	
3-5	333-345	investigated	_	
3-6	346-349	sex	_	
3-7	350-361	differences	_	
3-8	362-365	and	_	
3-9	366-373	whether	_	
3-10	374-381	altered	_	
3-11	382-387	error	_	
3-12	388-397	responses	_	
3-13	398-401	are	_	
3-14	402-409	related	_	
3-15	410-412	to	_	
3-16	413-423	post-error	_	
3-17	424-434	behavioral	_	
3-18	435-442	control	_	
3-19	442-443	.	_	

#Text=Methods
#Text=A sample of 145 non-dependent drinkers (77 women) performed the stop signal task during fMRI.
4-1	444-451	Methods	_	
4-2	452-453	A	_	
4-3	454-460	sample	_	
4-4	461-463	of	_	
4-5	464-467	145	_	
4-6	468-481	non-dependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[3]	
4-7	482-490	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[3]	
4-8	491-492	(	_	
4-9	492-494	77	_	
4-10	495-500	women	_	
4-11	500-501	)	_	
4-12	502-511	performed	_	
4-13	512-515	the	_	
4-14	516-520	stop	_	
4-15	521-527	signal	_	
4-16	528-532	task	_	
4-17	533-539	during	_	
4-18	540-544	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
4-19	544-545	.	_	

#Text=Imaging data were processed and modeled using statistical parametric mapping.
5-1	546-553	Imaging	_	
5-2	554-558	data	_	
5-3	559-563	were	_	
5-4	564-573	processed	_	
5-5	574-577	and	_	
5-6	578-585	modeled	_	
5-7	586-591	using	_	
5-8	592-603	statistical	_	
5-9	604-614	parametric	_	
5-10	615-622	mapping	_	
5-11	622-623	.	_	

#Text=Independent sample t-test and linear regression were employed to examine sex differences in error response and relationship between error response and problem drinking.
6-1	624-635	Independent	_	
6-2	636-642	sample	_	
6-3	643-649	t-test	_	
6-4	650-653	and	_	
6-5	654-660	linear	_	
6-6	661-671	regression	_	
6-7	672-676	were	_	
6-8	677-685	employed	_	
6-9	686-688	to	_	
6-10	689-696	examine	_	
6-11	697-700	sex	_	
6-12	701-712	differences	_	
6-13	713-715	in	_	
6-14	716-721	error	_	
6-15	722-730	response	_	
6-16	731-734	and	_	
6-17	735-747	relationship	_	
6-18	748-755	between	_	
6-19	756-761	error	_	
6-20	762-770	response	_	
6-21	771-774	and	_	
6-22	775-782	problem	_	
6-23	783-791	drinking	_	
6-24	791-792	.	_	

#Text=Results
#Text=Compared to men, women showed greater error-related (stop error > go success) activations in bilateral thalamus, right middle/superior temporal cortex and bilateral dorsal anterior cingulate cortex.
7-1	793-800	Results	_	
7-2	801-809	Compared	_	
7-3	810-812	to	_	
7-4	813-816	men	_	
7-5	816-817	,	_	
7-6	818-823	women	_	
7-7	824-830	showed	_	
7-8	831-838	greater	_	
7-9	839-852	error-related	_	
7-10	853-854	(	_	
7-11	854-858	stop	_	
7-12	859-864	error	_	
7-13	865-866	>	_	
7-14	867-869	go	_	
7-15	870-877	success	_	
7-16	877-878	)	_	
7-17	879-890	activations	_	
7-18	891-893	in	_	
7-19	894-903	bilateral	_	
7-20	904-912	thalamus	_	
7-21	912-913	,	_	
7-22	914-919	right	_	
7-23	920-926	middle	_	
7-24	926-927	/	_	
7-25	927-935	superior	_	
7-26	936-944	temporal	_	
7-27	945-951	cortex	_	
7-28	952-955	and	_	
7-29	956-965	bilateral	_	
7-30	966-972	dorsal	_	
7-31	973-981	anterior	_	
7-32	982-991	cingulate	_	
7-33	992-998	cortex	_	
7-34	998-999	.	_	

#Text=In whole-brain linear regression of error responses against the Alcohol Use Disorder Identification Test (AUDIT) score, a wide swath of cortical and subcortical regions, including the thalamus, showed decreased activation in association with problem drinking in women but not in men.
8-1	1000-1002	In	_	
8-2	1003-1014	whole-brain	_	
8-3	1015-1021	linear	_	
8-4	1022-1032	regression	_	
8-5	1033-1035	of	_	
8-6	1036-1041	error	_	
8-7	1042-1051	responses	_	
8-8	1052-1059	against	_	
8-9	1060-1063	the	_	
8-10	1064-1071	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-11	1072-1075	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-12	1076-1084	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-13	1085-1099	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-14	1100-1104	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-15	1105-1106	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-16	1106-1111	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-17	1111-1112	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[4]	
8-18	1113-1118	score	_	
8-19	1118-1119	,	_	
8-20	1120-1121	a	_	
8-21	1122-1126	wide	_	
8-22	1127-1132	swath	_	
8-23	1133-1135	of	_	
8-24	1136-1144	cortical	_	
8-25	1145-1148	and	_	
8-26	1149-1160	subcortical	_	
8-27	1161-1168	regions	_	
8-28	1168-1169	,	_	
8-29	1170-1179	including	_	
8-30	1180-1183	the	_	
8-31	1184-1192	thalamus	_	
8-32	1192-1193	,	_	
8-33	1194-1200	showed	_	
8-34	1201-1210	decreased	_	
8-35	1211-1221	activation	_	
8-36	1222-1224	in	_	
8-37	1225-1236	association	_	
8-38	1237-1241	with	_	
8-39	1242-1249	problem	_	
8-40	1250-1258	drinking	_	
8-41	1259-1261	in	_	
8-42	1262-1267	women	_	
8-43	1268-1271	but	_	
8-44	1272-1275	not	_	
8-45	1276-1278	in	_	
8-46	1279-1282	men	_	
8-47	1282-1283	.	_	

#Text=However, men and women were not different in the extent of post-error slowing (PES) and decreased thalamic error response in association with problem drinking was not related to the extent of PES in women.
9-1	1284-1291	However	_	
9-2	1291-1292	,	_	
9-3	1293-1296	men	_	
9-4	1297-1300	and	_	
9-5	1301-1306	women	_	
9-6	1307-1311	were	_	
9-7	1312-1315	not	_	
9-8	1316-1325	different	_	
9-9	1326-1328	in	_	
9-10	1329-1332	the	_	
9-11	1333-1339	extent	_	
9-12	1340-1342	of	_	
9-13	1343-1353	post-error	_	
9-14	1354-1361	slowing	_	
9-15	1362-1363	(	_	
9-16	1363-1366	PES	_	
9-17	1366-1367	)	_	
9-18	1368-1371	and	_	
9-19	1372-1381	decreased	_	
9-20	1382-1390	thalamic	_	
9-21	1391-1396	error	_	
9-22	1397-1405	response	_	
9-23	1406-1408	in	_	
9-24	1409-1420	association	_	
9-25	1421-1425	with	_	
9-26	1426-1433	problem	_	
9-27	1434-1442	drinking	_	
9-28	1443-1446	was	_	
9-29	1447-1450	not	_	
9-30	1451-1458	related	_	
9-31	1459-1461	to	_	
9-32	1462-1465	the	_	
9-33	1466-1472	extent	_	
9-34	1473-1475	of	_	
9-35	1476-1479	PES	_	
9-36	1480-1482	in	_	
9-37	1483-1488	women	_	
9-38	1488-1489	.	_	

#Text=Conclusions
#Text=The results suggest sex differences in error-related activations with heavier drinking associated with reduced error activations in women but not in men.
10-1	1490-1501	Conclusions	_	
10-2	1502-1505	The	_	
10-3	1506-1513	results	_	
10-4	1514-1521	suggest	_	
10-5	1522-1525	sex	_	
10-6	1526-1537	differences	_	
10-7	1538-1540	in	_	
10-8	1541-1554	error-related	_	
10-9	1555-1566	activations	_	
10-10	1567-1571	with	_	
10-11	1572-1579	heavier	_	
10-12	1580-1588	drinking	_	
10-13	1589-1599	associated	_	
10-14	1600-1604	with	_	
10-15	1605-1612	reduced	_	
10-16	1613-1618	error	_	
10-17	1619-1630	activations	_	
10-18	1631-1633	in	_	
10-19	1634-1639	women	_	
10-20	1640-1643	but	_	
10-21	1644-1647	not	_	
10-22	1648-1650	in	_	
10-23	1651-1654	men	_	
10-24	1654-1655	.	_	

#Text=These differences in cerebral activations may reflect higher physiological arousal in response to errors and greater vulnerability of saliency-related arousal response to problem drinking in female as compared to male social drinkers.
#Text=1.
11-1	1656-1661	These	_	
11-2	1662-1673	differences	_	
11-3	1674-1676	in	_	
11-4	1677-1685	cerebral	_	
11-5	1686-1697	activations	_	
11-6	1698-1701	may	_	
11-7	1702-1709	reflect	_	
11-8	1710-1716	higher	_	
11-9	1717-1730	physiological	_	
11-10	1731-1738	arousal	_	
11-11	1739-1741	in	_	
11-12	1742-1750	response	_	
11-13	1751-1753	to	_	
11-14	1754-1760	errors	_	
11-15	1761-1764	and	_	
11-16	1765-1772	greater	_	
11-17	1773-1786	vulnerability	_	
11-18	1787-1789	of	_	
11-19	1790-1806	saliency-related	_	
11-20	1807-1814	arousal	_	
11-21	1815-1823	response	_	
11-22	1824-1826	to	_	
11-23	1827-1834	problem	_	
11-24	1835-1843	drinking	_	
11-25	1844-1846	in	_	
11-26	1847-1853	female	_	
11-27	1854-1856	as	_	
11-28	1857-1865	compared	_	
11-29	1866-1868	to	_	
11-30	1869-1873	male	_	
11-31	1874-1880	social	_	
11-32	1881-1889	drinkers	_	
11-33	1889-1890	.	_	
11-34	1891-1892	1	_	
11-35	1892-1893	.	_	

#Text=Introduction
#Text=Error-related cerebral and behavioral responses are an important phenotype of various neuropsychiatric conditions including substance use disorders.
12-1	1894-1906	Introduction	_	
12-2	1907-1920	Error-related	_	
12-3	1921-1929	cerebral	_	
12-4	1930-1933	and	_	
12-5	1934-1944	behavioral	_	
12-6	1945-1954	responses	_	
12-7	1955-1958	are	_	
12-8	1959-1961	an	_	
12-9	1962-1971	important	_	
12-10	1972-1981	phenotype	_	
12-11	1982-1984	of	_	
12-12	1985-1992	various	_	
12-13	1993-2009	neuropsychiatric	_	
12-14	2010-2020	conditions	_	
12-15	2021-2030	including	_	
12-16	2031-2040	substance	_	
12-17	2041-2044	use	_	
12-18	2045-2054	disorders	_	
12-19	2054-2055	.	_	

#Text=Compared with non-drug users, chronic cannabis users showed diminished error-correcting behavior and error response in the dorsal anterior cingulate cortex and left hippocampus in a paired associative learning task.
13-1	2056-2064	Compared	_	
13-2	2065-2069	with	_	
13-3	2070-2078	non-drug	_	
13-4	2079-2084	users	_	
13-5	2084-2085	,	_	
13-6	2086-2093	chronic	_	
13-7	2094-2102	cannabis	_	
13-8	2103-2108	users	_	
13-9	2109-2115	showed	_	
13-10	2116-2126	diminished	_	
13-11	2127-2143	error-correcting	_	
13-12	2144-2152	behavior	_	
13-13	2153-2156	and	_	
13-14	2157-2162	error	_	
13-15	2163-2171	response	_	
13-16	2172-2174	in	_	
13-17	2175-2178	the	_	
13-18	2179-2185	dorsal	_	
13-19	2186-2194	anterior	_	
13-20	2195-2204	cingulate	_	
13-21	2205-2211	cortex	_	
13-22	2212-2215	and	_	
13-23	2216-2220	left	_	
13-24	2221-2232	hippocampus	_	
13-25	2233-2235	in	_	
13-26	2236-2237	a	_	
13-27	2238-2244	paired	_	
13-28	2245-2256	associative	_	
13-29	2257-2265	learning	_	
13-30	2266-2270	task	_	
13-31	2270-2271	.	_	

#Text=Similar findings were also documented for cocaine addicted individuals in behavioral paradigms of response inhibition.
14-1	2272-2279	Similar	_	
14-2	2280-2288	findings	_	
14-3	2289-2293	were	_	
14-4	2294-2298	also	_	
14-5	2299-2309	documented	_	
14-6	2310-2313	for	_	
14-7	2314-2321	cocaine	_	
14-8	2322-2330	addicted	_	
14-9	2331-2342	individuals	_	
14-10	2343-2345	in	_	
14-11	2346-2356	behavioral	_	
14-12	2357-2366	paradigms	_	
14-13	2367-2369	of	_	
14-14	2370-2378	response	_	
14-15	2379-2389	inhibition	_	
14-16	2389-2390	.	_	

#Text=Blunted left middle frontal cortical activations to commission errors in a go/no-go task predicted early substance use in adolescents.
15-1	2391-2398	Blunted	_	
15-2	2399-2403	left	_	
15-3	2404-2410	middle	_	
15-4	2411-2418	frontal	_	
15-5	2419-2427	cortical	_	
15-6	2428-2439	activations	_	
15-7	2440-2442	to	_	
15-8	2443-2453	commission	_	
15-9	2454-2460	errors	_	
15-10	2461-2463	in	_	
15-11	2464-2465	a	_	
15-12	2466-2468	go	_	
15-13	2468-2469	/	_	
15-14	2469-2474	no-go	_	
15-15	2475-2479	task	_	
15-16	2480-2489	predicted	_	
15-17	2490-2495	early	_	
15-18	2496-2505	substance	_	
15-19	2506-2509	use	_	
15-20	2510-2512	in	_	
15-21	2513-2524	adolescents	_	
15-22	2524-2525	.	_	

#Text=Together, these findings associate deficient error monitoring and error-related behavioral adjustment with substance misuse.
16-1	2526-2534	Together	_	
16-2	2534-2535	,	_	
16-3	2536-2541	these	_	
16-4	2542-2550	findings	_	
16-5	2551-2560	associate	_	
16-6	2561-2570	deficient	_	
16-7	2571-2576	error	_	
16-8	2577-2587	monitoring	_	
16-9	2588-2591	and	_	
16-10	2592-2605	error-related	_	
16-11	2606-2616	behavioral	_	
16-12	2617-2627	adjustment	_	
16-13	2628-2632	with	_	
16-14	2633-2642	substance	_	
16-15	2643-2649	misuse	_	
16-16	2649-2650	.	_	

#Text=Whereas the findings on illicit substance users appear to be largely consistent, the literature is mixed for alcohol misuse.
17-1	2651-2658	Whereas	_	
17-2	2659-2662	the	_	
17-3	2663-2671	findings	_	
17-4	2672-2674	on	_	
17-5	2675-2682	illicit	_	
17-6	2683-2692	substance	_	
17-7	2693-2698	users	_	
17-8	2699-2705	appear	_	
17-9	2706-2708	to	_	
17-10	2709-2711	be	_	
17-11	2712-2719	largely	_	
17-12	2720-2730	consistent	_	
17-13	2730-2731	,	_	
17-14	2732-2735	the	_	
17-15	2736-2746	literature	_	
17-16	2747-2749	is	_	
17-17	2750-2755	mixed	_	
17-18	2756-2759	for	_	
17-19	2760-2767	alcohol	_	
17-20	2768-2774	misuse	_	
17-21	2774-2775	.	_	

#Text=For instance, regional activations to no-go errors distinguished heavy and light non-dependent drinkers, each engaging predominantly visually-driven emotional and task control neural networks.
18-1	2776-2779	For	_	
18-2	2780-2788	instance	_	
18-3	2788-2789	,	_	
18-4	2790-2798	regional	_	
18-5	2799-2810	activations	_	
18-6	2811-2813	to	_	
18-7	2814-2819	no-go	_	
18-8	2820-2826	errors	_	
18-9	2827-2840	distinguished	_	
18-10	2841-2846	heavy	_	
18-11	2847-2850	and	_	
18-12	2851-2856	light	_	
18-13	2857-2870	non-dependent	_	
18-14	2871-2879	drinkers	_	
18-15	2879-2880	,	_	
18-16	2881-2885	each	_	
18-17	2886-2894	engaging	_	
18-18	2895-2908	predominantly	_	
18-19	2909-2924	visually-driven	_	
18-20	2925-2934	emotional	_	
18-21	2935-2938	and	_	
18-22	2939-2943	task	_	
18-23	2944-2951	control	_	
18-24	2952-2958	neural	_	
18-25	2959-2967	networks	_	
18-26	2967-2968	.	_	

#Text=Alcohol dependence and higher alcohol consumption is associated with less post-error behavioral adjustment in a stop signal task.
19-1	2969-2976	Alcohol	_	
19-2	2977-2987	dependence	_	
19-3	2988-2991	and	_	
19-4	2992-2998	higher	_	
19-5	2999-3006	alcohol	_	
19-6	3007-3018	consumption	_	
19-7	3019-3021	is	_	
19-8	3022-3032	associated	_	
19-9	3033-3037	with	_	
19-10	3038-3042	less	_	
19-11	3043-3053	post-error	_	
19-12	3054-3064	behavioral	_	
19-13	3065-3075	adjustment	_	
19-14	3076-3078	in	_	
19-15	3079-3080	a	_	
19-16	3081-3085	stop	_	
19-17	3086-3092	signal	_	
19-18	3093-3097	task	_	
19-19	3097-3098	.	_	

#Text=In contrast, some studies failed to identify differences in error-related brain response or in post-error behavioral adjustment in heavy as compared to light drinkers.
20-1	3099-3101	In	_	
20-2	3102-3110	contrast	_	
20-3	3110-3111	,	_	
20-4	3112-3116	some	_	
20-5	3117-3124	studies	_	
20-6	3125-3131	failed	_	
20-7	3132-3134	to	_	
20-8	3135-3143	identify	_	
20-9	3144-3155	differences	_	
20-10	3156-3158	in	_	
20-11	3159-3172	error-related	_	
20-12	3173-3178	brain	_	
20-13	3179-3187	response	_	
20-14	3188-3190	or	_	
20-15	3191-3193	in	_	
20-16	3194-3204	post-error	_	
20-17	3205-3215	behavioral	_	
20-18	3216-3226	adjustment	_	
20-19	3227-3229	in	_	
20-20	3230-3235	heavy	_	
20-21	3236-3238	as	_	
20-22	3239-3247	compared	_	
20-23	3248-3250	to	_	
20-24	3251-3256	light	_	
20-25	3257-3265	drinkers	_	
20-26	3265-3266	.	_	

#Text=In fact, alcohol dependent individuals appeared to demonstrate higher error-related responses as compared to controls.
21-1	3267-3269	In	_	
21-2	3270-3274	fact	_	
21-3	3274-3275	,	_	
21-4	3276-3283	alcohol	_	
21-5	3284-3293	dependent	_	
21-6	3294-3305	individuals	_	
21-7	3306-3314	appeared	_	
21-8	3315-3317	to	_	
21-9	3318-3329	demonstrate	_	
21-10	3330-3336	higher	_	
21-11	3337-3350	error-related	_	
21-12	3351-3360	responses	_	
21-13	3361-3363	as	_	
21-14	3364-3372	compared	_	
21-15	3373-3375	to	_	
21-16	3376-3384	controls	_	
21-17	3384-3385	.	_	

#Text=An earlier review highlighted the complexity in employing interference control as a cognitive phenotype as a severity marker of alcohol misuse, with many studies revealing negative findings.
22-1	3386-3388	An	_	
22-2	3389-3396	earlier	_	
22-3	3397-3403	review	_	
22-4	3404-3415	highlighted	_	
22-5	3416-3419	the	_	
22-6	3420-3430	complexity	_	
22-7	3431-3433	in	_	
22-8	3434-3443	employing	_	
22-9	3444-3456	interference	_	
22-10	3457-3464	control	_	
22-11	3465-3467	as	_	
22-12	3468-3469	a	_	
22-13	3470-3479	cognitive	_	
22-14	3480-3489	phenotype	_	
22-15	3490-3492	as	_	
22-16	3493-3494	a	_	
22-17	3495-3503	severity	_	
22-18	3504-3510	marker	_	
22-19	3511-3513	of	_	
22-20	3514-3521	alcohol	_	
22-21	3522-3528	misuse	_	
22-22	3528-3529	,	_	
22-23	3530-3534	with	_	
22-24	3535-3539	many	_	
22-25	3540-3547	studies	_	
22-26	3548-3557	revealing	_	
22-27	3558-3566	negative	_	
22-28	3567-3575	findings	_	
22-29	3575-3576	.	_	

#Text=However, what exactly accounted for the discrepancy in findings remained unclear.
23-1	3577-3584	However	_	
23-2	3584-3585	,	_	
23-3	3586-3590	what	_	
23-4	3591-3598	exactly	_	
23-5	3599-3608	accounted	_	
23-6	3609-3612	for	_	
23-7	3613-3616	the	_	
23-8	3617-3628	discrepancy	_	
23-9	3629-3631	in	_	
23-10	3632-3640	findings	_	
23-11	3641-3649	remained	_	
23-12	3650-3657	unclear	_	
23-13	3657-3658	.	_	

#Text=In particular, sex differences were often not considered in these studies.
24-1	3659-3661	In	_	
24-2	3662-3672	particular	_	
24-3	3672-3673	,	_	
24-4	3674-3677	sex	_	
24-5	3678-3689	differences	_	
24-6	3690-3694	were	_	
24-7	3695-3700	often	_	
24-8	3701-3704	not	_	
24-9	3705-3715	considered	_	
24-10	3716-3718	in	_	
24-11	3719-3724	these	_	
24-12	3725-3732	studies	_	
24-13	3732-3733	.	_	

#Text=Men and women demonstrate important differences in their drug and alcohol use behaviors, clinical profiles of substance and alcohol use disorders as well as the risk factors and consequences of problem drinking.
25-1	3734-3737	Men	_	
25-2	3738-3741	and	_	
25-3	3742-3747	women	_	
25-4	3748-3759	demonstrate	_	
25-5	3760-3769	important	_	
25-6	3770-3781	differences	_	
25-7	3782-3784	in	_	
25-8	3785-3790	their	_	
25-9	3791-3795	drug	_	
25-10	3796-3799	and	_	
25-11	3800-3807	alcohol	_	
25-12	3808-3811	use	_	
25-13	3812-3821	behaviors	_	
25-14	3821-3822	,	_	
25-15	3823-3831	clinical	_	
25-16	3832-3840	profiles	_	
25-17	3841-3843	of	_	
25-18	3844-3853	substance	_	
25-19	3854-3857	and	_	
25-20	3858-3865	alcohol	_	
25-21	3866-3869	use	_	
25-22	3870-3879	disorders	_	
25-23	3880-3882	as	_	
25-24	3883-3887	well	_	
25-25	3888-3890	as	_	
25-26	3891-3894	the	_	
25-27	3895-3899	risk	_	
25-28	3900-3907	factors	_	
25-29	3908-3911	and	_	
25-30	3912-3924	consequences	_	
25-31	3925-3927	of	_	
25-32	3928-3935	problem	_	
25-33	3936-3944	drinking	_	
25-34	3944-3945	.	_	

#Text=The biological bases of these sex differences have been a focus of active research and studies of brain imaging aimed to understand how men and women respond differently to psychological challenges of importance to habitual drug and alcohol use.
26-1	3946-3949	The	_	
26-2	3950-3960	biological	_	
26-3	3961-3966	bases	_	
26-4	3967-3969	of	_	
26-5	3970-3975	these	_	
26-6	3976-3979	sex	_	
26-7	3980-3991	differences	_	
26-8	3992-3996	have	_	
26-9	3997-4001	been	_	
26-10	4002-4003	a	_	
26-11	4004-4009	focus	_	
26-12	4010-4012	of	_	
26-13	4013-4019	active	_	
26-14	4020-4028	research	_	
26-15	4029-4032	and	_	
26-16	4033-4040	studies	_	
26-17	4041-4043	of	_	
26-18	4044-4049	brain	_	
26-19	4050-4057	imaging	_	
26-20	4058-4063	aimed	_	
26-21	4064-4066	to	_	
26-22	4067-4077	understand	_	
26-23	4078-4081	how	_	
26-24	4082-4085	men	_	
26-25	4086-4089	and	_	
26-26	4090-4095	women	_	
26-27	4096-4103	respond	_	
26-28	4104-4115	differently	_	
26-29	4116-4118	to	_	
26-30	4119-4132	psychological	_	
26-31	4133-4143	challenges	_	
26-32	4144-4146	of	_	
26-33	4147-4157	importance	_	
26-34	4158-4160	to	_	
26-35	4161-4169	habitual	_	
26-36	4170-4174	drug	_	
26-37	4175-4178	and	_	
26-38	4179-4186	alcohol	_	
26-39	4187-4190	use	_	
26-40	4190-4191	.	_	

#Text=For instance, stress may precipitate drug and alcohol use via distinct neural processes in men and women, with women more vulnerable to the influence of negative affect and stress.
27-1	4192-4195	For	_	
27-2	4196-4204	instance	_	
27-3	4204-4205	,	_	
27-4	4206-4212	stress	_	
27-5	4213-4216	may	_	
27-6	4217-4228	precipitate	_	
27-7	4229-4233	drug	_	
27-8	4234-4237	and	_	
27-9	4238-4245	alcohol	_	
27-10	4246-4249	use	_	
27-11	4250-4253	via	_	
27-12	4254-4262	distinct	_	
27-13	4263-4269	neural	_	
27-14	4270-4279	processes	_	
27-15	4280-4282	in	_	
27-16	4283-4286	men	_	
27-17	4287-4290	and	_	
27-18	4291-4296	women	_	
27-19	4296-4297	,	_	
27-20	4298-4302	with	_	
27-21	4303-4308	women	_	
27-22	4309-4313	more	_	
27-23	4314-4324	vulnerable	_	
27-24	4325-4327	to	_	
27-25	4328-4331	the	_	
27-26	4332-4341	influence	_	
27-27	4342-4344	of	_	
27-28	4345-4353	negative	_	
27-29	4354-4360	affect	_	
27-30	4361-4364	and	_	
27-31	4365-4371	stress	_	
27-32	4371-4372	.	_	

#Text=In support, stress induced by personalized guided imagery elicited sex-specific cerebral responses.
28-1	4373-4375	In	_	
28-2	4376-4383	support	_	
28-3	4383-4384	,	_	
28-4	4385-4391	stress	_	
28-5	4392-4399	induced	_	
28-6	4400-4402	by	_	
28-7	4403-4415	personalized	_	
28-8	4416-4422	guided	_	
28-9	4423-4430	imagery	_	
28-10	4431-4439	elicited	_	
28-11	4440-4452	sex-specific	_	
28-12	4453-4461	cerebral	_	
28-13	4462-4471	responses	_	
28-14	4471-4472	.	_	

#Text=More broadly, men and women engaged distinct neural circuits in affective processing; women but not men showed correlated activations of bilateral caudate head and left thalamus during experience of social conflicts, a potential risk factor for problem drinking.
29-1	4473-4477	More	_	
29-2	4478-4485	broadly	_	
29-3	4485-4486	,	_	
29-4	4487-4490	men	_	
29-5	4491-4494	and	_	
29-6	4495-4500	women	_	
29-7	4501-4508	engaged	_	
29-8	4509-4517	distinct	_	
29-9	4518-4524	neural	_	
29-10	4525-4533	circuits	_	
29-11	4534-4536	in	_	
29-12	4537-4546	affective	_	
29-13	4547-4557	processing	_	
29-14	4557-4558	;	_	
29-15	4559-4564	women	_	
29-16	4565-4568	but	_	
29-17	4569-4572	not	_	
29-18	4573-4576	men	_	
29-19	4577-4583	showed	_	
29-20	4584-4594	correlated	_	
29-21	4595-4606	activations	_	
29-22	4607-4609	of	_	
29-23	4610-4619	bilateral	_	
29-24	4620-4627	caudate	_	
29-25	4628-4632	head	_	
29-26	4633-4636	and	_	
29-27	4637-4641	left	_	
29-28	4642-4650	thalamus	_	
29-29	4651-4657	during	_	
29-30	4658-4668	experience	_	
29-31	4669-4671	of	_	
29-32	4672-4678	social	_	
29-33	4679-4688	conflicts	_	
29-34	4688-4689	,	_	
29-35	4690-4691	a	_	
29-36	4692-4701	potential	_	
29-37	4702-4706	risk	_	
29-38	4707-4713	factor	_	
29-39	4714-4717	for	_	
29-40	4718-4725	problem	_	
29-41	4726-4734	drinking	_	
29-42	4734-4735	.	_	

#Text=Of direct relevance to the current study, men and women exhibited differences in error-related responses, with women showing higher electrophysiological or blood oxygenation level dependent (BOLD) responses to errors as compared to men.
30-1	4736-4738	Of	_	
30-2	4739-4745	direct	_	
30-3	4746-4755	relevance	_	
30-4	4756-4758	to	_	
30-5	4759-4762	the	_	
30-6	4763-4770	current	_	
30-7	4771-4776	study	_	
30-8	4776-4777	,	_	
30-9	4778-4781	men	_	
30-10	4782-4785	and	_	
30-11	4786-4791	women	_	
30-12	4792-4801	exhibited	_	
30-13	4802-4813	differences	_	
30-14	4814-4816	in	_	
30-15	4817-4830	error-related	_	
30-16	4831-4840	responses	_	
30-17	4840-4841	,	_	
30-18	4842-4846	with	_	
30-19	4847-4852	women	_	
30-20	4853-4860	showing	_	
30-21	4861-4867	higher	_	
30-22	4868-4888	electrophysiological	_	
30-23	4889-4891	or	_	
30-24	4892-4897	blood	_	
30-25	4898-4909	oxygenation	_	
30-26	4910-4915	level	_	
30-27	4916-4925	dependent	_	
30-28	4926-4927	(	_	
30-29	4927-4931	BOLD	_	
30-30	4931-4932	)	_	
30-31	4933-4942	responses	_	
30-32	4943-4945	to	_	
30-33	4946-4952	errors	_	
30-34	4953-4955	as	_	
30-35	4956-4964	compared	_	
30-36	4965-4967	to	_	
30-37	4968-4971	men	_	
30-38	4971-4972	.	_	

#Text=On the other hand, men and women did not appear to differ in the extent of post-error behavioral control.
31-1	4973-4975	On	_	
31-2	4976-4979	the	_	
31-3	4980-4985	other	_	
31-4	4986-4990	hand	_	
31-5	4990-4991	,	_	
31-6	4992-4995	men	_	
31-7	4996-4999	and	_	
31-8	5000-5005	women	_	
31-9	5006-5009	did	_	
31-10	5010-5013	not	_	
31-11	5014-5020	appear	_	
31-12	5021-5023	to	_	
31-13	5024-5030	differ	_	
31-14	5031-5033	in	_	
31-15	5034-5037	the	_	
31-16	5038-5044	extent	_	
31-17	5045-5047	of	_	
31-18	5048-5058	post-error	_	
31-19	5059-5069	behavioral	_	
31-20	5070-5077	control	_	
31-21	5077-5078	.	_	

#Text=Thus, error-related responses may relate to problem drinking differently in men and women but whether these differences manifest in altered post-error behavioral control remains an open question.
32-1	5079-5083	Thus	_	
32-2	5083-5084	,	_	
32-3	5085-5098	error-related	_	
32-4	5099-5108	responses	_	
32-5	5109-5112	may	_	
32-6	5113-5119	relate	_	
32-7	5120-5122	to	_	
32-8	5123-5130	problem	_	
32-9	5131-5139	drinking	_	
32-10	5140-5151	differently	_	
32-11	5152-5154	in	_	
32-12	5155-5158	men	_	
32-13	5159-5162	and	_	
32-14	5163-5168	women	_	
32-15	5169-5172	but	_	
32-16	5173-5180	whether	_	
32-17	5181-5186	these	_	
32-18	5187-5198	differences	_	
32-19	5199-5207	manifest	_	
32-20	5208-5210	in	_	
32-21	5211-5218	altered	_	
32-22	5219-5229	post-error	_	
32-23	5230-5240	behavioral	_	
32-24	5241-5248	control	_	
32-25	5249-5256	remains	_	
32-26	5257-5259	an	_	
32-27	5260-5264	open	_	
32-28	5265-5273	question	_	
32-29	5273-5274	.	_	

#Text=In the current study, we investigated how problem drinking is associated with error-related cerebral responses and whether men and women differ in error-related response, and in its association with problem drinking and deficits in cognitive control.
33-1	5275-5277	In	_	
33-2	5278-5281	the	_	
33-3	5282-5289	current	_	
33-4	5290-5295	study	_	
33-5	5295-5296	,	_	
33-6	5297-5299	we	_	
33-7	5300-5312	investigated	_	
33-8	5313-5316	how	_	
33-9	5317-5324	problem	_	
33-10	5325-5333	drinking	_	
33-11	5334-5336	is	_	
33-12	5337-5347	associated	_	
33-13	5348-5352	with	_	
33-14	5353-5366	error-related	_	
33-15	5367-5375	cerebral	_	
33-16	5376-5385	responses	_	
33-17	5386-5389	and	_	
33-18	5390-5397	whether	_	
33-19	5398-5401	men	_	
33-20	5402-5405	and	_	
33-21	5406-5411	women	_	
33-22	5412-5418	differ	_	
33-23	5419-5421	in	_	
33-24	5422-5435	error-related	_	
33-25	5436-5444	response	_	
33-26	5444-5445	,	_	
33-27	5446-5449	and	_	
33-28	5450-5452	in	_	
33-29	5453-5456	its	_	
33-30	5457-5468	association	_	
33-31	5469-5473	with	_	
33-32	5474-5481	problem	_	
33-33	5482-5490	drinking	_	
33-34	5491-5494	and	_	
33-35	5495-5503	deficits	_	
33-36	5504-5506	in	_	
33-37	5507-5516	cognitive	_	
33-38	5517-5524	control	_	
33-39	5524-5525	.	_	

#Text=We combined fMRI and the stop signal task (SST) to address these questions.
34-1	5526-5528	We	_	
34-2	5529-5537	combined	_	
34-3	5538-5542	fMRI	_	
34-4	5543-5546	and	_	
34-5	5547-5550	the	_	
34-6	5551-5555	stop	_	
34-7	5556-5562	signal	_	
34-8	5563-5567	task	_	
34-9	5568-5569	(	_	
34-10	5569-5572	SST	_	
34-11	5572-5573	)	_	
34-12	5574-5576	to	_	
34-13	5577-5584	address	_	
34-14	5585-5590	these	_	
34-15	5591-5600	questions	_	
34-16	5600-5601	.	_	

#Text=In the SST participants are required to respond to a frequent go signal and withhold response to an occasional stop signal.
35-1	5602-5604	In	_	
35-2	5605-5608	the	_	
35-3	5609-5612	SST	_	
35-4	5613-5625	participants	_	
35-5	5626-5629	are	_	
35-6	5630-5638	required	_	
35-7	5639-5641	to	_	
35-8	5642-5649	respond	_	
35-9	5650-5652	to	_	
35-10	5653-5654	a	_	
35-11	5655-5663	frequent	_	
35-12	5664-5666	go	_	
35-13	5667-5673	signal	_	
35-14	5674-5677	and	_	
35-15	5678-5686	withhold	_	
35-16	5687-5695	response	_	
35-17	5696-5698	to	_	
35-18	5699-5701	an	_	
35-19	5702-5712	occasional	_	
35-20	5713-5717	stop	_	
35-21	5718-5724	signal	_	
35-22	5724-5725	.	_	

#Text=Participants showed higher skin conductance response, reflecting higher physiological arousal, to stop error as compared to both go and stop success trials.
36-1	5726-5738	Participants	_	
36-2	5739-5745	showed	_	
36-3	5746-5752	higher	_	
36-4	5753-5757	skin	_	
36-5	5758-5769	conductance	_	
36-6	5770-5778	response	_	
36-7	5778-5779	,	_	
36-8	5780-5790	reflecting	_	
36-9	5791-5797	higher	_	
36-10	5798-5811	physiological	_	
36-11	5812-5819	arousal	_	
36-12	5819-5820	,	_	
36-13	5821-5823	to	_	
36-14	5824-5828	stop	_	
36-15	5829-5834	error	_	
36-16	5835-5837	as	_	
36-17	5838-5846	compared	_	
36-18	5847-5849	to	_	
36-19	5850-5854	both	_	
36-20	5855-5857	go	_	
36-21	5858-5861	and	_	
36-22	5862-5866	stop	_	
36-23	5867-5874	success	_	
36-24	5875-5881	trials	_	
36-25	5881-5882	.	_	

#Text=Further, participants typically slowed down in response in go trials following a stop error trial as compared to those following another go trial.
37-1	5883-5890	Further	_	
37-2	5890-5891	,	_	
37-3	5892-5904	participants	_	
37-4	5905-5914	typically	_	
37-5	5915-5921	slowed	_	
37-6	5922-5926	down	_	
37-7	5927-5929	in	_	
37-8	5930-5938	response	_	
37-9	5939-5941	in	_	
37-10	5942-5944	go	_	
37-11	5945-5951	trials	_	
37-12	5952-5961	following	_	
37-13	5962-5963	a	_	
37-14	5964-5968	stop	_	
37-15	5969-5974	error	_	
37-16	5975-5980	trial	_	
37-17	5981-5983	as	_	
37-18	5984-5992	compared	_	
37-19	5993-5995	to	_	
37-20	5996-6001	those	_	
37-21	6002-6011	following	_	
37-22	6012-6019	another	_	
37-23	6020-6022	go	_	
37-24	6023-6028	trial	_	
37-25	6028-6029	.	_	

#Text=Post-error slowing reflects behavioral adjustment, a critical component process of cognitive control frequently compromised in individuals with substance use disorders.
38-1	6030-6040	Post-error	_	
38-2	6041-6048	slowing	_	
38-3	6049-6057	reflects	_	
38-4	6058-6068	behavioral	_	
38-5	6069-6079	adjustment	_	
38-6	6079-6080	,	_	
38-7	6081-6082	a	_	
38-8	6083-6091	critical	_	
38-9	6092-6101	component	_	
38-10	6102-6109	process	_	
38-11	6110-6112	of	_	
38-12	6113-6122	cognitive	_	
38-13	6123-6130	control	_	
38-14	6131-6141	frequently	_	
38-15	6142-6153	compromised	_	
38-16	6154-6156	in	_	
38-17	6157-6168	individuals	_	
38-18	6169-6173	with	_	
38-19	6174-6183	substance	_	
38-20	6184-6187	use	_	
38-21	6188-6197	disorders	_	
38-22	6197-6198	.	_	

#Text=Thus, the SST would provide an opportunity to investigate whether error-related cerebral responses are associated with problem drinking and deficits in cognitive control.
#Text=2.
39-1	6199-6203	Thus	_	
39-2	6203-6204	,	_	
39-3	6205-6208	the	_	
39-4	6209-6212	SST	_	
39-5	6213-6218	would	_	
39-6	6219-6226	provide	_	
39-7	6227-6229	an	_	
39-8	6230-6241	opportunity	_	
39-9	6242-6244	to	_	
39-10	6245-6256	investigate	_	
39-11	6257-6264	whether	_	
39-12	6265-6278	error-related	_	
39-13	6279-6287	cerebral	_	
39-14	6288-6297	responses	_	
39-15	6298-6301	are	_	
39-16	6302-6312	associated	_	
39-17	6313-6317	with	_	
39-18	6318-6325	problem	_	
39-19	6326-6334	drinking	_	
39-20	6335-6338	and	_	
39-21	6339-6347	deficits	_	
39-22	6348-6350	in	_	
39-23	6351-6360	cognitive	_	
39-24	6361-6368	control	_	
39-25	6368-6369	.	_	
39-26	6370-6371	2	_	
39-27	6371-6372	.	_	

#Text=Methods
#Text=2.1 Subjects, Informed Consent, and Assessment
#Text=Study participants were recruited with newspaper and radio advertisements as well as flyers posted in the greater New Haven area.
40-1	6373-6380	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
40-2	6381-6384	2.1	_	
40-3	6385-6393	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-4	6393-6394	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-5	6395-6403	Informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-6	6404-6411	Consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-7	6411-6412	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-8	6413-6416	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-9	6417-6427	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-10	6428-6433	Study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-11	6434-6446	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-12	6447-6451	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-13	6452-6461	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-14	6462-6466	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-15	6467-6476	newspaper	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-16	6477-6480	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-17	6481-6486	radio	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-18	6487-6501	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-19	6502-6504	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-20	6505-6509	well	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-21	6510-6512	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-22	6513-6519	flyers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-23	6520-6526	posted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-24	6527-6529	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-25	6530-6533	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-26	6534-6541	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-27	6542-6545	New	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-28	6546-6551	Haven	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-29	6552-6556	area	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
40-30	6556-6557	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=All participants were free of major medical illness, past or present neurological and psychiatric illnesses including substance use disorders (SCID-I for DSM-IV), denied current use of illicit substance, and showed negative urine toxicology tests for stimulants, opioids, marijuana, and benzodiazepines at the time of MRI.
41-1	6558-6561	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-2	6562-6574	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-3	6575-6579	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-4	6580-6584	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-5	6585-6587	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-6	6588-6593	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-7	6594-6601	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-8	6602-6609	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-9	6609-6610	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-10	6611-6615	past	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-11	6616-6618	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-12	6619-6626	present	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-13	6627-6639	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-14	6640-6643	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-15	6644-6655	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-16	6656-6665	illnesses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-17	6666-6675	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-18	6676-6685	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[6]	
41-19	6686-6689	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[6]	
41-20	6690-6699	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder[6]	
41-21	6700-6701	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-22	6701-6707	SCID-I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-23	6708-6711	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-24	6712-6718	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-25	6718-6719	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-26	6719-6720	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-27	6721-6727	denied	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-28	6728-6735	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-29	6736-6739	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-30	6740-6742	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-31	6743-6750	illicit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-32	6751-6760	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-33	6760-6761	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-34	6762-6765	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-35	6766-6772	showed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-36	6773-6781	negative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-37	6782-6787	urine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-38	6788-6798	toxicology	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-39	6799-6804	tests	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-40	6805-6808	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-41	6809-6819	stimulants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-42	6819-6820	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-43	6821-6828	opioids	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-44	6828-6829	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-45	6830-6839	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-46	6839-6840	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-47	6841-6844	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-48	6845-6860	benzodiazepines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-49	6861-6863	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-50	6864-6867	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-51	6868-6872	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-52	6873-6875	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
41-53	6876-6879	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[7]	
41-54	6879-6880	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=Individuals who were using any psychotropic medications were not invited to participate in the study.
42-1	6881-6892	Individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-2	6893-6896	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-3	6897-6901	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-4	6902-6907	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-5	6908-6911	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-6	6912-6924	psychotropic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-7	6925-6936	medications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-8	6937-6941	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-9	6942-6945	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-10	6946-6953	invited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-11	6954-6956	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-12	6957-6968	participate	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-13	6969-6971	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-14	6972-6975	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-15	6976-6981	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
42-16	6981-6982	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=Pregnant or lactating women were also excluded.
43-1	6983-6991	Pregnant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-2	6992-6994	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-3	6995-7004	lactating	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-4	7005-7010	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-5	7011-7015	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-6	7016-7020	also	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-7	7021-7029	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-8	7029-7030	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=Participants were further required to be free of MRI-contraindications per Yale Magnetic Resonance Research Center's safety guidelines.
44-1	7031-7043	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-2	7044-7048	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-3	7049-7056	further	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-4	7057-7065	required	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-5	7066-7068	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-6	7069-7071	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-7	7072-7076	free	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-8	7077-7079	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-9	7080-7101	MRI-contraindications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-10	7102-7105	per	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-11	7106-7110	Yale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-12	7111-7119	Magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-13	7120-7129	Resonance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-14	7130-7138	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-15	7139-7147	Center's	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-16	7148-7154	safety	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-17	7155-7165	guidelines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
44-18	7165-7166	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=One hundred and forty-five social drinkers (77 women; age 31 ± 13 years; all right-handed) were included in this study.
45-1	7167-7170	One	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-2	7171-7178	hundred	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-3	7179-7182	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-4	7183-7193	forty-five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-5	7194-7200	social	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-6	7201-7209	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-7	7210-7211	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-8	7211-7213	77	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-9	7214-7219	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-10	7219-7220	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-11	7221-7224	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-12	7225-7227	31	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-13	7228-7229	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-14	7230-7232	13	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-15	7233-7238	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-16	7238-7239	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-17	7240-7243	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-18	7244-7256	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-19	7256-7257	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-20	7258-7262	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-21	7263-7271	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-22	7272-7274	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-23	7275-7279	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-24	7280-7285	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
45-25	7285-7286	.	_	

#Text=This cohort is a subsample of the 158 (86 women) social drinkers reported in our recent work, where 13 subjects participated in fMRI of a different behavioral task.
46-1	7287-7291	This	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-2	7292-7298	cohort	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-3	7299-7301	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-4	7302-7303	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-5	7304-7313	subsample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-6	7314-7316	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-7	7317-7320	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-8	7321-7324	158	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-9	7325-7326	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-10	7326-7328	86	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-11	7329-7334	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-12	7334-7335	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-13	7336-7342	social	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-14	7343-7351	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-15	7352-7360	reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-16	7361-7363	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-17	7364-7367	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-18	7368-7374	recent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-19	7375-7379	work	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-20	7379-7380	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-21	7381-7386	where	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-22	7387-7389	13	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-23	7390-7398	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-24	7399-7411	participated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-25	7412-7414	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-26	7415-7419	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[9]	
46-27	7420-7422	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-28	7423-7424	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-29	7425-7434	different	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-30	7435-7445	behavioral	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-31	7446-7450	task	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
46-32	7450-7451	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=All participants completed questionnaires regarding alcohol use over the past year, including average number of days of drinking and average number of drinks consumed per occasion, framed on a monthly basis, as well as the Alcohol Use Disorders Identification Test (AUDIT).
47-1	7452-7455	All	_	
47-2	7456-7468	participants	_	
47-3	7469-7478	completed	_	
47-4	7479-7493	questionnaires	_	
47-5	7494-7503	regarding	_	
47-6	7504-7511	alcohol	_	
47-7	7512-7515	use	_	
47-8	7516-7520	over	_	
47-9	7521-7524	the	_	
47-10	7525-7529	past	_	
47-11	7530-7534	year	_	
47-12	7534-7535	,	_	
47-13	7536-7545	including	_	
47-14	7546-7553	average	_	
47-15	7554-7560	number	_	
47-16	7561-7563	of	_	
47-17	7564-7568	days	_	
47-18	7569-7571	of	_	
47-19	7572-7580	drinking	_	
47-20	7581-7584	and	_	
47-21	7585-7592	average	_	
47-22	7593-7599	number	_	
47-23	7600-7602	of	_	
47-24	7603-7609	drinks	_	
47-25	7610-7618	consumed	_	
47-26	7619-7622	per	_	
47-27	7623-7631	occasion	_	
47-28	7631-7632	,	_	
47-29	7633-7639	framed	_	
47-30	7640-7642	on	_	
47-31	7643-7644	a	_	
47-32	7645-7652	monthly	_	
47-33	7653-7658	basis	_	
47-34	7658-7659	,	_	
47-35	7660-7662	as	_	
47-36	7663-7667	well	_	
47-37	7668-7670	as	_	
47-38	7671-7674	the	_	
47-39	7675-7682	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-40	7683-7686	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-41	7687-7696	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-42	7697-7711	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-43	7712-7716	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-44	7717-7718	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-45	7718-7723	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-46	7723-7724	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[10]	
47-47	7724-7725	.	_	

#Text=AUDIT score was calculated by summing subscores of ten self-report questions regarding level of alcohol use, alcohol-related problems, and concern expressed by others for one's drinking behavior.
48-1	7726-7731	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest	
48-2	7732-7737	score	_	
48-3	7738-7741	was	_	
48-4	7742-7752	calculated	_	
48-5	7753-7755	by	_	
48-6	7756-7763	summing	_	
48-7	7764-7773	subscores	_	
48-8	7774-7776	of	_	
48-9	7777-7780	ten	_	
48-10	7781-7792	self-report	_	
48-11	7793-7802	questions	_	
48-12	7803-7812	regarding	_	
48-13	7813-7818	level	_	
48-14	7819-7821	of	_	
48-15	7822-7829	alcohol	_	
48-16	7830-7833	use	_	
48-17	7833-7834	,	_	
48-18	7835-7850	alcohol-related	_	
48-19	7851-7859	problems	_	
48-20	7859-7860	,	_	
48-21	7861-7864	and	_	
48-22	7865-7872	concern	_	
48-23	7873-7882	expressed	_	
48-24	7883-7885	by	_	
48-25	7886-7892	others	_	
48-26	7893-7896	for	_	
48-27	7897-7902	one's	_	
48-28	7903-7911	drinking	_	
48-29	7912-7920	behavior	_	
48-30	7920-7921	.	_	

#Text=Each question receives a score ranging from 0 to 4, with higher numbers corresponding to a greater level of risk for having or developing an alcohol use disorder.
49-1	7922-7926	Each	_	
49-2	7927-7935	question	_	
49-3	7936-7944	receives	_	
49-4	7945-7946	a	_	
49-5	7947-7952	score	_	
49-6	7953-7960	ranging	_	
49-7	7961-7965	from	_	
49-8	7966-7967	0	_	
49-9	7968-7970	to	_	
49-10	7971-7972	4	_	
49-11	7972-7973	,	_	
49-12	7974-7978	with	_	
49-13	7979-7985	higher	_	
49-14	7986-7993	numbers	_	
49-15	7994-8007	corresponding	_	
49-16	8008-8010	to	_	
49-17	8011-8012	a	_	
49-18	8013-8020	greater	_	
49-19	8021-8026	level	_	
49-20	8027-8029	of	_	
49-21	8030-8034	risk	_	
49-22	8035-8038	for	_	
49-23	8039-8045	having	_	
49-24	8046-8048	or	_	
49-25	8049-8059	developing	_	
49-26	8060-8062	an	_	
49-27	8063-8070	alcohol	_	
49-28	8071-8074	use	_	
49-29	8075-8083	disorder	_	
49-30	8083-8084	.	_	

#Text=The mean (± SD) AUDIT score was 5.1 (± 4.2) across all subjects, in a range typical of non-dependent drinkers and significantly lower than those reported for alcohol dependent individuals.
50-1	8085-8088	The	_	
50-2	8089-8093	mean	_	
50-3	8094-8095	(	_	
50-4	8095-8096	±	_	
50-5	8097-8099	SD	_	
50-6	8099-8100	)	_	
50-7	8101-8106	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest	
50-8	8107-8112	score	_	
50-9	8113-8116	was	_	
50-10	8117-8120	5.1	_	
50-11	8121-8122	(	_	
50-12	8122-8123	±	_	
50-13	8124-8127	4.2	_	
50-14	8127-8128	)	_	
50-15	8129-8135	across	_	
50-16	8136-8139	all	_	
50-17	8140-8148	subjects	_	
50-18	8148-8149	,	_	
50-19	8150-8152	in	_	
50-20	8153-8154	a	_	
50-21	8155-8160	range	_	
50-22	8161-8168	typical	_	
50-23	8169-8171	of	_	
50-24	8172-8185	non-dependent	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[11]	
50-25	8186-8194	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#NondependentAlcoholAbuse[11]	
50-26	8195-8198	and	_	
50-27	8199-8212	significantly	_	
50-28	8213-8218	lower	_	
50-29	8219-8223	than	_	
50-30	8224-8229	those	_	
50-31	8230-8238	reported	_	
50-32	8239-8242	for	_	
50-33	8243-8250	alcohol	_	
50-34	8251-8260	dependent	_	
50-35	8261-8272	individuals	_	
50-36	8272-8273	.	_	

#Text=Participants were also assessed with the Barratt Impulsivity Scale (BIS-11) and Alcohol Expectancy Questionnaire (AEQ-3).
51-1	8274-8286	Participants	_	
51-2	8287-8291	were	_	
51-3	8292-8296	also	_	
51-4	8297-8305	assessed	_	
51-5	8306-8310	with	_	
51-6	8311-8314	the	_	
51-7	8315-8322	Barratt	_	
51-8	8323-8334	Impulsivity	_	
51-9	8335-8340	Scale	_	
51-10	8341-8342	(	_	
51-11	8342-8345	BIS	_	
51-12	8345-8346	-	_	
51-13	8346-8348	11	_	
51-14	8348-8349	)	_	
51-15	8350-8353	and	_	
51-16	8354-8361	Alcohol	_	
51-17	8362-8372	Expectancy	_	
51-18	8373-8386	Questionnaire	_	
51-19	8387-8388	(	_	
51-20	8388-8391	AEQ	_	
51-21	8391-8392	-	_	
51-22	8392-8393	3	_	
51-23	8393-8394	)	_	
51-24	8394-8395	.	_	

#Text=BIS-11 is a 30-item self-report questionnaire designed to measure impulsivity.
52-1	8396-8399	BIS	_	
52-2	8399-8400	-	_	
52-3	8400-8402	11	_	
52-4	8403-8405	is	_	
52-5	8406-8407	a	_	
52-6	8408-8410	30	_	
52-7	8410-8411	-	_	
52-8	8411-8415	item	_	
52-9	8416-8427	self-report	_	
52-10	8428-8441	questionnaire	_	
52-11	8442-8450	designed	_	
52-12	8451-8453	to	_	
52-13	8454-8461	measure	_	
52-14	8462-8473	impulsivity	_	
52-15	8473-8474	.	_	

#Text=All items are scored on a 4-point scale (1 = rarely/never; 2 = occasionally; 3 = often; 4 = almost always/always).
53-1	8475-8478	All	_	
53-2	8479-8484	items	_	
53-3	8485-8488	are	_	
53-4	8489-8495	scored	_	
53-5	8496-8498	on	_	
53-6	8499-8500	a	_	
53-7	8501-8502	4	_	
53-8	8502-8503	-	_	
53-9	8503-8508	point	_	
53-10	8509-8514	scale	_	
53-11	8515-8516	(	_	
53-12	8516-8517	1	_	
53-13	8518-8519	=	_	
53-14	8520-8526	rarely	_	
53-15	8526-8527	/	_	
53-16	8527-8532	never	_	
53-17	8532-8533	;	_	
53-18	8534-8535	2	_	
53-19	8536-8537	=	_	
53-20	8538-8550	occasionally	_	
53-21	8550-8551	;	_	
53-22	8552-8553	3	_	
53-23	8554-8555	=	_	
53-24	8556-8561	often	_	
53-25	8561-8562	;	_	
53-26	8563-8564	4	_	
53-27	8565-8566	=	_	
53-28	8567-8573	almost	_	
53-29	8574-8580	always	_	
53-30	8580-8581	/	_	
53-31	8581-8587	always	_	
53-32	8587-8588	)	_	
53-33	8588-8589	.	_	

#Text=The total score thus ranges from 30 to 120, with a higher score indicating higher impulsivity.
54-1	8590-8593	The	_	
54-2	8594-8599	total	_	
54-3	8600-8605	score	_	
54-4	8606-8610	thus	_	
54-5	8611-8617	ranges	_	
54-6	8618-8622	from	_	
54-7	8623-8625	30	_	
54-8	8626-8628	to	_	
54-9	8629-8632	120	_	
54-10	8632-8633	,	_	
54-11	8634-8638	with	_	
54-12	8639-8640	a	_	
54-13	8641-8647	higher	_	
54-14	8648-8653	score	_	
54-15	8654-8664	indicating	_	
54-16	8665-8671	higher	_	
54-17	8672-8683	impulsivity	_	
54-18	8683-8684	.	_	

#Text=Eleven of the 30 items are reverse scored to avoid response bias.
55-1	8685-8691	Eleven	_	
55-2	8692-8694	of	_	
55-3	8695-8698	the	_	
55-4	8699-8701	30	_	
55-5	8702-8707	items	_	
55-6	8708-8711	are	_	
55-7	8712-8719	reverse	_	
55-8	8720-8726	scored	_	
55-9	8727-8729	to	_	
55-10	8730-8735	avoid	_	
55-11	8736-8744	response	_	
55-12	8745-8749	bias	_	
55-13	8749-8750	.	_	

#Text=The AEQ-3 consisted of 40 items to address both positive (6 subscales) and negative (2 subscales) alcohol expectancy, confirmed by factor analysis and invariant across sex and race.
56-1	8751-8754	The	_	
56-2	8755-8758	AEQ	_	
56-3	8758-8759	-	_	
56-4	8759-8760	3	_	
56-5	8761-8770	consisted	_	
56-6	8771-8773	of	_	
56-7	8774-8776	40	_	
56-8	8777-8782	items	_	
56-9	8783-8785	to	_	
56-10	8786-8793	address	_	
56-11	8794-8798	both	_	
56-12	8799-8807	positive	_	
56-13	8808-8809	(	_	
56-14	8809-8810	6	_	
56-15	8811-8820	subscales	_	
56-16	8820-8821	)	_	
56-17	8822-8825	and	_	
56-18	8826-8834	negative	_	
56-19	8835-8836	(	_	
56-20	8836-8837	2	_	
56-21	8838-8847	subscales	_	
56-22	8847-8848	)	_	
56-23	8849-8856	alcohol	_	
56-24	8857-8867	expectancy	_	
56-25	8867-8868	,	_	
56-26	8869-8878	confirmed	_	
56-27	8879-8881	by	_	
56-28	8882-8888	factor	_	
56-29	8889-8897	analysis	_	
56-30	8898-8901	and	_	
56-31	8902-8911	invariant	_	
56-32	8912-8918	across	_	
56-33	8919-8922	sex	_	
56-34	8923-8926	and	_	
56-35	8927-8931	race	_	
56-36	8931-8932	.	_	

#Text=Each subscale contains 4 to 6 statements that can be endorsed on a six-point scale, from “disagree strongly ” to “agree strongly ”.
57-1	8933-8937	Each	_	
57-2	8938-8946	subscale	_	
57-3	8947-8955	contains	_	
57-4	8956-8957	4	_	
57-5	8958-8960	to	_	
57-6	8961-8962	6	_	
57-7	8963-8973	statements	_	
57-8	8974-8978	that	_	
57-9	8979-8982	can	_	
57-10	8983-8985	be	_	
57-11	8986-8994	endorsed	_	
57-12	8995-8997	on	_	
57-13	8998-8999	a	_	
57-14	9000-9009	six-point	_	
57-15	9010-9015	scale	_	
57-16	9015-9016	,	_	
57-17	9017-9021	from	_	
57-18	9022-9023	“	_	
57-19	9023-9031	disagree	_	
57-20	9032-9040	strongly	_	
57-21	9041-9042	”	_	
57-22	9043-9045	to	_	
57-23	9046-9047	“	_	
57-24	9047-9052	agree	_	
57-25	9053-9061	strongly	_	
57-26	9062-9063	”	_	
57-27	9063-9064	.	_	

#Text=Despite the 8 factors identified and confirmed with factor analysis, ratings on the 8 factors are highly correlated (George et al, 1995).
58-1	9065-9072	Despite	_	
58-2	9073-9076	the	_	
58-3	9077-9078	8	_	
58-4	9079-9086	factors	_	
58-5	9087-9097	identified	_	
58-6	9098-9101	and	_	
58-7	9102-9111	confirmed	_	
58-8	9112-9116	with	_	
58-9	9117-9123	factor	_	
58-10	9124-9132	analysis	_	
58-11	9132-9133	,	_	
58-12	9134-9141	ratings	_	
58-13	9142-9144	on	_	
58-14	9145-9148	the	_	
58-15	9149-9150	8	_	
58-16	9151-9158	factors	_	
58-17	9159-9162	are	_	
58-18	9163-9169	highly	_	
58-19	9170-9180	correlated	_	
58-20	9181-9182	(	_	
58-21	9182-9188	George	_	
58-22	9189-9191	et	_	
58-23	9192-9194	al	_	
58-24	9194-9195	,	_	
58-25	9196-9200	1995	_	
58-26	9200-9201	)	_	
58-27	9201-9202	.	_	

#Text=Thus, the authors acknowledged that the discriminant validity among the 8 subscores was at best moderate.
59-1	9203-9207	Thus	_	
59-2	9207-9208	,	_	
59-3	9209-9212	the	_	
59-4	9213-9220	authors	_	
59-5	9221-9233	acknowledged	_	
59-6	9234-9238	that	_	
59-7	9239-9242	the	_	
59-8	9243-9255	discriminant	_	
59-9	9256-9264	validity	_	
59-10	9265-9270	among	_	
59-11	9271-9274	the	_	
59-12	9275-9276	8	_	
59-13	9277-9286	subscores	_	
59-14	9287-9290	was	_	
59-15	9291-9293	at	_	
59-16	9294-9298	best	_	
59-17	9299-9307	moderate	_	
59-18	9307-9308	.	_	

#Text=Here, we used the global positive subscore to represent alcohol expectancy.
60-1	9309-9313	Here	_	
60-2	9313-9314	,	_	
60-3	9315-9317	we	_	
60-4	9318-9322	used	_	
60-5	9323-9326	the	_	
60-6	9327-9333	global	_	
60-7	9334-9342	positive	_	
60-8	9343-9351	subscore	_	
60-9	9352-9354	to	_	
60-10	9355-9364	represent	_	
60-11	9365-9372	alcohol	_	
60-12	9373-9383	expectancy	_	
60-13	9383-9384	.	_	

#Text=A summary of demographic and clinical measures is presented in Table 1.
61-1	9385-9386	A	_	
61-2	9387-9394	summary	_	
61-3	9395-9397	of	_	
61-4	9398-9409	demographic	_	
61-5	9410-9413	and	_	
61-6	9414-9422	clinical	_	
61-7	9423-9431	measures	_	
61-8	9432-9434	is	_	
61-9	9435-9444	presented	_	
61-10	9445-9447	in	_	
61-11	9448-9453	Table	_	
61-12	9454-9455	1	_	
61-13	9455-9456	.	_	

#Text=All subjects signed a written informed consent, in accordance to a protocol approved by the Yale Human Investigation Committee, prior to the study.
#Text=2.2 Behavioral task
#Text=We employed a simple reaction time task in this stop-signal paradigm.
62-1	9457-9460	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-2	9461-9469	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-3	9470-9476	signed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-4	9477-9478	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-5	9479-9486	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-6	9487-9495	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-7	9496-9503	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-8	9503-9504	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-9	9505-9507	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-10	9508-9518	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-11	9519-9521	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-12	9522-9523	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-13	9524-9532	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-14	9533-9541	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-15	9542-9544	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-16	9545-9548	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-17	9549-9553	Yale	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-18	9554-9559	Human	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-19	9560-9573	Investigation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-20	9574-9583	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-21	9583-9584	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-22	9585-9590	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-23	9591-9593	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-24	9594-9597	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-25	9598-9603	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
62-26	9603-9604	.	_	
62-27	9605-9608	2.2	_	
62-28	9609-9619	Behavioral	_	
62-29	9620-9624	task	_	
62-30	9625-9627	We	_	
62-31	9628-9636	employed	_	
62-32	9637-9638	a	_	
62-33	9639-9645	simple	_	
62-34	9646-9654	reaction	_	
62-35	9655-9659	time	_	
62-36	9660-9664	task	_	
62-37	9665-9667	in	_	
62-38	9668-9672	this	_	
62-39	9673-9684	stop-signal	_	
62-40	9685-9693	paradigm	_	
62-41	9693-9694	.	_	

#Text=There were two trial types: “go” and “stop,” randomly intermixed in presentation each with a probability of 0.75 and 0.25, and with an inter-trial interval of 2 s.
63-1	9695-9700	There	_	
63-2	9701-9705	were	_	
63-3	9706-9709	two	_	
63-4	9710-9715	trial	_	
63-5	9716-9721	types	_	
63-6	9721-9722	:	_	
63-7	9723-9724	“	_	
63-8	9724-9726	go	_	
63-9	9726-9727	”	_	
63-10	9728-9731	and	_	
63-11	9732-9733	“	_	
63-12	9733-9737	stop	_	
63-13	9737-9738	,	_	
63-14	9738-9739	”	_	
63-15	9740-9748	randomly	_	
63-16	9749-9759	intermixed	_	
63-17	9760-9762	in	_	
63-18	9763-9775	presentation	_	
63-19	9776-9780	each	_	
63-20	9781-9785	with	_	
63-21	9786-9787	a	_	
63-22	9788-9799	probability	_	
63-23	9800-9802	of	_	
63-24	9803-9807	0.75	_	
63-25	9808-9811	and	_	
63-26	9812-9816	0.25	_	
63-27	9816-9817	,	_	
63-28	9818-9821	and	_	
63-29	9822-9826	with	_	
63-30	9827-9829	an	_	
63-31	9830-9841	inter-trial	_	
63-32	9842-9850	interval	_	
63-33	9851-9853	of	_	
63-34	9854-9855	2	_	
63-35	9856-9857	s	_	
63-36	9857-9858	.	_	

#Text=A small dot appeared on the screen to engage attention at the beginning of a go trial.
64-1	9859-9860	A	_	
64-2	9861-9866	small	_	
64-3	9867-9870	dot	_	
64-4	9871-9879	appeared	_	
64-5	9880-9882	on	_	
64-6	9883-9886	the	_	
64-7	9887-9893	screen	_	
64-8	9894-9896	to	_	
64-9	9897-9903	engage	_	
64-10	9904-9913	attention	_	
64-11	9914-9916	at	_	
64-12	9917-9920	the	_	
64-13	9921-9930	beginning	_	
64-14	9931-9933	of	_	
64-15	9934-9935	a	_	
64-16	9936-9938	go	_	
64-17	9939-9944	trial	_	
64-18	9944-9945	.	_	

#Text=After a randomized time interval between 1 and 5 s, drawn from a uniform distribution, the dot turned into a circle (the “go” signal), prompting the subjects to quickly press a button.
65-1	9946-9951	After	_	
65-2	9952-9953	a	_	
65-3	9954-9964	randomized	_	
65-4	9965-9969	time	_	
65-5	9970-9978	interval	_	
65-6	9979-9986	between	_	
65-7	9987-9988	1	_	
65-8	9989-9992	and	_	
65-9	9993-9994	5	_	
65-10	9995-9996	s	_	
65-11	9996-9997	,	_	
65-12	9998-10003	drawn	_	
65-13	10004-10008	from	_	
65-14	10009-10010	a	_	
65-15	10011-10018	uniform	_	
65-16	10019-10031	distribution	_	
65-17	10031-10032	,	_	
65-18	10033-10036	the	_	
65-19	10037-10040	dot	_	
65-20	10041-10047	turned	_	
65-21	10048-10052	into	_	
65-22	10053-10054	a	_	
65-23	10055-10061	circle	_	
65-24	10062-10063	(	_	
65-25	10063-10066	the	_	
65-26	10067-10068	“	_	
65-27	10068-10070	go	_	
65-28	10070-10071	”	_	
65-29	10072-10078	signal	_	
65-30	10078-10079	)	_	
65-31	10079-10080	,	_	
65-32	10081-10090	prompting	_	
65-33	10091-10094	the	_	
65-34	10095-10103	subjects	_	
65-35	10104-10106	to	_	
65-36	10107-10114	quickly	_	
65-37	10115-10120	press	_	
65-38	10121-10122	a	_	
65-39	10123-10129	button	_	
65-40	10129-10130	.	_	

#Text=The circle vanished at a button press or after 1 s has elapsed, whichever came first, and the trial terminated.
66-1	10131-10134	The	_	
66-2	10135-10141	circle	_	
66-3	10142-10150	vanished	_	
66-4	10151-10153	at	_	
66-5	10154-10155	a	_	
66-6	10156-10162	button	_	
66-7	10163-10168	press	_	
66-8	10169-10171	or	_	
66-9	10172-10177	after	_	
66-10	10178-10179	1	_	
66-11	10180-10181	s	_	
66-12	10182-10185	has	_	
66-13	10186-10193	elapsed	_	
66-14	10193-10194	,	_	
66-15	10195-10204	whichever	_	
66-16	10205-10209	came	_	
66-17	10210-10215	first	_	
66-18	10215-10216	,	_	
66-19	10217-10220	and	_	
66-20	10221-10224	the	_	
66-21	10225-10230	trial	_	
66-22	10231-10241	terminated	_	
66-23	10241-10242	.	_	

#Text=A premature button press prior to the appearance of the circle also terminated the trial.
67-1	10243-10244	A	_	
67-2	10245-10254	premature	_	
67-3	10255-10261	button	_	
67-4	10262-10267	press	_	
67-5	10268-10273	prior	_	
67-6	10274-10276	to	_	
67-7	10277-10280	the	_	
67-8	10281-10291	appearance	_	
67-9	10292-10294	of	_	
67-10	10295-10298	the	_	
67-11	10299-10305	circle	_	
67-12	10306-10310	also	_	
67-13	10311-10321	terminated	_	
67-14	10322-10325	the	_	
67-15	10326-10331	trial	_	
67-16	10331-10332	.	_	

#Text=In a stop trial, an additional “X,” the “stop” signal, appeared after and replaced the go signal, and instructed participants to withhold their response.
68-1	10333-10335	In	_	
68-2	10336-10337	a	_	
68-3	10338-10342	stop	_	
68-4	10343-10348	trial	_	
68-5	10348-10349	,	_	
68-6	10350-10352	an	_	
68-7	10353-10363	additional	_	
68-8	10364-10365	“	_	
68-9	10365-10366	X	_	
68-10	10366-10367	,	_	
68-11	10367-10368	”	_	
68-12	10369-10372	the	_	
68-13	10373-10374	“	_	
68-14	10374-10378	stop	_	
68-15	10378-10379	”	_	
68-16	10380-10386	signal	_	
68-17	10386-10387	,	_	
68-18	10388-10396	appeared	_	
68-19	10397-10402	after	_	
68-20	10403-10406	and	_	
68-21	10407-10415	replaced	_	
68-22	10416-10419	the	_	
68-23	10420-10422	go	_	
68-24	10423-10429	signal	_	
68-25	10429-10430	,	_	
68-26	10431-10434	and	_	
68-27	10435-10445	instructed	_	
68-28	10446-10458	participants	_	
68-29	10459-10461	to	_	
68-30	10462-10470	withhold	_	
68-31	10471-10476	their	_	
68-32	10477-10485	response	_	
68-33	10485-10486	.	_	

#Text=Similar to go trials, a stop trial terminated at button press or 1 s after the appearance of the stop signal.
69-1	10487-10494	Similar	_	
69-2	10495-10497	to	_	
69-3	10498-10500	go	_	
69-4	10501-10507	trials	_	
69-5	10507-10508	,	_	
69-6	10509-10510	a	_	
69-7	10511-10515	stop	_	
69-8	10516-10521	trial	_	
69-9	10522-10532	terminated	_	
69-10	10533-10535	at	_	
69-11	10536-10542	button	_	
69-12	10543-10548	press	_	
69-13	10549-10551	or	_	
69-14	10552-10553	1	_	
69-15	10554-10555	s	_	
69-16	10556-10561	after	_	
69-17	10562-10565	the	_	
69-18	10566-10576	appearance	_	
69-19	10577-10579	of	_	
69-20	10580-10583	the	_	
69-21	10584-10588	stop	_	
69-22	10589-10595	signal	_	
69-23	10595-10596	.	_	

#Text=Failure to withhold the response for the 1 s constituted a stop error.
70-1	10597-10604	Failure	_	
70-2	10605-10607	to	_	
70-3	10608-10616	withhold	_	
70-4	10617-10620	the	_	
70-5	10621-10629	response	_	
70-6	10630-10633	for	_	
70-7	10634-10637	the	_	
70-8	10638-10639	1	_	
70-9	10640-10641	s	_	
70-10	10642-10653	constituted	_	
70-11	10654-10655	a	_	
70-12	10656-10660	stop	_	
70-13	10661-10666	error	_	
70-14	10666-10667	.	_	

#Text=The stop signal delay (SSD) – the time interval between go and stop signals – started at 200 ms and was adjusted according to a staircase procedure, increasing and decreasing by 67 ms each after a successful and failed stop.
71-1	10668-10671	The	_	
71-2	10672-10676	stop	_	
71-3	10677-10683	signal	_	
71-4	10684-10689	delay	_	
71-5	10690-10691	(	_	
71-6	10691-10694	SSD	_	
71-7	10694-10695	)	_	
71-8	10696-10697	–	_	
71-9	10698-10701	the	_	
71-10	10702-10706	time	_	
71-11	10707-10715	interval	_	
71-12	10716-10723	between	_	
71-13	10724-10726	go	_	
71-14	10727-10730	and	_	
71-15	10731-10735	stop	_	
71-16	10736-10743	signals	_	
71-17	10744-10745	–	_	
71-18	10746-10753	started	_	
71-19	10754-10756	at	_	
71-20	10757-10760	200	_	
71-21	10761-10763	ms	_	
71-22	10764-10767	and	_	
71-23	10768-10771	was	_	
71-24	10772-10780	adjusted	_	
71-25	10781-10790	according	_	
71-26	10791-10793	to	_	
71-27	10794-10795	a	_	
71-28	10796-10805	staircase	_	
71-29	10806-10815	procedure	_	
71-30	10815-10816	,	_	
71-31	10817-10827	increasing	_	
71-32	10828-10831	and	_	
71-33	10832-10842	decreasing	_	
71-34	10843-10845	by	_	
71-35	10846-10848	67	_	
71-36	10849-10851	ms	_	
71-37	10852-10856	each	_	
71-38	10857-10862	after	_	
71-39	10863-10864	a	_	
71-40	10865-10875	successful	_	
71-41	10876-10879	and	_	
71-42	10880-10886	failed	_	
71-43	10887-10891	stop	_	
71-44	10891-10892	.	_	

#Text=Subjects were instructed to respond to the go signal quickly while keeping in mind that a stop signal could come up occasionally.
72-1	10893-10901	Subjects	_	
72-2	10902-10906	were	_	
72-3	10907-10917	instructed	_	
72-4	10918-10920	to	_	
72-5	10921-10928	respond	_	
72-6	10929-10931	to	_	
72-7	10932-10935	the	_	
72-8	10936-10938	go	_	
72-9	10939-10945	signal	_	
72-10	10946-10953	quickly	_	
72-11	10954-10959	while	_	
72-12	10960-10967	keeping	_	
72-13	10968-10970	in	_	
72-14	10971-10975	mind	_	
72-15	10976-10980	that	_	
72-16	10981-10982	a	_	
72-17	10983-10987	stop	_	
72-18	10988-10994	signal	_	
72-19	10995-11000	could	_	
72-20	11001-11005	come	_	
72-21	11006-11008	up	_	
72-22	11009-11021	occasionally	_	
72-23	11021-11022	.	_	

#Text=The staircase procedure ensures that subjects would succeed in withholding their response in approximately half of the stop trials.
#Text=2.3 Analyses of behavioral performance in the stop signal task
#Text=We computed a critical SSD that represents the time delay between go and stop signals that a subject would need to succeed in 50% of the stop trials.
73-1	11023-11026	The	_	
73-2	11027-11036	staircase	_	
73-3	11037-11046	procedure	_	
73-4	11047-11054	ensures	_	
73-5	11055-11059	that	_	
73-6	11060-11068	subjects	_	
73-7	11069-11074	would	_	
73-8	11075-11082	succeed	_	
73-9	11083-11085	in	_	
73-10	11086-11097	withholding	_	
73-11	11098-11103	their	_	
73-12	11104-11112	response	_	
73-13	11113-11115	in	_	
73-14	11116-11129	approximately	_	
73-15	11130-11134	half	_	
73-16	11135-11137	of	_	
73-17	11138-11141	the	_	
73-18	11142-11146	stop	_	
73-19	11147-11153	trials	_	
73-20	11153-11154	.	_	
73-21	11155-11158	2.3	_	
73-22	11159-11167	Analyses	_	
73-23	11168-11170	of	_	
73-24	11171-11181	behavioral	_	
73-25	11182-11193	performance	_	
73-26	11194-11196	in	_	
73-27	11197-11200	the	_	
73-28	11201-11205	stop	_	
73-29	11206-11212	signal	_	
73-30	11213-11217	task	_	
73-31	11218-11220	We	_	
73-32	11221-11229	computed	_	
73-33	11230-11231	a	_	
73-34	11232-11240	critical	_	
73-35	11241-11244	SSD	_	
73-36	11245-11249	that	_	
73-37	11250-11260	represents	_	
73-38	11261-11264	the	_	
73-39	11265-11269	time	_	
73-40	11270-11275	delay	_	
73-41	11276-11283	between	_	
73-42	11284-11286	go	_	
73-43	11287-11290	and	_	
73-44	11291-11295	stop	_	
73-45	11296-11303	signals	_	
73-46	11304-11308	that	_	
73-47	11309-11310	a	_	
73-48	11311-11318	subject	_	
73-49	11319-11324	would	_	
73-50	11325-11329	need	_	
73-51	11330-11332	to	_	
73-52	11333-11340	succeed	_	
73-53	11341-11343	in	_	
73-54	11344-11347	50%	_	
73-55	11348-11350	of	_	
73-56	11351-11354	the	_	
73-57	11355-11359	stop	_	
73-58	11360-11366	trials	_	
73-59	11366-11367	.	_	

#Text=Specifically, SSDs across trials were grouped into runs, with each run defined as a monotonically increasing or decreasing series.
74-1	11368-11380	Specifically	_	
74-2	11380-11381	,	_	
74-3	11382-11386	SSDs	_	
74-4	11387-11393	across	_	
74-5	11394-11400	trials	_	
74-6	11401-11405	were	_	
74-7	11406-11413	grouped	_	
74-8	11414-11418	into	_	
74-9	11419-11423	runs	_	
74-10	11423-11424	,	_	
74-11	11425-11429	with	_	
74-12	11430-11434	each	_	
74-13	11435-11438	run	_	
74-14	11439-11446	defined	_	
74-15	11447-11449	as	_	
74-16	11450-11451	a	_	
74-17	11452-11465	monotonically	_	
74-18	11466-11476	increasing	_	
74-19	11477-11479	or	_	
74-20	11480-11490	decreasing	_	
74-21	11491-11497	series	_	
74-22	11497-11498	.	_	

#Text=We derived a mid-run estimate by taking the median SSD of every second run.
75-1	11499-11501	We	_	
75-2	11502-11509	derived	_	
75-3	11510-11511	a	_	
75-4	11512-11519	mid-run	_	
75-5	11520-11528	estimate	_	
75-6	11529-11531	by	_	
75-7	11532-11538	taking	_	
75-8	11539-11542	the	_	
75-9	11543-11549	median	_	
75-10	11550-11553	SSD	_	
75-11	11554-11556	of	_	
75-12	11557-11562	every	_	
75-13	11563-11569	second	_	
75-14	11570-11573	run	_	
75-15	11573-11574	.	_	

#Text=The critical SSD was computed by taking the mean of all mid-run SSDs.
76-1	11575-11578	The	_	
76-2	11579-11587	critical	_	
76-3	11588-11591	SSD	_	
76-4	11592-11595	was	_	
76-5	11596-11604	computed	_	
76-6	11605-11607	by	_	
76-7	11608-11614	taking	_	
76-8	11615-11618	the	_	
76-9	11619-11623	mean	_	
76-10	11624-11626	of	_	
76-11	11627-11630	all	_	
76-12	11631-11638	mid-run	_	
76-13	11639-11643	SSDs	_	
76-14	11643-11644	.	_	

#Text=It was reported that, except for experiments with a small number of trials (less than 30), the mid-run estimate was close to the maximum likelihood estimate of X50 (50% positive response; i.e., 50% stop success in the SST,).
77-1	11645-11647	It	_	
77-2	11648-11651	was	_	
77-3	11652-11660	reported	_	
77-4	11661-11665	that	_	
77-5	11665-11666	,	_	
77-6	11667-11673	except	_	
77-7	11674-11677	for	_	
77-8	11678-11689	experiments	_	
77-9	11690-11694	with	_	
77-10	11695-11696	a	_	
77-11	11697-11702	small	_	
77-12	11703-11709	number	_	
77-13	11710-11712	of	_	
77-14	11713-11719	trials	_	
77-15	11720-11721	(	_	
77-16	11721-11725	less	_	
77-17	11726-11730	than	_	
77-18	11731-11733	30	_	
77-19	11733-11734	)	_	
77-20	11734-11735	,	_	
77-21	11736-11739	the	_	
77-22	11740-11747	mid-run	_	
77-23	11748-11756	estimate	_	
77-24	11757-11760	was	_	
77-25	11761-11766	close	_	
77-26	11767-11769	to	_	
77-27	11770-11773	the	_	
77-28	11774-11781	maximum	_	
77-29	11782-11792	likelihood	_	
77-30	11793-11801	estimate	_	
77-31	11802-11804	of	_	
77-32	11805-11808	X50	_	
77-33	11809-11810	(	_	
77-34	11810-11813	50%	_	
77-35	11814-11822	positive	_	
77-36	11823-11831	response	_	
77-37	11831-11832	;	_	
77-38	11833-11836	i.e	_	
77-39	11836-11837	.	_	
77-40	11837-11838	,	_	
77-41	11839-11842	50%	_	
77-42	11843-11847	stop	_	
77-43	11848-11855	success	_	
77-44	11856-11858	in	_	
77-45	11859-11862	the	_	
77-46	11863-11866	SST	_	
77-47	11866-11867	,	_	
77-48	11867-11868	)	_	
77-49	11868-11869	.	_	

#Text=The stop signal reaction time (SSRT) was computed by subtracting the critical SSD from the median go trial RT.
78-1	11870-11873	The	_	
78-2	11874-11878	stop	_	
78-3	11879-11885	signal	_	
78-4	11886-11894	reaction	_	
78-5	11895-11899	time	_	
78-6	11900-11901	(	_	
78-7	11901-11905	SSRT	_	
78-8	11905-11906	)	_	
78-9	11907-11910	was	_	
78-10	11911-11919	computed	_	
78-11	11920-11922	by	_	
78-12	11923-11934	subtracting	_	
78-13	11935-11938	the	_	
78-14	11939-11947	critical	_	
78-15	11948-11951	SSD	_	
78-16	11952-11956	from	_	
78-17	11957-11960	the	_	
78-18	11961-11967	median	_	
78-19	11968-11970	go	_	
78-20	11971-11976	trial	_	
78-21	11977-11979	RT	_	
78-22	11979-11980	.	_	

#Text=It is known that in the SST the RT of a correct response is prolonged following a stop-error trial, compared with other correct responses, and this prolonged RT is thought to reflect error-detection and conflict monitoring (Hendrick et al., 2010).
79-1	11981-11983	It	_	
79-2	11984-11986	is	_	
79-3	11987-11992	known	_	
79-4	11993-11997	that	_	
79-5	11998-12000	in	_	
79-6	12001-12004	the	_	
79-7	12005-12008	SST	_	
79-8	12009-12012	the	_	
79-9	12013-12015	RT	_	
79-10	12016-12018	of	_	
79-11	12019-12020	a	_	
79-12	12021-12028	correct	_	
79-13	12029-12037	response	_	
79-14	12038-12040	is	_	
79-15	12041-12050	prolonged	_	
79-16	12051-12060	following	_	
79-17	12061-12062	a	_	
79-18	12063-12073	stop-error	_	
79-19	12074-12079	trial	_	
79-20	12079-12080	,	_	
79-21	12081-12089	compared	_	
79-22	12090-12094	with	_	
79-23	12095-12100	other	_	
79-24	12101-12108	correct	_	
79-25	12109-12118	responses	_	
79-26	12118-12119	,	_	
79-27	12120-12123	and	_	
79-28	12124-12128	this	_	
79-29	12129-12138	prolonged	_	
79-30	12139-12141	RT	_	
79-31	12142-12144	is	_	
79-32	12145-12152	thought	_	
79-33	12153-12155	to	_	
79-34	12156-12163	reflect	_	
79-35	12164-12179	error-detection	_	
79-36	12180-12183	and	_	
79-37	12184-12192	conflict	_	
79-38	12193-12203	monitoring	_	
79-39	12204-12205	(	_	
79-40	12205-12213	Hendrick	_	
79-41	12214-12216	et	_	
79-42	12217-12219	al	_	
79-43	12219-12220	.	_	
79-44	12220-12221	,	_	
79-45	12222-12226	2010	_	
79-46	12226-12227	)	_	
79-47	12227-12228	.	_	

#Text=We thus compared the RT of the go trials that followed a stop-error trial and those that followed another go trial, and termed the effect size of this RT difference “post-error slowing” (PES).
#Text=2.4 Image acquisition, preprocessing and statistical tests
#Text=All imaging data were collected in the same 3T Siemens Trio scanner (Erlangen, Germany) while subjects performed the SST, as described in detail in our previous work.
80-1	12229-12231	We	_	
80-2	12232-12236	thus	_	
80-3	12237-12245	compared	_	
80-4	12246-12249	the	_	
80-5	12250-12252	RT	_	
80-6	12253-12255	of	_	
80-7	12256-12259	the	_	
80-8	12260-12262	go	_	
80-9	12263-12269	trials	_	
80-10	12270-12274	that	_	
80-11	12275-12283	followed	_	
80-12	12284-12285	a	_	
80-13	12286-12296	stop-error	_	
80-14	12297-12302	trial	_	
80-15	12303-12306	and	_	
80-16	12307-12312	those	_	
80-17	12313-12317	that	_	
80-18	12318-12326	followed	_	
80-19	12327-12334	another	_	
80-20	12335-12337	go	_	
80-21	12338-12343	trial	_	
80-22	12343-12344	,	_	
80-23	12345-12348	and	_	
80-24	12349-12355	termed	_	
80-25	12356-12359	the	_	
80-26	12360-12366	effect	_	
80-27	12367-12371	size	_	
80-28	12372-12374	of	_	
80-29	12375-12379	this	_	
80-30	12380-12382	RT	_	
80-31	12383-12393	difference	_	
80-32	12394-12395	“	_	
80-33	12395-12405	post-error	_	
80-34	12406-12413	slowing	_	
80-35	12413-12414	”	_	
80-36	12415-12416	(	_	
80-37	12416-12419	PES	_	
80-38	12419-12420	)	_	
80-39	12420-12421	.	_	
80-40	12422-12425	2.4	_	
80-41	12426-12431	Image	_	
80-42	12432-12443	acquisition	_	
80-43	12443-12444	,	_	
80-44	12445-12458	preprocessing	_	
80-45	12459-12462	and	_	
80-46	12463-12474	statistical	_	
80-47	12475-12480	tests	_	
80-48	12481-12484	All	_	
80-49	12485-12492	imaging	_	
80-50	12493-12497	data	_	
80-51	12498-12502	were	_	
80-52	12503-12512	collected	_	
80-53	12513-12515	in	_	
80-54	12516-12519	the	_	
80-55	12520-12524	same	_	
80-56	12525-12527	3T	_	
80-57	12528-12535	Siemens	_	
80-58	12536-12540	Trio	_	
80-59	12541-12548	scanner	_	
80-60	12549-12550	(	_	
80-61	12550-12558	Erlangen	_	
80-62	12558-12559	,	_	
80-63	12560-12567	Germany	_	
80-64	12567-12568	)	_	
80-65	12569-12574	while	_	
80-66	12575-12583	subjects	_	
80-67	12584-12593	performed	_	
80-68	12594-12597	the	_	
80-69	12598-12601	SST	_	
80-70	12601-12602	,	_	
80-71	12603-12605	as	_	
80-72	12606-12615	described	_	
80-73	12616-12618	in	_	
80-74	12619-12625	detail	_	
80-75	12626-12628	in	_	
80-76	12629-12632	our	_	
80-77	12633-12641	previous	_	
80-78	12642-12646	work	_	
80-79	12646-12647	.	_	

#Text=Each scan comprised four 10-minute runs of the SST.
81-1	12648-12652	Each	_	
81-2	12653-12657	scan	_	
81-3	12658-12667	comprised	_	
81-4	12668-12672	four	_	
81-5	12673-12675	10	_	
81-6	12675-12676	-	_	
81-7	12676-12682	minute	_	
81-8	12683-12687	runs	_	
81-9	12688-12690	of	_	
81-10	12691-12694	the	_	
81-11	12695-12698	SST	_	
81-12	12698-12699	.	_	

#Text=Caffeine-using subjects were allowed drink coffee or other caffeinated beverages until 30 minutes before MRI.
82-1	12700-12714	Caffeine-using	_	
82-2	12715-12723	subjects	_	
82-3	12724-12728	were	_	
82-4	12729-12736	allowed	_	
82-5	12737-12742	drink	_	
82-6	12743-12749	coffee	_	
82-7	12750-12752	or	_	
82-8	12753-12758	other	_	
82-9	12759-12770	caffeinated	_	
82-10	12771-12780	beverages	_	
82-11	12781-12786	until	_	
82-12	12787-12789	30	_	
82-13	12790-12797	minutes	_	
82-14	12798-12804	before	_	
82-15	12805-12808	MRI	_	
82-16	12808-12809	.	_	

#Text=Functional blood oxygenation-level dependent (BOLD) signals were acquired with a single-shot gradient echo echo-planar imaging sequence, with 32 axial slices parallel to the AC-PC line covering the whole brain, using published parameters: TR=2000 ms, TE=25 ms, bandwidth=2004 Hz/pixel, flip angle=85°, FOV=220×220 mm2, matrix=64×64, slice thickness=4 mm and no gap.
83-1	12810-12820	Functional	_	
83-2	12821-12826	blood	_	
83-3	12827-12844	oxygenation-level	_	
83-4	12845-12854	dependent	_	
83-5	12855-12856	(	_	
83-6	12856-12860	BOLD	_	
83-7	12860-12861	)	_	
83-8	12862-12869	signals	_	
83-9	12870-12874	were	_	
83-10	12875-12883	acquired	_	
83-11	12884-12888	with	_	
83-12	12889-12890	a	_	
83-13	12891-12902	single-shot	_	
83-14	12903-12911	gradient	_	
83-15	12912-12916	echo	_	
83-16	12917-12928	echo-planar	_	
83-17	12929-12936	imaging	_	
83-18	12937-12945	sequence	_	
83-19	12945-12946	,	_	
83-20	12947-12951	with	_	
83-21	12952-12954	32	_	
83-22	12955-12960	axial	_	
83-23	12961-12967	slices	_	
83-24	12968-12976	parallel	_	
83-25	12977-12979	to	_	
83-26	12980-12983	the	_	
83-27	12984-12989	AC-PC	_	
83-28	12990-12994	line	_	
83-29	12995-13003	covering	_	
83-30	13004-13007	the	_	
83-31	13008-13013	whole	_	
83-32	13014-13019	brain	_	
83-33	13019-13020	,	_	
83-34	13021-13026	using	_	
83-35	13027-13036	published	_	
83-36	13037-13047	parameters	_	
83-37	13047-13048	:	_	
83-38	13049-13051	TR	_	
83-39	13051-13052	=	_	
83-40	13052-13056	2000	_	
83-41	13057-13059	ms	_	
83-42	13059-13060	,	_	
83-43	13061-13063	TE	_	
83-44	13063-13064	=	_	
83-45	13064-13066	25	_	
83-46	13067-13069	ms	_	
83-47	13069-13070	,	_	
83-48	13071-13080	bandwidth	_	
83-49	13080-13081	=	_	
83-50	13081-13085	2004	_	
83-51	13086-13088	Hz	_	
83-52	13088-13089	/	_	
83-53	13089-13094	pixel	_	
83-54	13094-13095	,	_	
83-55	13096-13100	flip	_	
83-56	13101-13106	angle	_	
83-57	13106-13107	=	_	
83-58	13107-13109	85	_	
83-59	13109-13110	°	_	
83-60	13110-13111	,	_	
83-61	13112-13115	FOV	_	
83-62	13115-13116	=	_	
83-63	13116-13119	220	_	
83-64	13119-13120	×	_	
83-65	13120-13123	220	_	
83-66	13124-13127	mm2	_	
83-67	13127-13128	,	_	
83-68	13129-13135	matrix	_	
83-69	13135-13136	=	_	
83-70	13136-13138	64	_	
83-71	13138-13139	×	_	
83-72	13139-13141	64	_	
83-73	13141-13142	,	_	
83-74	13143-13148	slice	_	
83-75	13149-13158	thickness	_	
83-76	13158-13159	=	_	
83-77	13159-13160	4	_	
83-78	13161-13163	mm	_	
83-79	13164-13167	and	_	
83-80	13168-13170	no	_	
83-81	13171-13174	gap	_	
83-82	13174-13175	.	_	

#Text=A high-resolution 3D structural image (MPRAGE; 1 mm resolution) was also obtained for anatomical co-registration.
84-1	13176-13177	A	_	
84-2	13178-13193	high-resolution	_	
84-3	13194-13196	3D	_	
84-4	13197-13207	structural	_	
84-5	13208-13213	image	_	
84-6	13214-13215	(	_	
84-7	13215-13221	MPRAGE	_	
84-8	13221-13222	;	_	
84-9	13223-13224	1	_	
84-10	13225-13227	mm	_	
84-11	13228-13238	resolution	_	
84-12	13238-13239	)	_	
84-13	13240-13243	was	_	
84-14	13244-13248	also	_	
84-15	13249-13257	obtained	_	
84-16	13258-13261	for	_	
84-17	13262-13272	anatomical	_	
84-18	13273-13288	co-registration	_	
84-19	13288-13289	.	_	

#Text=Functional MRI data was preprocessed with Statistical Parametric Mapping 12 (SPM12) (Wellcome Department of Imaging Neuroscience, University College London, U.K.).
85-1	13290-13300	Functional	_	
85-2	13301-13304	MRI	_	
85-3	13305-13309	data	_	
85-4	13310-13313	was	_	
85-5	13314-13326	preprocessed	_	
85-6	13327-13331	with	_	
85-7	13332-13343	Statistical	_	
85-8	13344-13354	Parametric	_	
85-9	13355-13362	Mapping	_	
85-10	13363-13365	12	_	
85-11	13366-13367	(	_	
85-12	13367-13372	SPM12	_	
85-13	13372-13373	)	_	
85-14	13374-13375	(	_	
85-15	13375-13383	Wellcome	_	
85-16	13384-13394	Department	_	
85-17	13395-13397	of	_	
85-18	13398-13405	Imaging	_	
85-19	13406-13418	Neuroscience	_	
85-20	13418-13419	,	_	
85-21	13420-13430	University	_	
85-22	13431-13438	College	_	
85-23	13439-13445	London	_	
85-24	13445-13446	,	_	
85-25	13447-13450	U.K	_	
85-26	13450-13451	.	_	
85-27	13451-13452	)	_	
85-28	13452-13453	.	_	

#Text=Images from the first five TRs at the beginning of each trial were discarded so only BOLD signals in a steady state were included in analyses.
86-1	13454-13460	Images	_	
86-2	13461-13465	from	_	
86-3	13466-13469	the	_	
86-4	13470-13475	first	_	
86-5	13476-13480	five	_	
86-6	13481-13484	TRs	_	
86-7	13485-13487	at	_	
86-8	13488-13491	the	_	
86-9	13492-13501	beginning	_	
86-10	13502-13504	of	_	
86-11	13505-13509	each	_	
86-12	13510-13515	trial	_	
86-13	13516-13520	were	_	
86-14	13521-13530	discarded	_	
86-15	13531-13533	so	_	
86-16	13534-13538	only	_	
86-17	13539-13543	BOLD	_	
86-18	13544-13551	signals	_	
86-19	13552-13554	in	_	
86-20	13555-13556	a	_	
86-21	13557-13563	steady	_	
86-22	13564-13569	state	_	
86-23	13570-13574	were	_	
86-24	13575-13583	included	_	
86-25	13584-13586	in	_	
86-26	13587-13595	analyses	_	
86-27	13595-13596	.	_	

#Text=Images of each individual subject were first corrected for slice timing, realigned (motion-corrected).
87-1	13597-13603	Images	_	
87-2	13604-13606	of	_	
87-3	13607-13611	each	_	
87-4	13612-13622	individual	_	
87-5	13623-13630	subject	_	
87-6	13631-13635	were	_	
87-7	13636-13641	first	_	
87-8	13642-13651	corrected	_	
87-9	13652-13655	for	_	
87-10	13656-13661	slice	_	
87-11	13662-13668	timing	_	
87-12	13668-13669	,	_	
87-13	13670-13679	realigned	_	
87-14	13680-13681	(	_	
87-15	13681-13697	motion-corrected	_	
87-16	13697-13698	)	_	
87-17	13698-13699	.	_	

#Text=A mean functional image volume was constructed for each subject for each run from the realigned image volumes.
88-1	13700-13701	A	_	
88-2	13702-13706	mean	_	
88-3	13707-13717	functional	_	
88-4	13718-13723	image	_	
88-5	13724-13730	volume	_	
88-6	13731-13734	was	_	
88-7	13735-13746	constructed	_	
88-8	13747-13750	for	_	
88-9	13751-13755	each	_	
88-10	13756-13763	subject	_	
88-11	13764-13767	for	_	
88-12	13768-13772	each	_	
88-13	13773-13776	run	_	
88-14	13777-13781	from	_	
88-15	13782-13785	the	_	
88-16	13786-13795	realigned	_	
88-17	13796-13801	image	_	
88-18	13802-13809	volumes	_	
88-19	13809-13810	.	_	

#Text=The anatomical images (T1-weighted) were co-registered to the mean functional image, and normalized to an MNI (Montreal Neurological Institute) template with affine registration followed by nonlinear transformation using a unified segmentation and registration approach.
89-1	13811-13814	The	_	
89-2	13815-13825	anatomical	_	
89-3	13826-13832	images	_	
89-4	13833-13834	(	_	
89-5	13834-13836	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[13]	
89-6	13836-13837	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[13]	
89-7	13837-13845	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[13]	
89-8	13845-13846	)	_	
89-9	13847-13851	were	_	
89-10	13852-13865	co-registered	_	
89-11	13866-13868	to	_	
89-12	13869-13872	the	_	
89-13	13873-13877	mean	_	
89-14	13878-13888	functional	_	
89-15	13889-13894	image	_	
89-16	13894-13895	,	_	
89-17	13896-13899	and	_	
89-18	13900-13910	normalized	_	
89-19	13911-13913	to	_	
89-20	13914-13916	an	_	
89-21	13917-13920	MNI	_	
89-22	13921-13922	(	_	
89-23	13922-13930	Montreal	_	
89-24	13931-13943	Neurological	_	
89-25	13944-13953	Institute	_	
89-26	13953-13954	)	_	
89-27	13955-13963	template	_	
89-28	13964-13968	with	_	
89-29	13969-13975	affine	_	
89-30	13976-13988	registration	_	
89-31	13989-13997	followed	_	
89-32	13998-14000	by	_	
89-33	14001-14010	nonlinear	_	
89-34	14011-14025	transformation	_	
89-35	14026-14031	using	_	
89-36	14032-14033	a	_	
89-37	14034-14041	unified	_	
89-38	14042-14054	segmentation	_	
89-39	14055-14058	and	_	
89-40	14059-14071	registration	_	
89-41	14072-14080	approach	_	
89-42	14080-14081	.	_	

#Text=The normalization parameters determined for the anatomical volume were then applied to the corresponding functional image volumes for each subject.
90-1	14082-14085	The	_	
90-2	14086-14099	normalization	_	
90-3	14100-14110	parameters	_	
90-4	14111-14121	determined	_	
90-5	14122-14125	for	_	
90-6	14126-14129	the	_	
90-7	14130-14140	anatomical	_	
90-8	14141-14147	volume	_	
90-9	14148-14152	were	_	
90-10	14153-14157	then	_	
90-11	14158-14165	applied	_	
90-12	14166-14168	to	_	
90-13	14169-14172	the	_	
90-14	14173-14186	corresponding	_	
90-15	14187-14197	functional	_	
90-16	14198-14203	image	_	
90-17	14204-14211	volumes	_	
90-18	14212-14215	for	_	
90-19	14216-14220	each	_	
90-20	14221-14228	subject	_	
90-21	14228-14229	.	_	

#Text=Finally, images were smoothed with a Gaussian kernel of 8 mm at Full Width at Half Maximum.
91-1	14230-14237	Finally	_	
91-2	14237-14238	,	_	
91-3	14239-14245	images	_	
91-4	14246-14250	were	_	
91-5	14251-14259	smoothed	_	
91-6	14260-14264	with	_	
91-7	14265-14266	a	_	
91-8	14267-14275	Gaussian	_	
91-9	14276-14282	kernel	_	
91-10	14283-14285	of	_	
91-11	14286-14287	8	_	
91-12	14288-14290	mm	_	
91-13	14291-14293	at	_	
91-14	14294-14298	Full	_	
91-15	14299-14304	Width	_	
91-16	14305-14307	at	_	
91-17	14308-14312	Half	_	
91-18	14313-14320	Maximum	_	
91-19	14320-14321	.	_	

#Text=Images from the first five TRs at the beginning of each session were discarded so only signals with steady-state equilibrium between radio frequency pulsing and relaxation were included in data analyses.
92-1	14322-14328	Images	_	
92-2	14329-14333	from	_	
92-3	14334-14337	the	_	
92-4	14338-14343	first	_	
92-5	14344-14348	five	_	
92-6	14349-14352	TRs	_	
92-7	14353-14355	at	_	
92-8	14356-14359	the	_	
92-9	14360-14369	beginning	_	
92-10	14370-14372	of	_	
92-11	14373-14377	each	_	
92-12	14378-14385	session	_	
92-13	14386-14390	were	_	
92-14	14391-14400	discarded	_	
92-15	14401-14403	so	_	
92-16	14404-14408	only	_	
92-17	14409-14416	signals	_	
92-18	14417-14421	with	_	
92-19	14422-14434	steady-state	_	
92-20	14435-14446	equilibrium	_	
92-21	14447-14454	between	_	
92-22	14455-14460	radio	_	
92-23	14461-14470	frequency	_	
92-24	14471-14478	pulsing	_	
92-25	14479-14482	and	_	
92-26	14483-14493	relaxation	_	
92-27	14494-14498	were	_	
92-28	14499-14507	included	_	
92-29	14508-14510	in	_	
92-30	14511-14515	data	_	
92-31	14516-14524	analyses	_	
92-32	14524-14525	.	_	

#Text=We distinguished four trial outcomes in this event-related study: go success (GS), go error, stop success (SS), and stop error (SE), and modeled BOLD signals by convolving the onsets of the go signals of each trial with a canonical hemodynamic response function (HRF) and the temporal derivative of the canonical HRF.
93-1	14526-14528	We	_	
93-2	14529-14542	distinguished	_	
93-3	14543-14547	four	_	
93-4	14548-14553	trial	_	
93-5	14554-14562	outcomes	_	
93-6	14563-14565	in	_	
93-7	14566-14570	this	_	
93-8	14571-14584	event-related	_	
93-9	14585-14590	study	_	
93-10	14590-14591	:	_	
93-11	14592-14594	go	_	
93-12	14595-14602	success	_	
93-13	14603-14604	(	_	
93-14	14604-14606	GS	_	
93-15	14606-14607	)	_	
93-16	14607-14608	,	_	
93-17	14609-14611	go	_	
93-18	14612-14617	error	_	
93-19	14617-14618	,	_	
93-20	14619-14623	stop	_	
93-21	14624-14631	success	_	
93-22	14632-14633	(	_	
93-23	14633-14635	SS	_	
93-24	14635-14636	)	_	
93-25	14636-14637	,	_	
93-26	14638-14641	and	_	
93-27	14642-14646	stop	_	
93-28	14647-14652	error	_	
93-29	14653-14654	(	_	
93-30	14654-14656	SE	_	
93-31	14656-14657	)	_	
93-32	14657-14658	,	_	
93-33	14659-14662	and	_	
93-34	14663-14670	modeled	_	
93-35	14671-14675	BOLD	_	
93-36	14676-14683	signals	_	
93-37	14684-14686	by	_	
93-38	14687-14697	convolving	_	
93-39	14698-14701	the	_	
93-40	14702-14708	onsets	_	
93-41	14709-14711	of	_	
93-42	14712-14715	the	_	
93-43	14716-14718	go	_	
93-44	14719-14726	signals	_	
93-45	14727-14729	of	_	
93-46	14730-14734	each	_	
93-47	14735-14740	trial	_	
93-48	14741-14745	with	_	
93-49	14746-14747	a	_	
93-50	14748-14757	canonical	_	
93-51	14758-14769	hemodynamic	_	
93-52	14770-14778	response	_	
93-53	14779-14787	function	_	
93-54	14788-14789	(	_	
93-55	14789-14792	HRF	_	
93-56	14792-14793	)	_	
93-57	14794-14797	and	_	
93-58	14798-14801	the	_	
93-59	14802-14810	temporal	_	
93-60	14811-14821	derivative	_	
93-61	14822-14824	of	_	
93-62	14825-14828	the	_	
93-63	14829-14838	canonical	_	
93-64	14839-14842	HRF	_	
93-65	14842-14843	.	_	

#Text=Realignment parameters in all six dimensions were entered in the model.
94-1	14844-14855	Realignment	_	
94-2	14856-14866	parameters	_	
94-3	14867-14869	in	_	
94-4	14870-14873	all	_	
94-5	14874-14877	six	_	
94-6	14878-14888	dimensions	_	
94-7	14889-14893	were	_	
94-8	14894-14901	entered	_	
94-9	14902-14904	in	_	
94-10	14905-14908	the	_	
94-11	14909-14914	model	_	
94-12	14914-14915	.	_	

#Text=We included the following variables as parametric modulators in the model: RT of GS trials, SSD of SS trials, and SSD of SE trials, in that order.
95-1	14916-14918	We	_	
95-2	14919-14927	included	_	
95-3	14928-14931	the	_	
95-4	14932-14941	following	_	
95-5	14942-14951	variables	_	
95-6	14952-14954	as	_	
95-7	14955-14965	parametric	_	
95-8	14966-14976	modulators	_	
95-9	14977-14979	in	_	
95-10	14980-14983	the	_	
95-11	14984-14989	model	_	
95-12	14989-14990	:	_	
95-13	14991-14993	RT	_	
95-14	14994-14996	of	_	
95-15	14997-14999	GS	_	
95-16	15000-15006	trials	_	
95-17	15006-15007	,	_	
95-18	15008-15011	SSD	_	
95-19	15012-15014	of	_	
95-20	15015-15017	SS	_	
95-21	15018-15024	trials	_	
95-22	15024-15025	,	_	
95-23	15026-15029	and	_	
95-24	15030-15033	SSD	_	
95-25	15034-15036	of	_	
95-26	15037-15039	SE	_	
95-27	15040-15046	trials	_	
95-28	15046-15047	,	_	
95-29	15048-15050	in	_	
95-30	15051-15055	that	_	
95-31	15056-15061	order	_	
95-32	15061-15062	.	_	

#Text=Serial autocorrelation of the time series was corrected by a first degree autoregressive or AR model.
96-1	15063-15069	Serial	_	
96-2	15070-15085	autocorrelation	_	
96-3	15086-15088	of	_	
96-4	15089-15092	the	_	
96-5	15093-15097	time	_	
96-6	15098-15104	series	_	
96-7	15105-15108	was	_	
96-8	15109-15118	corrected	_	
96-9	15119-15121	by	_	
96-10	15122-15123	a	_	
96-11	15124-15129	first	_	
96-12	15130-15136	degree	_	
96-13	15137-15151	autoregressive	_	
96-14	15152-15154	or	_	
96-15	15155-15157	AR	_	
96-16	15158-15163	model	_	
96-17	15163-15164	.	_	

#Text=The data were high- pass filtered (1/128 Hz cutoff) to remove low-frequency signal drifts.
97-1	15165-15168	The	_	
97-2	15169-15173	data	_	
97-3	15174-15178	were	_	
97-4	15179-15183	high	_	
97-5	15183-15184	-	_	
97-6	15185-15189	pass	_	
97-7	15190-15198	filtered	_	
97-8	15199-15200	(	_	
97-9	15200-15201	1	_	
97-10	15201-15202	/	_	
97-11	15202-15205	128	_	
97-12	15206-15208	Hz	_	
97-13	15209-15215	cutoff	_	
97-14	15215-15216	)	_	
97-15	15217-15219	to	_	
97-16	15220-15226	remove	_	
97-17	15227-15240	low-frequency	_	
97-18	15241-15247	signal	_	
97-19	15248-15254	drifts	_	
97-20	15254-15255	.	_	

#Text=Group analyses were performed also using SPM12 on the error contrast maps (SE>GS) using one and two sample t-tests and multiple regressions, with age as covariate.
98-1	15256-15261	Group	_	
98-2	15262-15270	analyses	_	
98-3	15271-15275	were	_	
98-4	15276-15285	performed	_	
98-5	15286-15290	also	_	
98-6	15291-15296	using	_	
98-7	15297-15302	SPM12	_	
98-8	15303-15305	on	_	
98-9	15306-15309	the	_	
98-10	15310-15315	error	_	
98-11	15316-15324	contrast	_	
98-12	15325-15329	maps	_	
98-13	15330-15331	(	_	
98-14	15331-15333	SE	_	
98-15	15333-15334	>	_	
98-16	15334-15336	GS	_	
98-17	15336-15337	)	_	
98-18	15338-15343	using	_	
98-19	15344-15347	one	_	
98-20	15348-15351	and	_	
98-21	15352-15355	two	_	
98-22	15356-15362	sample	_	
98-23	15363-15370	t-tests	_	
98-24	15371-15374	and	_	
98-25	15375-15383	multiple	_	
98-26	15384-15395	regressions	_	
98-27	15395-15396	,	_	
98-28	15397-15401	with	_	
98-29	15402-15405	age	_	
98-30	15406-15408	as	_	
98-31	15409-15418	covariate	_	
98-32	15418-15419	.	_	

#Text=Specifically, we employed a whole-brain regression against AUDIT score to examine regional responses to errors in association with problem drinking for men and women separately.
99-1	15420-15432	Specifically	_	
99-2	15432-15433	,	_	
99-3	15434-15436	we	_	
99-4	15437-15445	employed	_	
99-5	15446-15447	a	_	
99-6	15448-15459	whole-brain	_	
99-7	15460-15470	regression	_	
99-8	15471-15478	against	_	
99-9	15479-15484	AUDIT	_	
99-10	15485-15490	score	_	
99-11	15491-15493	to	_	
99-12	15494-15501	examine	_	
99-13	15502-15510	regional	_	
99-14	15511-15520	responses	_	
99-15	15521-15523	to	_	
99-16	15524-15530	errors	_	
99-17	15531-15533	in	_	
99-18	15534-15545	association	_	
99-19	15546-15550	with	_	
99-20	15551-15558	problem	_	
99-21	15559-15567	drinking	_	
99-22	15568-15571	for	_	
99-23	15572-15575	men	_	
99-24	15576-15579	and	_	
99-25	15580-15585	women	_	
99-26	15586-15596	separately	_	
99-27	15596-15597	.	_	

#Text=All group analyses were examined with a threshold of voxel p<0.001 uncorrected in combination with cluster p<0.05, FWE corrected, according to current reporting standards.
#Text=3.
100-1	15598-15601	All	_	
100-2	15602-15607	group	_	
100-3	15608-15616	analyses	_	
100-4	15617-15621	were	_	
100-5	15622-15630	examined	_	
100-6	15631-15635	with	_	
100-7	15636-15637	a	_	
100-8	15638-15647	threshold	_	
100-9	15648-15650	of	_	
100-10	15651-15656	voxel	_	
100-11	15657-15658	p	_	
100-12	15658-15659	<	_	
100-13	15659-15664	0.001	_	
100-14	15665-15676	uncorrected	_	
100-15	15677-15679	in	_	
100-16	15680-15691	combination	_	
100-17	15692-15696	with	_	
100-18	15697-15704	cluster	_	
100-19	15705-15706	p	_	
100-20	15706-15707	<	_	
100-21	15707-15711	0.05	_	
100-22	15711-15712	,	_	
100-23	15713-15716	FWE	_	
100-24	15717-15726	corrected	_	
100-25	15726-15727	,	_	
100-26	15728-15737	according	_	
100-27	15738-15740	to	_	
100-28	15741-15748	current	_	
100-29	15749-15758	reporting	_	
100-30	15759-15768	standards	_	
100-31	15768-15769	.	_	
100-32	15770-15771	3	_	
100-33	15771-15772	.	_	

#Text=Results
#Text=3.1 Clinical assessment and behavioral performance
#Text=As shown in Table 1, men showed higher AUDIT score, BIS score and average monthly number of drinks in the prior year, compared to women.
101-1	15773-15780	Results	_	
101-2	15781-15784	3.1	_	
101-3	15785-15793	Clinical	_	
101-4	15794-15804	assessment	_	
101-5	15805-15808	and	_	
101-6	15809-15819	behavioral	_	
101-7	15820-15831	performance	_	
101-8	15832-15834	As	_	
101-9	15835-15840	shown	_	
101-10	15841-15843	in	_	
101-11	15844-15849	Table	_	
101-12	15850-15851	1	_	
101-13	15851-15852	,	_	
101-14	15853-15856	men	_	
101-15	15857-15863	showed	_	
101-16	15864-15870	higher	_	
101-17	15871-15876	AUDIT	_	
101-18	15877-15882	score	_	
101-19	15882-15883	,	_	
101-20	15884-15887	BIS	_	
101-21	15888-15893	score	_	
101-22	15894-15897	and	_	
101-23	15898-15905	average	_	
101-24	15906-15913	monthly	_	
101-25	15914-15920	number	_	
101-26	15921-15923	of	_	
101-27	15924-15930	drinks	_	
101-28	15931-15933	in	_	
101-29	15934-15937	the	_	
101-30	15938-15943	prior	_	
101-31	15944-15948	year	_	
101-32	15948-15949	,	_	
101-33	15950-15958	compared	_	
101-34	15959-15961	to	_	
101-35	15962-15967	women	_	
101-36	15967-15968	.	_	

#Text=In linear regression, the AUDIT score was correlated with alcohol expectancy score in men and women combined (r=0.52, p=2.39e-11), as well as in men (r=0.45, p=0.0001) and women (r=0.60, p=7.54e-09) separately.
102-1	15969-15971	In	_	
102-2	15972-15978	linear	_	
102-3	15979-15989	regression	_	
102-4	15989-15990	,	_	
102-5	15991-15994	the	_	
102-6	15995-16000	AUDIT	_	
102-7	16001-16006	score	_	
102-8	16007-16010	was	_	
102-9	16011-16021	correlated	_	
102-10	16022-16026	with	_	
102-11	16027-16034	alcohol	_	
102-12	16035-16045	expectancy	_	
102-13	16046-16051	score	_	
102-14	16052-16054	in	_	
102-15	16055-16058	men	_	
102-16	16059-16062	and	_	
102-17	16063-16068	women	_	
102-18	16069-16077	combined	_	
102-19	16078-16079	(	_	
102-20	16079-16080	r	_	
102-21	16080-16081	=	_	
102-22	16081-16085	0.52	_	
102-23	16085-16086	,	_	
102-24	16087-16088	p	_	
102-25	16088-16089	=	_	
102-26	16089-16094	2.39e	_	
102-27	16094-16095	-	_	
102-28	16095-16097	11	_	
102-29	16097-16098	)	_	
102-30	16098-16099	,	_	
102-31	16100-16102	as	_	
102-32	16103-16107	well	_	
102-33	16108-16110	as	_	
102-34	16111-16113	in	_	
102-35	16114-16117	men	_	
102-36	16118-16119	(	_	
102-37	16119-16120	r	_	
102-38	16120-16121	=	_	
102-39	16121-16125	0.45	_	
102-40	16125-16126	,	_	
102-41	16127-16128	p	_	
102-42	16128-16129	=	_	
102-43	16129-16135	0.0001	_	
102-44	16135-16136	)	_	
102-45	16137-16140	and	_	
102-46	16141-16146	women	_	
102-47	16147-16148	(	_	
102-48	16148-16149	r	_	
102-49	16149-16150	=	_	
102-50	16150-16154	0.60	_	
102-51	16154-16155	,	_	
102-52	16156-16157	p	_	
102-53	16157-16158	=	_	
102-54	16158-16163	7.54e	_	
102-55	16163-16164	-	_	
102-56	16164-16166	09	_	
102-57	16166-16167	)	_	
102-58	16168-16178	separately	_	
102-59	16178-16179	.	_	

#Text=The AUDIT score was also correlated with BIS score in men and women combined (r=0.29, p=0.0003) and in men (r=0.40, p=0.0007), but not in women (r=0.13, p=0.2770) alone.
103-1	16180-16183	The	_	
103-2	16184-16189	AUDIT	_	
103-3	16190-16195	score	_	
103-4	16196-16199	was	_	
103-5	16200-16204	also	_	
103-6	16205-16215	correlated	_	
103-7	16216-16220	with	_	
103-8	16221-16224	BIS	_	
103-9	16225-16230	score	_	
103-10	16231-16233	in	_	
103-11	16234-16237	men	_	
103-12	16238-16241	and	_	
103-13	16242-16247	women	_	
103-14	16248-16256	combined	_	
103-15	16257-16258	(	_	
103-16	16258-16259	r	_	
103-17	16259-16260	=	_	
103-18	16260-16264	0.29	_	
103-19	16264-16265	,	_	
103-20	16266-16267	p	_	
103-21	16267-16268	=	_	
103-22	16268-16274	0.0003	_	
103-23	16274-16275	)	_	
103-24	16276-16279	and	_	
103-25	16280-16282	in	_	
103-26	16283-16286	men	_	
103-27	16287-16288	(	_	
103-28	16288-16289	r	_	
103-29	16289-16290	=	_	
103-30	16290-16294	0.40	_	
103-31	16294-16295	,	_	
103-32	16296-16297	p	_	
103-33	16297-16298	=	_	
103-34	16298-16304	0.0007	_	
103-35	16304-16305	)	_	
103-36	16305-16306	,	_	
103-37	16307-16310	but	_	
103-38	16311-16314	not	_	
103-39	16315-16317	in	_	
103-40	16318-16323	women	_	
103-41	16324-16325	(	_	
103-42	16325-16326	r	_	
103-43	16326-16327	=	_	
103-44	16327-16331	0.13	_	
103-45	16331-16332	,	_	
103-46	16333-16334	p	_	
103-47	16334-16335	=	_	
103-48	16335-16341	0.2770	_	
103-49	16341-16342	)	_	
103-50	16343-16348	alone	_	
103-51	16348-16349	.	_	

#Text=Behavioral performance in the SST is summarized in Table 2.
104-1	16350-16360	Behavioral	_	
104-2	16361-16372	performance	_	
104-3	16373-16375	in	_	
104-4	16376-16379	the	_	
104-5	16380-16383	SST	_	
104-6	16384-16386	is	_	
104-7	16387-16397	summarized	_	
104-8	16398-16400	in	_	
104-9	16401-16406	Table	_	
104-10	16407-16408	2	_	
104-11	16408-16409	.	_	

#Text=Men and women did not differ in any aspects of task performance, including the extent of post-error slowing (PES).
105-1	16410-16413	Men	_	
105-2	16414-16417	and	_	
105-3	16418-16423	women	_	
105-4	16424-16427	did	_	
105-5	16428-16431	not	_	
105-6	16432-16438	differ	_	
105-7	16439-16441	in	_	
105-8	16442-16445	any	_	
105-9	16446-16453	aspects	_	
105-10	16454-16456	of	_	
105-11	16457-16461	task	_	
105-12	16462-16473	performance	_	
105-13	16473-16474	,	_	
105-14	16475-16484	including	_	
105-15	16485-16488	the	_	
105-16	16489-16495	extent	_	
105-17	16496-16498	of	_	
105-18	16499-16509	post-error	_	
105-19	16510-16517	slowing	_	
105-20	16518-16519	(	_	
105-21	16519-16522	PES	_	
105-22	16522-16523	)	_	
105-23	16523-16524	.	_	

#Text=The effect size of the PES was correlated negatively with AUDIT score in men (r=-0.271, p=0.0255), but not in women (r=0.113, p=0.3300) or in men and women combined (r=-0.097, p=0.2440).
#Text=3.2 Error-related responses and sex differences
#Text=We contrasted stop error and go success trials in a one-sample t-test, which showed higher activations in bilateral frontal and parietal structures, medial frontal cortex, thalamus, bilateral insula and cerebellum (Figure 1A and Table 3).
106-1	16525-16528	The	_	
106-2	16529-16535	effect	_	
106-3	16536-16540	size	_	
106-4	16541-16543	of	_	
106-5	16544-16547	the	_	
106-6	16548-16551	PES	_	
106-7	16552-16555	was	_	
106-8	16556-16566	correlated	_	
106-9	16567-16577	negatively	_	
106-10	16578-16582	with	_	
106-11	16583-16588	AUDIT	_	
106-12	16589-16594	score	_	
106-13	16595-16597	in	_	
106-14	16598-16601	men	_	
106-15	16602-16603	(	_	
106-16	16603-16604	r	_	
106-17	16604-16605	=	_	
106-18	16605-16606	-	_	
106-19	16606-16611	0.271	_	
106-20	16611-16612	,	_	
106-21	16613-16614	p	_	
106-22	16614-16615	=	_	
106-23	16615-16621	0.0255	_	
106-24	16621-16622	)	_	
106-25	16622-16623	,	_	
106-26	16624-16627	but	_	
106-27	16628-16631	not	_	
106-28	16632-16634	in	_	
106-29	16635-16640	women	_	
106-30	16641-16642	(	_	
106-31	16642-16643	r	_	
106-32	16643-16644	=	_	
106-33	16644-16649	0.113	_	
106-34	16649-16650	,	_	
106-35	16651-16652	p	_	
106-36	16652-16653	=	_	
106-37	16653-16659	0.3300	_	
106-38	16659-16660	)	_	
106-39	16661-16663	or	_	
106-40	16664-16666	in	_	
106-41	16667-16670	men	_	
106-42	16671-16674	and	_	
106-43	16675-16680	women	_	
106-44	16681-16689	combined	_	
106-45	16690-16691	(	_	
106-46	16691-16692	r	_	
106-47	16692-16693	=	_	
106-48	16693-16694	-	_	
106-49	16694-16699	0.097	_	
106-50	16699-16700	,	_	
106-51	16701-16702	p	_	
106-52	16702-16703	=	_	
106-53	16703-16709	0.2440	_	
106-54	16709-16710	)	_	
106-55	16710-16711	.	_	
106-56	16712-16715	3.2	_	
106-57	16716-16729	Error-related	_	
106-58	16730-16739	responses	_	
106-59	16740-16743	and	_	
106-60	16744-16747	sex	_	
106-61	16748-16759	differences	_	
106-62	16760-16762	We	_	
106-63	16763-16773	contrasted	_	
106-64	16774-16778	stop	_	
106-65	16779-16784	error	_	
106-66	16785-16788	and	_	
106-67	16789-16791	go	_	
106-68	16792-16799	success	_	
106-69	16800-16806	trials	_	
106-70	16807-16809	in	_	
106-71	16810-16811	a	_	
106-72	16812-16822	one-sample	_	
106-73	16823-16829	t-test	_	
106-74	16829-16830	,	_	
106-75	16831-16836	which	_	
106-76	16837-16843	showed	_	
106-77	16844-16850	higher	_	
106-78	16851-16862	activations	_	
106-79	16863-16865	in	_	
106-80	16866-16875	bilateral	_	
106-81	16876-16883	frontal	_	
106-82	16884-16887	and	_	
106-83	16888-16896	parietal	_	
106-84	16897-16907	structures	_	
106-85	16907-16908	,	_	
106-86	16909-16915	medial	_	
106-87	16916-16923	frontal	_	
106-88	16924-16930	cortex	_	
106-89	16930-16931	,	_	
106-90	16932-16940	thalamus	_	
106-91	16940-16941	,	_	
106-92	16942-16951	bilateral	_	
106-93	16952-16958	insula	_	
106-94	16959-16962	and	_	
106-95	16963-16973	cerebellum	_	
106-96	16974-16975	(	_	
106-97	16975-16981	Figure	_	
106-98	16982-16984	1A	_	
106-99	16985-16988	and	_	
106-100	16989-16994	Table	_	
106-101	16995-16996	3	_	
106-102	16996-16997	)	_	
106-103	16997-16998	.	_	

#Text=In a two-sample t-test we compared men and women in error-related responses.
107-1	16999-17001	In	_	
107-2	17002-17003	a	_	
107-3	17004-17014	two-sample	_	
107-4	17015-17021	t-test	_	
107-5	17022-17024	we	_	
107-6	17025-17033	compared	_	
107-7	17034-17037	men	_	
107-8	17038-17041	and	_	
107-9	17042-17047	women	_	
107-10	17048-17050	in	_	
107-11	17051-17064	error-related	_	
107-12	17065-17074	responses	_	
107-13	17074-17075	.	_	

#Text=Compared to men, women showed higher activities in the thalamus, middle/superior temporal gyrus, and dorsal anterior cingulate cortex (Figure 1B and Table 4).
108-1	17076-17084	Compared	_	
108-2	17085-17087	to	_	
108-3	17088-17091	men	_	
108-4	17091-17092	,	_	
108-5	17093-17098	women	_	
108-6	17099-17105	showed	_	
108-7	17106-17112	higher	_	
108-8	17113-17123	activities	_	
108-9	17124-17126	in	_	
108-10	17127-17130	the	_	
108-11	17131-17139	thalamus	_	
108-12	17139-17140	,	_	
108-13	17141-17147	middle	_	
108-14	17147-17148	/	_	
108-15	17148-17156	superior	_	
108-16	17157-17165	temporal	_	
108-17	17166-17171	gyrus	_	
108-18	17171-17172	,	_	
108-19	17173-17176	and	_	
108-20	17177-17183	dorsal	_	
108-21	17184-17192	anterior	_	
108-22	17193-17202	cingulate	_	
108-23	17203-17209	cortex	_	
108-24	17210-17211	(	_	
108-25	17211-17217	Figure	_	
108-26	17218-17220	1B	_	
108-27	17221-17224	and	_	
108-28	17225-17230	Table	_	
108-29	17231-17232	4	_	
108-30	17232-17233	)	_	
108-31	17233-17234	.	_	

#Text=In contrast, no brain regions showed higher activations in men as compared to women when examined at the same threshold.
109-1	17235-17237	In	_	
109-2	17238-17246	contrast	_	
109-3	17246-17247	,	_	
109-4	17248-17250	no	_	
109-5	17251-17256	brain	_	
109-6	17257-17264	regions	_	
109-7	17265-17271	showed	_	
109-8	17272-17278	higher	_	
109-9	17279-17290	activations	_	
109-10	17291-17293	in	_	
109-11	17294-17297	men	_	
109-12	17298-17300	as	_	
109-13	17301-17309	compared	_	
109-14	17310-17312	to	_	
109-15	17313-17318	women	_	
109-16	17319-17323	when	_	
109-17	17324-17332	examined	_	
109-18	17333-17335	at	_	
109-19	17336-17339	the	_	
109-20	17340-17344	same	_	
109-21	17345-17354	threshold	_	
109-22	17354-17355	.	_	

#Text=To examine whether error-related activations are related to PES across subjects, we conducted a voxel-wise linear regression against PES with age as a covariate for men and women combined and for men and women separately.
110-1	17356-17358	To	_	
110-2	17359-17366	examine	_	
110-3	17367-17374	whether	_	
110-4	17375-17388	error-related	_	
110-5	17389-17400	activations	_	
110-6	17401-17404	are	_	
110-7	17405-17412	related	_	
110-8	17413-17415	to	_	
110-9	17416-17419	PES	_	
110-10	17420-17426	across	_	
110-11	17427-17435	subjects	_	
110-12	17435-17436	,	_	
110-13	17437-17439	we	_	
110-14	17440-17449	conducted	_	
110-15	17450-17451	a	_	
110-16	17452-17462	voxel-wise	_	
110-17	17463-17469	linear	_	
110-18	17470-17480	regression	_	
110-19	17481-17488	against	_	
110-20	17489-17492	PES	_	
110-21	17493-17497	with	_	
110-22	17498-17501	age	_	
110-23	17502-17504	as	_	
110-24	17505-17506	a	_	
110-25	17507-17516	covariate	_	
110-26	17517-17520	for	_	
110-27	17521-17524	men	_	
110-28	17525-17528	and	_	
110-29	17529-17534	women	_	
110-30	17535-17543	combined	_	
110-31	17544-17547	and	_	
110-32	17548-17551	for	_	
110-33	17552-17555	men	_	
110-34	17556-17559	and	_	
110-35	17560-17565	women	_	
110-36	17566-17576	separately	_	
110-37	17576-17577	.	_	

#Text=The results showed that, at the same threshold, no clusters were significantly correlated with PES in any of the three samples of participants.
#Text=3.3 Error-related responses in association with AUDIT score
#Text=In a whole-brain linear regression against AUDIT score, with age as a covariate, we examined how error-related responses are related to problem drinking.
111-1	17578-17581	The	_	
111-2	17582-17589	results	_	
111-3	17590-17596	showed	_	
111-4	17597-17601	that	_	
111-5	17601-17602	,	_	
111-6	17603-17605	at	_	
111-7	17606-17609	the	_	
111-8	17610-17614	same	_	
111-9	17615-17624	threshold	_	
111-10	17624-17625	,	_	
111-11	17626-17628	no	_	
111-12	17629-17637	clusters	_	
111-13	17638-17642	were	_	
111-14	17643-17656	significantly	_	
111-15	17657-17667	correlated	_	
111-16	17668-17672	with	_	
111-17	17673-17676	PES	_	
111-18	17677-17679	in	_	
111-19	17680-17683	any	_	
111-20	17684-17686	of	_	
111-21	17687-17690	the	_	
111-22	17691-17696	three	_	
111-23	17697-17704	samples	_	
111-24	17705-17707	of	_	
111-25	17708-17720	participants	_	
111-26	17720-17721	.	_	
111-27	17722-17725	3.3	_	
111-28	17726-17739	Error-related	_	
111-29	17740-17749	responses	_	
111-30	17750-17752	in	_	
111-31	17753-17764	association	_	
111-32	17765-17769	with	_	
111-33	17770-17775	AUDIT	_	
111-34	17776-17781	score	_	
111-35	17782-17784	In	_	
111-36	17785-17786	a	_	
111-37	17787-17798	whole-brain	_	
111-38	17799-17805	linear	_	
111-39	17806-17816	regression	_	
111-40	17817-17824	against	_	
111-41	17825-17830	AUDIT	_	
111-42	17831-17836	score	_	
111-43	17836-17837	,	_	
111-44	17838-17842	with	_	
111-45	17843-17846	age	_	
111-46	17847-17849	as	_	
111-47	17850-17851	a	_	
111-48	17852-17861	covariate	_	
111-49	17861-17862	,	_	
111-50	17863-17865	we	_	
111-51	17866-17874	examined	_	
111-52	17875-17878	how	_	
111-53	17879-17892	error-related	_	
111-54	17893-17902	responses	_	
111-55	17903-17906	are	_	
111-56	17907-17914	related	_	
111-57	17915-17917	to	_	
111-58	17918-17925	problem	_	
111-59	17926-17934	drinking	_	
111-60	17934-17935	.	_	

#Text=At the threshold of voxel p<0.001, uncorrected and cluster p<0.05 FWE, no clusters showed significant correlations with AUDIT score in men and women combined.
112-1	17936-17938	At	_	
112-2	17939-17942	the	_	
112-3	17943-17952	threshold	_	
112-4	17953-17955	of	_	
112-5	17956-17961	voxel	_	
112-6	17962-17963	p	_	
112-7	17963-17964	<	_	
112-8	17964-17969	0.001	_	
112-9	17969-17970	,	_	
112-10	17971-17982	uncorrected	_	
112-11	17983-17986	and	_	
112-12	17987-17994	cluster	_	
112-13	17995-17996	p	_	
112-14	17996-17997	<	_	
112-15	17997-18001	0.05	_	
112-16	18002-18005	FWE	_	
112-17	18005-18006	,	_	
112-18	18007-18009	no	_	
112-19	18010-18018	clusters	_	
112-20	18019-18025	showed	_	
112-21	18026-18037	significant	_	
112-22	18038-18050	correlations	_	
112-23	18051-18055	with	_	
112-24	18056-18061	AUDIT	_	
112-25	18062-18067	score	_	
112-26	18068-18070	in	_	
112-27	18071-18074	men	_	
112-28	18075-18078	and	_	
112-29	18079-18084	women	_	
112-30	18085-18093	combined	_	
112-31	18093-18094	.	_	

#Text=We performed the same analyses for men and women separately.
113-1	18095-18097	We	_	
113-2	18098-18107	performed	_	
113-3	18108-18111	the	_	
113-4	18112-18116	same	_	
113-5	18117-18125	analyses	_	
113-6	18126-18129	for	_	
113-7	18130-18133	men	_	
113-8	18134-18137	and	_	
113-9	18138-18143	women	_	
113-10	18144-18154	separately	_	
113-11	18154-18155	.	_	

#Text=At the same threshold, no clusters were significantly correlated with AUDIT in men; in contrast, a number of cortical and subcortical structures, including the thalamus, showed negative correlation with AUDIT score in women (Figure 2 and Table 5).
114-1	18156-18158	At	_	
114-2	18159-18162	the	_	
114-3	18163-18167	same	_	
114-4	18168-18177	threshold	_	
114-5	18177-18178	,	_	
114-6	18179-18181	no	_	
114-7	18182-18190	clusters	_	
114-8	18191-18195	were	_	
114-9	18196-18209	significantly	_	
114-10	18210-18220	correlated	_	
114-11	18221-18225	with	_	
114-12	18226-18231	AUDIT	_	
114-13	18232-18234	in	_	
114-14	18235-18238	men	_	
114-15	18238-18239	;	_	
114-16	18240-18242	in	_	
114-17	18243-18251	contrast	_	
114-18	18251-18252	,	_	
114-19	18253-18254	a	_	
114-20	18255-18261	number	_	
114-21	18262-18264	of	_	
114-22	18265-18273	cortical	_	
114-23	18274-18277	and	_	
114-24	18278-18289	subcortical	_	
114-25	18290-18300	structures	_	
114-26	18300-18301	,	_	
114-27	18302-18311	including	_	
114-28	18312-18315	the	_	
114-29	18316-18324	thalamus	_	
114-30	18324-18325	,	_	
114-31	18326-18332	showed	_	
114-32	18333-18341	negative	_	
114-33	18342-18353	correlation	_	
114-34	18354-18358	with	_	
114-35	18359-18364	AUDIT	_	
114-36	18365-18370	score	_	
114-37	18371-18373	in	_	
114-38	18374-18379	women	_	
114-39	18380-18381	(	_	
114-40	18381-18387	Figure	_	
114-41	18388-18389	2	_	
114-42	18390-18393	and	_	
114-43	18394-18399	Table	_	
114-44	18400-18401	5	_	
114-45	18401-18402	)	_	
114-46	18402-18403	.	_	

#Text=In a slope test, the correlations between error-related response of the thalamus and AUDIT score, as well as average monthly number of drinks were significantly different between men and women (Figure 3A and 3B).
115-1	18404-18406	In	_	
115-2	18407-18408	a	_	
115-3	18409-18414	slope	_	
115-4	18415-18419	test	_	
115-5	18419-18420	,	_	
115-6	18421-18424	the	_	
115-7	18425-18437	correlations	_	
115-8	18438-18445	between	_	
115-9	18446-18459	error-related	_	
115-10	18460-18468	response	_	
115-11	18469-18471	of	_	
115-12	18472-18475	the	_	
115-13	18476-18484	thalamus	_	
115-14	18485-18488	and	_	
115-15	18489-18494	AUDIT	_	
115-16	18495-18500	score	_	
115-17	18500-18501	,	_	
115-18	18502-18504	as	_	
115-19	18505-18509	well	_	
115-20	18510-18512	as	_	
115-21	18513-18520	average	_	
115-22	18521-18528	monthly	_	
115-23	18529-18535	number	_	
115-24	18536-18538	of	_	
115-25	18539-18545	drinks	_	
115-26	18546-18550	were	_	
115-27	18551-18564	significantly	_	
115-28	18565-18574	different	_	
115-29	18575-18582	between	_	
115-30	18583-18586	men	_	
115-31	18587-18590	and	_	
115-32	18591-18596	women	_	
115-33	18597-18598	(	_	
115-34	18598-18604	Figure	_	
115-35	18605-18607	3A	_	
115-36	18608-18611	and	_	
115-37	18612-18614	3B	_	
115-38	18614-18615	)	_	
115-39	18615-18616	.	_	

#Text=Notably, at this threshold, the thalamic cluster showing negative correlation with AUDIT score did not appear to overlap with the cluster showing greater error-related activation in women as compared to men.
#Text=4.
116-1	18617-18624	Notably	_	
116-2	18624-18625	,	_	
116-3	18626-18628	at	_	
116-4	18629-18633	this	_	
116-5	18634-18643	threshold	_	
116-6	18643-18644	,	_	
116-7	18645-18648	the	_	
116-8	18649-18657	thalamic	_	
116-9	18658-18665	cluster	_	
116-10	18666-18673	showing	_	
116-11	18674-18682	negative	_	
116-12	18683-18694	correlation	_	
116-13	18695-18699	with	_	
116-14	18700-18705	AUDIT	_	
116-15	18706-18711	score	_	
116-16	18712-18715	did	_	
116-17	18716-18719	not	_	
116-18	18720-18726	appear	_	
116-19	18727-18729	to	_	
116-20	18730-18737	overlap	_	
116-21	18738-18742	with	_	
116-22	18743-18746	the	_	
116-23	18747-18754	cluster	_	
116-24	18755-18762	showing	_	
116-25	18763-18770	greater	_	
116-26	18771-18784	error-related	_	
116-27	18785-18795	activation	_	
116-28	18796-18798	in	_	
116-29	18799-18804	women	_	
116-30	18805-18807	as	_	
116-31	18808-18816	compared	_	
116-32	18817-18819	to	_	
116-33	18820-18823	men	_	
116-34	18823-18824	.	_	
116-35	18825-18826	4	_	
116-36	18826-18827	.	_	

#Text=Discussion
#Text=4.1 Sex differences in error-related activations
#Text=Consistent with a recent meta-analytic review, women showed higher error-related activations as compared to men in the thalamus, middle/superior temporal gyrus, and dorsal anterior cingulate cortex (dACC).
117-1	18828-18838	Discussion	_	
117-2	18839-18842	4.1	_	
117-3	18843-18846	Sex	_	
117-4	18847-18858	differences	_	
117-5	18859-18861	in	_	
117-6	18862-18875	error-related	_	
117-7	18876-18887	activations	_	
117-8	18888-18898	Consistent	_	
117-9	18899-18903	with	_	
117-10	18904-18905	a	_	
117-11	18906-18912	recent	_	
117-12	18913-18926	meta-analytic	_	
117-13	18927-18933	review	_	
117-14	18933-18934	,	_	
117-15	18935-18940	women	_	
117-16	18941-18947	showed	_	
117-17	18948-18954	higher	_	
117-18	18955-18968	error-related	_	
117-19	18969-18980	activations	_	
117-20	18981-18983	as	_	
117-21	18984-18992	compared	_	
117-22	18993-18995	to	_	
117-23	18996-18999	men	_	
117-24	19000-19002	in	_	
117-25	19003-19006	the	_	
117-26	19007-19015	thalamus	_	
117-27	19015-19016	,	_	
117-28	19017-19023	middle	_	
117-29	19023-19024	/	_	
117-30	19024-19032	superior	_	
117-31	19033-19041	temporal	_	
117-32	19042-19047	gyrus	_	
117-33	19047-19048	,	_	
117-34	19049-19052	and	_	
117-35	19053-19059	dorsal	_	
117-36	19060-19068	anterior	_	
117-37	19069-19078	cingulate	_	
117-38	19079-19085	cortex	_	
117-39	19086-19087	(	_	
117-40	19087-19091	dACC	_	
117-41	19091-19092	)	_	
117-42	19092-19093	.	_	

#Text=The thalamus and dACC respond to salient stimuli, likely via noradrenergic projections from the midbrain.
118-1	19094-19097	The	_	
118-2	19098-19106	thalamus	_	
118-3	19107-19110	and	_	
118-4	19111-19115	dACC	_	
118-5	19116-19123	respond	_	
118-6	19124-19126	to	_	
118-7	19127-19134	salient	_	
118-8	19135-19142	stimuli	_	
118-9	19142-19143	,	_	
118-10	19144-19150	likely	_	
118-11	19151-19154	via	_	
118-12	19155-19168	noradrenergic	_	
118-13	19169-19180	projections	_	
118-14	19181-19185	from	_	
118-15	19186-19189	the	_	
118-16	19190-19198	midbrain	_	
118-17	19198-19199	.	_	

#Text=However, women and men did not differ in the extent of post-error slowing and none of the regional activations to errors were related to the extent of post-error slowing either in women or in men, or in women and men combined.
119-1	19200-19207	However	_	
119-2	19207-19208	,	_	
119-3	19209-19214	women	_	
119-4	19215-19218	and	_	
119-5	19219-19222	men	_	
119-6	19223-19226	did	_	
119-7	19227-19230	not	_	
119-8	19231-19237	differ	_	
119-9	19238-19240	in	_	
119-10	19241-19244	the	_	
119-11	19245-19251	extent	_	
119-12	19252-19254	of	_	
119-13	19255-19265	post-error	_	
119-14	19266-19273	slowing	_	
119-15	19274-19277	and	_	
119-16	19278-19282	none	_	
119-17	19283-19285	of	_	
119-18	19286-19289	the	_	
119-19	19290-19298	regional	_	
119-20	19299-19310	activations	_	
119-21	19311-19313	to	_	
119-22	19314-19320	errors	_	
119-23	19321-19325	were	_	
119-24	19326-19333	related	_	
119-25	19334-19336	to	_	
119-26	19337-19340	the	_	
119-27	19341-19347	extent	_	
119-28	19348-19350	of	_	
119-29	19351-19361	post-error	_	
119-30	19362-19369	slowing	_	
119-31	19370-19376	either	_	
119-32	19377-19379	in	_	
119-33	19380-19385	women	_	
119-34	19386-19388	or	_	
119-35	19389-19391	in	_	
119-36	19392-19395	men	_	
119-37	19395-19396	,	_	
119-38	19397-19399	or	_	
119-39	19400-19402	in	_	
119-40	19403-19408	women	_	
119-41	19409-19412	and	_	
119-42	19413-19416	men	_	
119-43	19417-19425	combined	_	
119-44	19425-19426	.	_	

#Text=These findings suggested that increased error-related activities may not reflect a mechanism in women to support post-error behavioral control but simply higher saliency and/or physiological arousal elicited by outcome discrepancy.
120-1	19427-19432	These	_	
120-2	19433-19441	findings	_	
120-3	19442-19451	suggested	_	
120-4	19452-19456	that	_	
120-5	19457-19466	increased	_	
120-6	19467-19480	error-related	_	
120-7	19481-19491	activities	_	
120-8	19492-19495	may	_	
120-9	19496-19499	not	_	
120-10	19500-19507	reflect	_	
120-11	19508-19509	a	_	
120-12	19510-19519	mechanism	_	
120-13	19520-19522	in	_	
120-14	19523-19528	women	_	
120-15	19529-19531	to	_	
120-16	19532-19539	support	_	
120-17	19540-19550	post-error	_	
120-18	19551-19561	behavioral	_	
120-19	19562-19569	control	_	
120-20	19570-19573	but	_	
120-21	19574-19580	simply	_	
120-22	19581-19587	higher	_	
120-23	19588-19596	saliency	_	
120-24	19597-19600	and	_	
120-25	19600-19601	/	_	
120-26	19601-19603	or	_	
120-27	19604-19617	physiological	_	
120-28	19618-19625	arousal	_	
120-29	19626-19634	elicited	_	
120-30	19635-19637	by	_	
120-31	19638-19645	outcome	_	
120-32	19646-19657	discrepancy	_	
120-33	19657-19658	.	_	

#Text=In support, increased thalamic responses were also reported to uncued electric shock in contrast to cued safe condition in female but not male patients with irritable bowel syndrome and to conditioning cues of painful rectal extension in female but not male healthy participants.
121-1	19659-19661	In	_	
121-2	19662-19669	support	_	
121-3	19669-19670	,	_	
121-4	19671-19680	increased	_	
121-5	19681-19689	thalamic	_	
121-6	19690-19699	responses	_	
121-7	19700-19704	were	_	
121-8	19705-19709	also	_	
121-9	19710-19718	reported	_	
121-10	19719-19721	to	_	
121-11	19722-19728	uncued	_	
121-12	19729-19737	electric	_	
121-13	19738-19743	shock	_	
121-14	19744-19746	in	_	
121-15	19747-19755	contrast	_	
121-16	19756-19758	to	_	
121-17	19759-19763	cued	_	
121-18	19764-19768	safe	_	
121-19	19769-19778	condition	_	
121-20	19779-19781	in	_	
121-21	19782-19788	female	_	
121-22	19789-19792	but	_	
121-23	19793-19796	not	_	
121-24	19797-19801	male	_	
121-25	19802-19810	patients	_	
121-26	19811-19815	with	_	
121-27	19816-19825	irritable	_	
121-28	19826-19831	bowel	_	
121-29	19832-19840	syndrome	_	
121-30	19841-19844	and	_	
121-31	19845-19847	to	_	
121-32	19848-19860	conditioning	_	
121-33	19861-19865	cues	_	
121-34	19866-19868	of	_	
121-35	19869-19876	painful	_	
121-36	19877-19883	rectal	_	
121-37	19884-19893	extension	_	
121-38	19894-19896	in	_	
121-39	19897-19903	female	_	
121-40	19904-19907	but	_	
121-41	19908-19911	not	_	
121-42	19912-19916	male	_	
121-43	19917-19924	healthy	_	
121-44	19925-19937	participants	_	
121-45	19937-19938	.	_	

#Text=A rodent study similarly demonstrated greater thalamic and dACC response to visceral pain in female than in male rats.
122-1	19939-19940	A	_	
122-2	19941-19947	rodent	_	
122-3	19948-19953	study	_	
122-4	19954-19963	similarly	_	
122-5	19964-19976	demonstrated	_	
122-6	19977-19984	greater	_	
122-7	19985-19993	thalamic	_	
122-8	19994-19997	and	_	
122-9	19998-20002	dACC	_	
122-10	20003-20011	response	_	
122-11	20012-20014	to	_	
122-12	20015-20023	visceral	_	
122-13	20024-20028	pain	_	
122-14	20029-20031	in	_	
122-15	20032-20038	female	_	
122-16	20039-20043	than	_	
122-17	20044-20046	in	_	
122-18	20047-20051	male	_	
122-19	20052-20056	rats	_	
122-20	20056-20057	.	_	

#Text=In a study of the effects of stress on fear conditioning, administration of hydrocortisone reduced differential thalamic responses to conditioned and unconditioned stimulus in men but enhanced the responses in women.
123-1	20058-20060	In	_	
123-2	20061-20062	a	_	
123-3	20063-20068	study	_	
123-4	20069-20071	of	_	
123-5	20072-20075	the	_	
123-6	20076-20083	effects	_	
123-7	20084-20086	of	_	
123-8	20087-20093	stress	_	
123-9	20094-20096	on	_	
123-10	20097-20101	fear	_	
123-11	20102-20114	conditioning	_	
123-12	20114-20115	,	_	
123-13	20116-20130	administration	_	
123-14	20131-20133	of	_	
123-15	20134-20148	hydrocortisone	_	
123-16	20149-20156	reduced	_	
123-17	20157-20169	differential	_	
123-18	20170-20178	thalamic	_	
123-19	20179-20188	responses	_	
123-20	20189-20191	to	_	
123-21	20192-20203	conditioned	_	
123-22	20204-20207	and	_	
123-23	20208-20221	unconditioned	_	
123-24	20222-20230	stimulus	_	
123-25	20231-20233	in	_	
123-26	20234-20237	men	_	
123-27	20238-20241	but	_	
123-28	20242-20250	enhanced	_	
123-29	20251-20254	the	_	
123-30	20255-20264	responses	_	
123-31	20265-20267	in	_	
123-32	20268-20273	women	_	
123-33	20273-20274	.	_	

#Text=In resting state functional connectivity of the anterior insula, a core structure of the salience processing network, women but not men showed right-lateralized connectivity to the thalamus.
124-1	20275-20277	In	_	
124-2	20278-20285	resting	_	
124-3	20286-20291	state	_	
124-4	20292-20302	functional	_	
124-5	20303-20315	connectivity	_	
124-6	20316-20318	of	_	
124-7	20319-20322	the	_	
124-8	20323-20331	anterior	_	
124-9	20332-20338	insula	_	
124-10	20338-20339	,	_	
124-11	20340-20341	a	_	
124-12	20342-20346	core	_	
124-13	20347-20356	structure	_	
124-14	20357-20359	of	_	
124-15	20360-20363	the	_	
124-16	20364-20372	salience	_	
124-17	20373-20383	processing	_	
124-18	20384-20391	network	_	
124-19	20391-20392	,	_	
124-20	20393-20398	women	_	
124-21	20399-20402	but	_	
124-22	20403-20406	not	_	
124-23	20407-20410	men	_	
124-24	20411-20417	showed	_	
124-25	20418-20435	right-lateralized	_	
124-26	20436-20448	connectivity	_	
124-27	20449-20451	to	_	
124-28	20452-20455	the	_	
124-29	20456-20464	thalamus	_	
124-30	20464-20465	.	_	

#Text=Together, these studies support increased thalamic responses to error-related saliency in women as compared to men.
125-1	20466-20474	Together	_	
125-2	20474-20475	,	_	
125-3	20476-20481	these	_	
125-4	20482-20489	studies	_	
125-5	20490-20497	support	_	
125-6	20498-20507	increased	_	
125-7	20508-20516	thalamic	_	
125-8	20517-20526	responses	_	
125-9	20527-20529	to	_	
125-10	20530-20543	error-related	_	
125-11	20544-20552	saliency	_	
125-12	20553-20555	in	_	
125-13	20556-20561	women	_	
125-14	20562-20564	as	_	
125-15	20565-20573	compared	_	
125-16	20574-20576	to	_	
125-17	20577-20580	men	_	
125-18	20580-20581	.	_	

#Text=More broadly, saliency response is supported by the midbrain noradrenergic system.
126-1	20582-20586	More	_	
126-2	20587-20594	broadly	_	
126-3	20594-20595	,	_	
126-4	20596-20604	saliency	_	
126-5	20605-20613	response	_	
126-6	20614-20616	is	_	
126-7	20617-20626	supported	_	
126-8	20627-20629	by	_	
126-9	20630-20633	the	_	
126-10	20634-20642	midbrain	_	
126-11	20643-20656	noradrenergic	_	
126-12	20657-20663	system	_	
126-13	20663-20664	.	_	

#Text=Animal studies have documented the cellular and molecular mechanisms involving the locus coeruleus (LC) and noradrenergic signaling that underlie sex differences in hyperarousal and other stress-related physiological responses.
127-1	20665-20671	Animal	_	
127-2	20672-20679	studies	_	
127-3	20680-20684	have	_	
127-4	20685-20695	documented	_	
127-5	20696-20699	the	_	
127-6	20700-20708	cellular	_	
127-7	20709-20712	and	_	
127-8	20713-20722	molecular	_	
127-9	20723-20733	mechanisms	_	
127-10	20734-20743	involving	_	
127-11	20744-20747	the	_	
127-12	20748-20753	locus	_	
127-13	20754-20763	coeruleus	_	
127-14	20764-20765	(	_	
127-15	20765-20767	LC	_	
127-16	20767-20768	)	_	
127-17	20769-20772	and	_	
127-18	20773-20786	noradrenergic	_	
127-19	20787-20796	signaling	_	
127-20	20797-20801	that	_	
127-21	20802-20810	underlie	_	
127-22	20811-20814	sex	_	
127-23	20815-20826	differences	_	
127-24	20827-20829	in	_	
127-25	20830-20842	hyperarousal	_	
127-26	20843-20846	and	_	
127-27	20847-20852	other	_	
127-28	20853-20867	stress-related	_	
127-29	20868-20881	physiological	_	
127-30	20882-20891	responses	_	
127-31	20891-20892	.	_	

#Text=For instance, there were important sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the LC.
128-1	20893-20896	For	_	
128-2	20897-20905	instance	_	
128-3	20905-20906	,	_	
128-4	20907-20912	there	_	
128-5	20913-20917	were	_	
128-6	20918-20927	important	_	
128-7	20928-20931	sex	_	
128-8	20932-20943	differences	_	
128-9	20944-20946	in	_	
128-10	20947-20950	the	_	
128-11	20951-20961	regulation	_	
128-12	20962-20964	of	_	
128-13	20965-20973	tyrosine	_	
128-14	20974-20985	hydroxylase	_	
128-15	20986-20990	gene	_	
128-16	20991-21004	transcription	_	
128-17	21005-21007	by	_	
128-18	21008-21016	estrogen	_	
128-19	21017-21019	in	_	
128-20	21020-21023	the	_	
128-21	21024-21026	LC	_	
128-22	21026-21027	.	_	

#Text=Further, hyperarousal has been attributed to corticotropin-releasing factor (CRF) regulation of LC activity, with females particularly affected by conditions resulting in elevated CRF receptor trafficking and LC discharge rate.
129-1	21028-21035	Further	_	
129-2	21035-21036	,	_	
129-3	21037-21049	hyperarousal	_	
129-4	21050-21053	has	_	
129-5	21054-21058	been	_	
129-6	21059-21069	attributed	_	
129-7	21070-21072	to	_	
129-8	21073-21096	corticotropin-releasing	_	
129-9	21097-21103	factor	_	
129-10	21104-21105	(	_	
129-11	21105-21108	CRF	_	
129-12	21108-21109	)	_	
129-13	21110-21120	regulation	_	
129-14	21121-21123	of	_	
129-15	21124-21126	LC	_	
129-16	21127-21135	activity	_	
129-17	21135-21136	,	_	
129-18	21137-21141	with	_	
129-19	21142-21149	females	_	
129-20	21150-21162	particularly	_	
129-21	21163-21171	affected	_	
129-22	21172-21174	by	_	
129-23	21175-21185	conditions	_	
129-24	21186-21195	resulting	_	
129-25	21196-21198	in	_	
129-26	21199-21207	elevated	_	
129-27	21208-21211	CRF	_	
129-28	21212-21220	receptor	_	
129-29	21221-21232	trafficking	_	
129-30	21233-21236	and	_	
129-31	21237-21239	LC	_	
129-32	21240-21249	discharge	_	
129-33	21250-21254	rate	_	
129-34	21254-21255	.	_	

#Text=Heightened LC activity and saliency response may contribute to the increased incidence of stress-related psychiatric disorders in females.
130-1	21256-21266	Heightened	_	
130-2	21267-21269	LC	_	
130-3	21270-21278	activity	_	
130-4	21279-21282	and	_	
130-5	21283-21291	saliency	_	
130-6	21292-21300	response	_	
130-7	21301-21304	may	_	
130-8	21305-21315	contribute	_	
130-9	21316-21318	to	_	
130-10	21319-21322	the	_	
130-11	21323-21332	increased	_	
130-12	21333-21342	incidence	_	
130-13	21343-21345	of	_	
130-14	21346-21360	stress-related	_	
130-15	21361-21372	psychiatric	_	
130-16	21373-21382	disorders	_	
130-17	21383-21385	in	_	
130-18	21386-21393	females	_	
130-19	21393-21394	.	_	

#Text=More studies are needed to directly investigate the role of the LC and saliency circuit in error-elicited stress response and sex differences in the saliency circuit functions.
#Text=4.2 Error-related activations and problem drinking
#Text=In women but not in men, AUDIT score was correlated with decreased thalamic and medial prefrontal cortical activations.
131-1	21395-21399	More	_	
131-2	21400-21407	studies	_	
131-3	21408-21411	are	_	
131-4	21412-21418	needed	_	
131-5	21419-21421	to	_	
131-6	21422-21430	directly	_	
131-7	21431-21442	investigate	_	
131-8	21443-21446	the	_	
131-9	21447-21451	role	_	
131-10	21452-21454	of	_	
131-11	21455-21458	the	_	
131-12	21459-21461	LC	_	
131-13	21462-21465	and	_	
131-14	21466-21474	saliency	_	
131-15	21475-21482	circuit	_	
131-16	21483-21485	in	_	
131-17	21486-21500	error-elicited	_	
131-18	21501-21507	stress	_	
131-19	21508-21516	response	_	
131-20	21517-21520	and	_	
131-21	21521-21524	sex	_	
131-22	21525-21536	differences	_	
131-23	21537-21539	in	_	
131-24	21540-21543	the	_	
131-25	21544-21552	saliency	_	
131-26	21553-21560	circuit	_	
131-27	21561-21570	functions	_	
131-28	21570-21571	.	_	
131-29	21572-21575	4.2	_	
131-30	21576-21589	Error-related	_	
131-31	21590-21601	activations	_	
131-32	21602-21605	and	_	
131-33	21606-21613	problem	_	
131-34	21614-21622	drinking	_	
131-35	21623-21625	In	_	
131-36	21626-21631	women	_	
131-37	21632-21635	but	_	
131-38	21636-21639	not	_	
131-39	21640-21642	in	_	
131-40	21643-21646	men	_	
131-41	21646-21647	,	_	
131-42	21648-21653	AUDIT	_	
131-43	21654-21659	score	_	
131-44	21660-21663	was	_	
131-45	21664-21674	correlated	_	
131-46	21675-21679	with	_	
131-47	21680-21689	decreased	_	
131-48	21690-21698	thalamic	_	
131-49	21699-21702	and	_	
131-50	21703-21709	medial	_	
131-51	21710-21720	prefrontal	_	
131-52	21721-21729	cortical	_	
131-53	21730-21741	activations	_	
131-54	21741-21742	.	_	

#Text=In the context of thalamic response to saliency, this finding suggested that problem drinking is associated with less thalamic activation to saliency in women.
132-1	21743-21745	In	_	
132-2	21746-21749	the	_	
132-3	21750-21757	context	_	
132-4	21758-21760	of	_	
132-5	21761-21769	thalamic	_	
132-6	21770-21778	response	_	
132-7	21779-21781	to	_	
132-8	21782-21790	saliency	_	
132-9	21790-21791	,	_	
132-10	21792-21796	this	_	
132-11	21797-21804	finding	_	
132-12	21805-21814	suggested	_	
132-13	21815-21819	that	_	
132-14	21820-21827	problem	_	
132-15	21828-21836	drinking	_	
132-16	21837-21839	is	_	
132-17	21840-21850	associated	_	
132-18	21851-21855	with	_	
132-19	21856-21860	less	_	
132-20	21861-21869	thalamic	_	
132-21	21870-21880	activation	_	
132-22	21881-21883	to	_	
132-23	21884-21892	saliency	_	
132-24	21893-21895	in	_	
132-25	21896-21901	women	_	
132-26	21901-21902	.	_	

#Text=Alcohol consumption is known to impair detection of performance errors in the dACC.
133-1	21903-21910	Alcohol	_	
133-2	21911-21922	consumption	_	
133-3	21923-21925	is	_	
133-4	21926-21931	known	_	
133-5	21932-21934	to	_	
133-6	21935-21941	impair	_	
133-7	21942-21951	detection	_	
133-8	21952-21954	of	_	
133-9	21955-21966	performance	_	
133-10	21967-21973	errors	_	
133-11	21974-21976	in	_	
133-12	21977-21980	the	_	
133-13	21981-21985	dACC	_	
133-14	21985-21986	.	_	

#Text=Another study examined the effects of emotional distracters on working memory performance.
134-1	21987-21994	Another	_	
134-2	21995-22000	study	_	
134-3	22001-22009	examined	_	
134-4	22010-22013	the	_	
134-5	22014-22021	effects	_	
134-6	22022-22024	of	_	
134-7	22025-22034	emotional	_	
134-8	22035-22046	distracters	_	
134-9	22047-22049	on	_	
134-10	22050-22057	working	_	
134-11	22058-22064	memory	_	
134-12	22065-22076	performance	_	
134-13	22076-22077	.	_	

#Text=Although the study did not focus on sex differences, compared to participants with attention deficit hyperactive disorder, individuals with alcohol dependence were less vulnerable to the intrusion of salient emotional stimuli.
135-1	22078-22086	Although	_	
135-2	22087-22090	the	_	
135-3	22091-22096	study	_	
135-4	22097-22100	did	_	
135-5	22101-22104	not	_	
135-6	22105-22110	focus	_	
135-7	22111-22113	on	_	
135-8	22114-22117	sex	_	
135-9	22118-22129	differences	_	
135-10	22129-22130	,	_	
135-11	22131-22139	compared	_	
135-12	22140-22142	to	_	
135-13	22143-22155	participants	_	
135-14	22156-22160	with	_	
135-15	22161-22170	attention	_	
135-16	22171-22178	deficit	_	
135-17	22179-22190	hyperactive	_	
135-18	22191-22199	disorder	_	
135-19	22199-22200	,	_	
135-20	22201-22212	individuals	_	
135-21	22213-22217	with	_	
135-22	22218-22225	alcohol	_	
135-23	22226-22236	dependence	_	
135-24	22237-22241	were	_	
135-25	22242-22246	less	_	
135-26	22247-22257	vulnerable	_	
135-27	22258-22260	to	_	
135-28	22261-22264	the	_	
135-29	22265-22274	intrusion	_	
135-30	22275-22277	of	_	
135-31	22278-22285	salient	_	
135-32	22286-22295	emotional	_	
135-33	22296-22303	stimuli	_	
135-34	22303-22304	.	_	

#Text=In an event-related potential study heavy drinkers demonstrated reduced P3 amplitude to visual oddball stimuli (Chen et al., 2007).
136-1	22305-22307	In	_	
136-2	22308-22310	an	_	
136-3	22311-22324	event-related	_	
136-4	22325-22334	potential	_	
136-5	22335-22340	study	_	
136-6	22341-22346	heavy	_	
136-7	22347-22355	drinkers	_	
136-8	22356-22368	demonstrated	_	
136-9	22369-22376	reduced	_	
136-10	22377-22379	P3	_	
136-11	22380-22389	amplitude	_	
136-12	22390-22392	to	_	
136-13	22393-22399	visual	_	
136-14	22400-22407	oddball	_	
136-15	22408-22415	stimuli	_	
136-16	22416-22417	(	_	
136-17	22417-22421	Chen	_	
136-18	22422-22424	et	_	
136-19	22425-22427	al	_	
136-20	22427-22428	.	_	
136-21	22428-22429	,	_	
136-22	22430-22434	2007	_	
136-23	22434-22435	)	_	
136-24	22435-22436	.	_	

#Text=A more recent study showed that alcohol dampened functional connectivity between the bilateral anterior insula and the dACC, with greater reduction in right insula-dACC connectivity associated with calmer subjective experience.
137-1	22437-22438	A	_	
137-2	22439-22443	more	_	
137-3	22444-22450	recent	_	
137-4	22451-22456	study	_	
137-5	22457-22463	showed	_	
137-6	22464-22468	that	_	
137-7	22469-22476	alcohol	_	
137-8	22477-22485	dampened	_	
137-9	22486-22496	functional	_	
137-10	22497-22509	connectivity	_	
137-11	22510-22517	between	_	
137-12	22518-22521	the	_	
137-13	22522-22531	bilateral	_	
137-14	22532-22540	anterior	_	
137-15	22541-22547	insula	_	
137-16	22548-22551	and	_	
137-17	22552-22555	the	_	
137-18	22556-22560	dACC	_	
137-19	22560-22561	,	_	
137-20	22562-22566	with	_	
137-21	22567-22574	greater	_	
137-22	22575-22584	reduction	_	
137-23	22585-22587	in	_	
137-24	22588-22593	right	_	
137-25	22594-22605	insula-dACC	_	
137-26	22606-22618	connectivity	_	
137-27	22619-22629	associated	_	
137-28	22630-22634	with	_	
137-29	22635-22641	calmer	_	
137-30	22642-22652	subjective	_	
137-31	22653-22663	experience	_	
137-32	22663-22664	.	_	

#Text=The current findings suggest that, compared to men, women are more vulnerable to the influence of problem drinking in cerebral responses to salient stimuli.
138-1	22665-22668	The	_	
138-2	22669-22676	current	_	
138-3	22677-22685	findings	_	
138-4	22686-22693	suggest	_	
138-5	22694-22698	that	_	
138-6	22698-22699	,	_	
138-7	22700-22708	compared	_	
138-8	22709-22711	to	_	
138-9	22712-22715	men	_	
138-10	22715-22716	,	_	
138-11	22717-22722	women	_	
138-12	22723-22726	are	_	
138-13	22727-22731	more	_	
138-14	22732-22742	vulnerable	_	
138-15	22743-22745	to	_	
138-16	22746-22749	the	_	
138-17	22750-22759	influence	_	
138-18	22760-22762	of	_	
138-19	22763-22770	problem	_	
138-20	22771-22779	drinking	_	
138-21	22780-22782	in	_	
138-22	22783-22791	cerebral	_	
138-23	22792-22801	responses	_	
138-24	22802-22804	to	_	
138-25	22805-22812	salient	_	
138-26	22813-22820	stimuli	_	
138-27	22820-22821	.	_	

#Text=An alternative explanation is that diminished saliency response may represent a more significant risk to problem drinking in women than in men.
139-1	22822-22824	An	_	
139-2	22825-22836	alternative	_	
139-3	22837-22848	explanation	_	
139-4	22849-22851	is	_	
139-5	22852-22856	that	_	
139-6	22857-22867	diminished	_	
139-7	22868-22876	saliency	_	
139-8	22877-22885	response	_	
139-9	22886-22889	may	_	
139-10	22890-22899	represent	_	
139-11	22900-22901	a	_	
139-12	22902-22906	more	_	
139-13	22907-22918	significant	_	
139-14	22919-22923	risk	_	
139-15	22924-22926	to	_	
139-16	22927-22934	problem	_	
139-17	22935-22943	drinking	_	
139-18	22944-22946	in	_	
139-19	22947-22952	women	_	
139-20	22953-22957	than	_	
139-21	22958-22960	in	_	
139-22	22961-22964	men	_	
139-23	22964-22965	.	_	

#Text=Thalamic medial prefrontal cortical circuits are critical to performance monitoring.
140-1	22966-22974	Thalamic	_	
140-2	22975-22981	medial	_	
140-3	22982-22992	prefrontal	_	
140-4	22993-23001	cortical	_	
140-5	23002-23010	circuits	_	
140-6	23011-23014	are	_	
140-7	23015-23023	critical	_	
140-8	23024-23026	to	_	
140-9	23027-23038	performance	_	
140-10	23039-23049	monitoring	_	
140-11	23049-23050	.	_	

#Text=However, here, diminished thalamic and dACC responses to errors were not associated with changes in post-error behavioral adjustment.
141-1	23051-23058	However	_	
141-2	23058-23059	,	_	
141-3	23060-23064	here	_	
141-4	23064-23065	,	_	
141-5	23066-23076	diminished	_	
141-6	23077-23085	thalamic	_	
141-7	23086-23089	and	_	
141-8	23090-23094	dACC	_	
141-9	23095-23104	responses	_	
141-10	23105-23107	to	_	
141-11	23108-23114	errors	_	
141-12	23115-23119	were	_	
141-13	23120-23123	not	_	
141-14	23124-23134	associated	_	
141-15	23135-23139	with	_	
141-16	23140-23147	changes	_	
141-17	23148-23150	in	_	
141-18	23151-23161	post-error	_	
141-19	23162-23172	behavioral	_	
141-20	23173-23183	adjustment	_	
141-21	23183-23184	.	_	

#Text=One possibility is that women were able to elicit reserve mechanisms to compensate for the disruption in saliency response in cognitive control.
142-1	23185-23188	One	_	
142-2	23189-23200	possibility	_	
142-3	23201-23203	is	_	
142-4	23204-23208	that	_	
142-5	23209-23214	women	_	
142-6	23215-23219	were	_	
142-7	23220-23224	able	_	
142-8	23225-23227	to	_	
142-9	23228-23234	elicit	_	
142-10	23235-23242	reserve	_	
142-11	23243-23253	mechanisms	_	
142-12	23254-23256	to	_	
142-13	23257-23267	compensate	_	
142-14	23268-23271	for	_	
142-15	23272-23275	the	_	
142-16	23276-23286	disruption	_	
142-17	23287-23289	in	_	
142-18	23290-23298	saliency	_	
142-19	23299-23307	response	_	
142-20	23308-23310	in	_	
142-21	23311-23320	cognitive	_	
142-22	23321-23328	control	_	
142-23	23328-23329	.	_	

#Text=Interestingly, a closer examination showed that problem drinking is associated with decreased thalamic activity in the ventral and posterior lateral nuclei and the pulvinar in women whereas, compared to men, women showed higher response in the area of dorsal medial and ventral anterior nuclei, according to a recent functional parcellation study of the thalamus.
143-1	23330-23343	Interestingly	_	
143-2	23343-23344	,	_	
143-3	23345-23346	a	_	
143-4	23347-23353	closer	_	
143-5	23354-23365	examination	_	
143-6	23366-23372	showed	_	
143-7	23373-23377	that	_	
143-8	23378-23385	problem	_	
143-9	23386-23394	drinking	_	
143-10	23395-23397	is	_	
143-11	23398-23408	associated	_	
143-12	23409-23413	with	_	
143-13	23414-23423	decreased	_	
143-14	23424-23432	thalamic	_	
143-15	23433-23441	activity	_	
143-16	23442-23444	in	_	
143-17	23445-23448	the	_	
143-18	23449-23456	ventral	_	
143-19	23457-23460	and	_	
143-20	23461-23470	posterior	_	
143-21	23471-23478	lateral	_	
143-22	23479-23485	nuclei	_	
143-23	23486-23489	and	_	
143-24	23490-23493	the	_	
143-25	23494-23502	pulvinar	_	
143-26	23503-23505	in	_	
143-27	23506-23511	women	_	
143-28	23512-23519	whereas	_	
143-29	23519-23520	,	_	
143-30	23521-23529	compared	_	
143-31	23530-23532	to	_	
143-32	23533-23536	men	_	
143-33	23536-23537	,	_	
143-34	23538-23543	women	_	
143-35	23544-23550	showed	_	
143-36	23551-23557	higher	_	
143-37	23558-23566	response	_	
143-38	23567-23569	in	_	
143-39	23570-23573	the	_	
143-40	23574-23578	area	_	
143-41	23579-23581	of	_	
143-42	23582-23588	dorsal	_	
143-43	23589-23595	medial	_	
143-44	23596-23599	and	_	
143-45	23600-23607	ventral	_	
143-46	23608-23616	anterior	_	
143-47	23617-23623	nuclei	_	
143-48	23623-23624	,	_	
143-49	23625-23634	according	_	
143-50	23635-23637	to	_	
143-51	23638-23639	a	_	
143-52	23640-23646	recent	_	
143-53	23647-23657	functional	_	
143-54	23658-23670	parcellation	_	
143-55	23671-23676	study	_	
143-56	23677-23679	of	_	
143-57	23680-23683	the	_	
143-58	23684-23692	thalamus	_	
143-59	23692-23693	.	_	

#Text=We speculate that, by engaging the frontal executive thalamic subregions to a greater extent, women may be better able to accommodate behavioral control despite diminished saliency related activities in the perceptual thalamus.
144-1	23694-23696	We	_	
144-2	23697-23706	speculate	_	
144-3	23707-23711	that	_	
144-4	23711-23712	,	_	
144-5	23713-23715	by	_	
144-6	23716-23724	engaging	_	
144-7	23725-23728	the	_	
144-8	23729-23736	frontal	_	
144-9	23737-23746	executive	_	
144-10	23747-23755	thalamic	_	
144-11	23756-23766	subregions	_	
144-12	23767-23769	to	_	
144-13	23770-23771	a	_	
144-14	23772-23779	greater	_	
144-15	23780-23786	extent	_	
144-16	23786-23787	,	_	
144-17	23788-23793	women	_	
144-18	23794-23797	may	_	
144-19	23798-23800	be	_	
144-20	23801-23807	better	_	
144-21	23808-23812	able	_	
144-22	23813-23815	to	_	
144-23	23816-23827	accommodate	_	
144-24	23828-23838	behavioral	_	
144-25	23839-23846	control	_	
144-26	23847-23854	despite	_	
144-27	23855-23865	diminished	_	
144-28	23866-23874	saliency	_	
144-29	23875-23882	related	_	
144-30	23883-23893	activities	_	
144-31	23894-23896	in	_	
144-32	23897-23900	the	_	
144-33	23901-23911	perceptual	_	
144-34	23912-23920	thalamus	_	
144-35	23920-23921	.	_	

#Text=Compared to women, men are more prone to risk taking and impulsive behavior.
145-1	23922-23930	Compared	_	
145-2	23931-23933	to	_	
145-3	23934-23939	women	_	
145-4	23939-23940	,	_	
145-5	23941-23944	men	_	
145-6	23945-23948	are	_	
145-7	23949-23953	more	_	
145-8	23954-23959	prone	_	
145-9	23960-23962	to	_	
145-10	23963-23967	risk	_	
145-11	23968-23974	taking	_	
145-12	23975-23978	and	_	
145-13	23979-23988	impulsive	_	
145-14	23989-23997	behavior	_	
145-15	23997-23998	.	_	

#Text=Here, men demonstrated higher BIS score, which was associated with elevated physiological arousal to salient stimuli (Zhang et al., 2015), and a significant correlation between BIS and AUDIT scores.
146-1	23999-24003	Here	_	
146-2	24003-24004	,	_	
146-3	24005-24008	men	_	
146-4	24009-24021	demonstrated	_	
146-5	24022-24028	higher	_	
146-6	24029-24032	BIS	_	
146-7	24033-24038	score	_	
146-8	24038-24039	,	_	
146-9	24040-24045	which	_	
146-10	24046-24049	was	_	
146-11	24050-24060	associated	_	
146-12	24061-24065	with	_	
146-13	24066-24074	elevated	_	
146-14	24075-24088	physiological	_	
146-15	24089-24096	arousal	_	
146-16	24097-24099	to	_	
146-17	24100-24107	salient	_	
146-18	24108-24115	stimuli	_	
146-19	24116-24117	(	_	
146-20	24117-24122	Zhang	_	
146-21	24123-24125	et	_	
146-22	24126-24128	al	_	
146-23	24128-24129	.	_	
146-24	24129-24130	,	_	
146-25	24131-24135	2015	_	
146-26	24135-24136	)	_	
146-27	24136-24137	,	_	
146-28	24138-24141	and	_	
146-29	24142-24143	a	_	
146-30	24144-24155	significant	_	
146-31	24156-24167	correlation	_	
146-32	24168-24175	between	_	
146-33	24176-24179	BIS	_	
146-34	24180-24183	and	_	
146-35	24184-24189	AUDIT	_	
146-36	24190-24196	scores	_	
146-37	24196-24197	.	_	

#Text=Thus, although men overall showed less cerebral activations to errors, heavy-drinking men may be more impulsive with higher error response masking the influence of alcohol use.
147-1	24198-24202	Thus	_	
147-2	24202-24203	,	_	
147-3	24204-24212	although	_	
147-4	24213-24216	men	_	
147-5	24217-24224	overall	_	
147-6	24225-24231	showed	_	
147-7	24232-24236	less	_	
147-8	24237-24245	cerebral	_	
147-9	24246-24257	activations	_	
147-10	24258-24260	to	_	
147-11	24261-24267	errors	_	
147-12	24267-24268	,	_	
147-13	24269-24283	heavy-drinking	_	
147-14	24284-24287	men	_	
147-15	24288-24291	may	_	
147-16	24292-24294	be	_	
147-17	24295-24299	more	_	
147-18	24300-24309	impulsive	_	
147-19	24310-24314	with	_	
147-20	24315-24321	higher	_	
147-21	24322-24327	error	_	
147-22	24328-24336	response	_	
147-23	24337-24344	masking	_	
147-24	24345-24348	the	_	
147-25	24349-24358	influence	_	
147-26	24359-24361	of	_	
147-27	24362-24369	alcohol	_	
147-28	24370-24373	use	_	
147-29	24373-24374	.	_	

#Text=These considerations suggest the importance in considering personality traits, including impulsivity, and their interacting effects with alcohol consumption in understanding cerebral responses to cognitive challenges.
#Text=4.3 Limitations and conclusions
#Text=There are a few limitations to consider.
148-1	24375-24380	These	_	
148-2	24381-24395	considerations	_	
148-3	24396-24403	suggest	_	
148-4	24404-24407	the	_	
148-5	24408-24418	importance	_	
148-6	24419-24421	in	_	
148-7	24422-24433	considering	_	
148-8	24434-24445	personality	_	
148-9	24446-24452	traits	_	
148-10	24452-24453	,	_	
148-11	24454-24463	including	_	
148-12	24464-24475	impulsivity	_	
148-13	24475-24476	,	_	
148-14	24477-24480	and	_	
148-15	24481-24486	their	_	
148-16	24487-24498	interacting	_	
148-17	24499-24506	effects	_	
148-18	24507-24511	with	_	
148-19	24512-24519	alcohol	_	
148-20	24520-24531	consumption	_	
148-21	24532-24534	in	_	
148-22	24535-24548	understanding	_	
148-23	24549-24557	cerebral	_	
148-24	24558-24567	responses	_	
148-25	24568-24570	to	_	
148-26	24571-24580	cognitive	_	
148-27	24581-24591	challenges	_	
148-28	24591-24592	.	_	
148-29	24593-24596	4.3	_	
148-30	24597-24608	Limitations	_	
148-31	24609-24612	and	_	
148-32	24613-24624	conclusions	_	
148-33	24625-24630	There	_	
148-34	24631-24634	are	_	
148-35	24635-24636	a	_	
148-36	24637-24640	few	_	
148-37	24641-24652	limitations	_	
148-38	24653-24655	to	_	
148-39	24656-24664	consider	_	
148-40	24664-24665	.	_	

#Text=First, we employed a convenience sample in the current study and did not perform a power analysis of the sample size needed to detect a correlation between error-related activities and post-error slowing.
149-1	24666-24671	First	_	
149-2	24671-24672	,	_	
149-3	24673-24675	we	_	
149-4	24676-24684	employed	_	
149-5	24685-24686	a	_	
149-6	24687-24698	convenience	_	
149-7	24699-24705	sample	_	
149-8	24706-24708	in	_	
149-9	24709-24712	the	_	
149-10	24713-24720	current	_	
149-11	24721-24726	study	_	
149-12	24727-24730	and	_	
149-13	24731-24734	did	_	
149-14	24735-24738	not	_	
149-15	24739-24746	perform	_	
149-16	24747-24748	a	_	
149-17	24749-24754	power	_	
149-18	24755-24763	analysis	_	
149-19	24764-24766	of	_	
149-20	24767-24770	the	_	
149-21	24771-24777	sample	_	
149-22	24778-24782	size	_	
149-23	24783-24789	needed	_	
149-24	24790-24792	to	_	
149-25	24793-24799	detect	_	
149-26	24800-24801	a	_	
149-27	24802-24813	correlation	_	
149-28	24814-24821	between	_	
149-29	24822-24835	error-related	_	
149-30	24836-24846	activities	_	
149-31	24847-24850	and	_	
149-32	24851-24861	post-error	_	
149-33	24862-24869	slowing	_	
149-34	24869-24870	.	_	

#Text=Thus, whether sex and drinking related differences in error response relate to post-error control remains to be clarified.
150-1	24871-24875	Thus	_	
150-2	24875-24876	,	_	
150-3	24877-24884	whether	_	
150-4	24885-24888	sex	_	
150-5	24889-24892	and	_	
150-6	24893-24901	drinking	_	
150-7	24902-24909	related	_	
150-8	24910-24921	differences	_	
150-9	24922-24924	in	_	
150-10	24925-24930	error	_	
150-11	24931-24939	response	_	
150-12	24940-24946	relate	_	
150-13	24947-24949	to	_	
150-14	24950-24960	post-error	_	
150-15	24961-24968	control	_	
150-16	24969-24976	remains	_	
150-17	24977-24979	to	_	
150-18	24980-24982	be	_	
150-19	24983-24992	clarified	_	
150-20	24992-24993	.	_	

#Text=Second, it is not clear from the cross-sectional findings whether decreased error-related responses reflect the effects of alcohol use or a neural process that may dispose women to heavier drinking.
151-1	24994-25000	Second	_	
151-2	25000-25001	,	_	
151-3	25002-25004	it	_	
151-4	25005-25007	is	_	
151-5	25008-25011	not	_	
151-6	25012-25017	clear	_	
151-7	25018-25022	from	_	
151-8	25023-25026	the	_	
151-9	25027-25042	cross-sectional	_	
151-10	25043-25051	findings	_	
151-11	25052-25059	whether	_	
151-12	25060-25069	decreased	_	
151-13	25070-25083	error-related	_	
151-14	25084-25093	responses	_	
151-15	25094-25101	reflect	_	
151-16	25102-25105	the	_	
151-17	25106-25113	effects	_	
151-18	25114-25116	of	_	
151-19	25117-25124	alcohol	_	
151-20	25125-25128	use	_	
151-21	25129-25131	or	_	
151-22	25132-25133	a	_	
151-23	25134-25140	neural	_	
151-24	25141-25148	process	_	
151-25	25149-25153	that	_	
151-26	25154-25157	may	_	
151-27	25158-25165	dispose	_	
151-28	25166-25171	women	_	
151-29	25172-25174	to	_	
151-30	25175-25182	heavier	_	
151-31	25183-25191	drinking	_	
151-32	25191-25192	.	_	

#Text=Further, an earlier study reported diminished error-related negativity in heavy as compared to light or non-drinkers but noted no sex differences.
152-1	25193-25200	Further	_	
152-2	25200-25201	,	_	
152-3	25202-25204	an	_	
152-4	25205-25212	earlier	_	
152-5	25213-25218	study	_	
152-6	25219-25227	reported	_	
152-7	25228-25238	diminished	_	
152-8	25239-25252	error-related	_	
152-9	25253-25263	negativity	_	
152-10	25264-25266	in	_	
152-11	25267-25272	heavy	_	
152-12	25273-25275	as	_	
152-13	25276-25284	compared	_	
152-14	25285-25287	to	_	
152-15	25288-25293	light	_	
152-16	25294-25296	or	_	
152-17	25297-25309	non-drinkers	_	
152-18	25310-25313	but	_	
152-19	25314-25319	noted	_	
152-20	25320-25322	no	_	
152-21	25323-25326	sex	_	
152-22	25327-25338	differences	_	
152-23	25338-25339	.	_	

#Text=Thus, a prospective study involving more heavier-drinking individuals is needed to address these issues.
153-1	25340-25344	Thus	_	
153-2	25344-25345	,	_	
153-3	25346-25347	a	_	
153-4	25348-25359	prospective	_	
153-5	25360-25365	study	_	
153-6	25366-25375	involving	_	
153-7	25376-25380	more	_	
153-8	25381-25397	heavier-drinking	_	
153-9	25398-25409	individuals	_	
153-10	25410-25412	is	_	
153-11	25413-25419	needed	_	
153-12	25420-25422	to	_	
153-13	25423-25430	address	_	
153-14	25431-25436	these	_	
153-15	25437-25443	issues	_	
153-16	25443-25444	.	_	

#Text=In particular, men showed higher AUDIT and BIS score than women, and studies with more women with higher impulsivity and more severe drinking problems would clarify the sources and significance of the sex differences reported here.
154-1	25445-25447	In	_	
154-2	25448-25458	particular	_	
154-3	25458-25459	,	_	
154-4	25460-25463	men	_	
154-5	25464-25470	showed	_	
154-6	25471-25477	higher	_	
154-7	25478-25483	AUDIT	_	
154-8	25484-25487	and	_	
154-9	25488-25491	BIS	_	
154-10	25492-25497	score	_	
154-11	25498-25502	than	_	
154-12	25503-25508	women	_	
154-13	25508-25509	,	_	
154-14	25510-25513	and	_	
154-15	25514-25521	studies	_	
154-16	25522-25526	with	_	
154-17	25527-25531	more	_	
154-18	25532-25537	women	_	
154-19	25538-25542	with	_	
154-20	25543-25549	higher	_	
154-21	25550-25561	impulsivity	_	
154-22	25562-25565	and	_	
154-23	25566-25570	more	_	
154-24	25571-25577	severe	_	
154-25	25578-25586	drinking	_	
154-26	25587-25595	problems	_	
154-27	25596-25601	would	_	
154-28	25602-25609	clarify	_	
154-29	25610-25613	the	_	
154-30	25614-25621	sources	_	
154-31	25622-25625	and	_	
154-32	25626-25638	significance	_	
154-33	25639-25641	of	_	
154-34	25642-25645	the	_	
154-35	25646-25649	sex	_	
154-36	25650-25661	differences	_	
154-37	25662-25670	reported	_	
154-38	25671-25675	here	_	
154-39	25675-25676	.	_	

#Text=Another critical limitation concerns the lack of menstrual cycle information of female participants.
155-1	25677-25684	Another	_	
155-2	25685-25693	critical	_	
155-3	25694-25704	limitation	_	
155-4	25705-25713	concerns	_	
155-5	25714-25717	the	_	
155-6	25718-25722	lack	_	
155-7	25723-25725	of	_	
155-8	25726-25735	menstrual	_	
155-9	25736-25741	cycle	_	
155-10	25742-25753	information	_	
155-11	25754-25756	of	_	
155-12	25757-25763	female	_	
155-13	25764-25776	participants	_	
155-14	25776-25777	.	_	

#Text=Women are known to demonstrate behavioral and cerebral functional differences as hormones fluctuate between follicular and luteal phases.
156-1	25778-25783	Women	_	
156-2	25784-25787	are	_	
156-3	25788-25793	known	_	
156-4	25794-25796	to	_	
156-5	25797-25808	demonstrate	_	
156-6	25809-25819	behavioral	_	
156-7	25820-25823	and	_	
156-8	25824-25832	cerebral	_	
156-9	25833-25843	functional	_	
156-10	25844-25855	differences	_	
156-11	25856-25858	as	_	
156-12	25859-25867	hormones	_	
156-13	25868-25877	fluctuate	_	
156-14	25878-25885	between	_	
156-15	25886-25896	follicular	_	
156-16	25897-25900	and	_	
156-17	25901-25907	luteal	_	
156-18	25908-25914	phases	_	
156-19	25914-25915	.	_	

#Text=More studies are needed to confirm and extend the current findings on sex differences.
157-1	25916-25920	More	_	
157-2	25921-25928	studies	_	
157-3	25929-25932	are	_	
157-4	25933-25939	needed	_	
157-5	25940-25942	to	_	
157-6	25943-25950	confirm	_	
157-7	25951-25954	and	_	
157-8	25955-25961	extend	_	
157-9	25962-25965	the	_	
157-10	25966-25973	current	_	
157-11	25974-25982	findings	_	
157-12	25983-25985	on	_	
157-13	25986-25989	sex	_	
157-14	25990-26001	differences	_	
157-15	26001-26002	.	_	

#Text=Finally, the current cohort comprised primarily light, social drinkers and the findings should be considered as specific to this population.
158-1	26003-26010	Finally	_	
158-2	26010-26011	,	_	
158-3	26012-26015	the	_	
158-4	26016-26023	current	_	
158-5	26024-26030	cohort	_	
158-6	26031-26040	comprised	_	
158-7	26041-26050	primarily	_	
158-8	26051-26056	light	_	
158-9	26056-26057	,	_	
158-10	26058-26064	social	_	
158-11	26065-26073	drinkers	_	
158-12	26074-26077	and	_	
158-13	26078-26081	the	_	
158-14	26082-26090	findings	_	
158-15	26091-26097	should	_	
158-16	26098-26100	be	_	
158-17	26101-26111	considered	_	
158-18	26112-26114	as	_	
158-19	26115-26123	specific	_	
158-20	26124-26126	to	_	
158-21	26127-26131	this	_	
158-22	26132-26142	population	_	
158-23	26142-26143	.	_	

#Text=Further, we did not assess family history of alcoholism, which is known to increase the risk of dysfunctional impulse control and alcohol drinking.
159-1	26144-26151	Further	_	
159-2	26151-26152	,	_	
159-3	26153-26155	we	_	
159-4	26156-26159	did	_	
159-5	26160-26163	not	_	
159-6	26164-26170	assess	_	
159-7	26171-26177	family	_	
159-8	26178-26185	history	_	
159-9	26186-26188	of	_	
159-10	26189-26199	alcoholism	_	
159-11	26199-26200	,	_	
159-12	26201-26206	which	_	
159-13	26207-26209	is	_	
159-14	26210-26215	known	_	
159-15	26216-26218	to	_	
159-16	26219-26227	increase	_	
159-17	26228-26231	the	_	
159-18	26232-26236	risk	_	
159-19	26237-26239	of	_	
159-20	26240-26253	dysfunctional	_	
159-21	26254-26261	impulse	_	
159-22	26262-26269	control	_	
159-23	26270-26273	and	_	
159-24	26274-26281	alcohol	_	
159-25	26282-26290	drinking	_	
159-26	26290-26291	.	_	

#Text=Future work is warranted to address these issues and extend the findings.
160-1	26292-26298	Future	_	
160-2	26299-26303	work	_	
160-3	26304-26306	is	_	
160-4	26307-26316	warranted	_	
160-5	26317-26319	to	_	
160-6	26320-26327	address	_	
160-7	26328-26333	these	_	
160-8	26334-26340	issues	_	
160-9	26341-26344	and	_	
160-10	26345-26351	extend	_	
160-11	26352-26355	the	_	
160-12	26356-26364	findings	_	
160-13	26364-26365	.	_	

#Text=In conclusion, women as compared to men showed higher thalamic cortical responses to errors and reduction in the error responses in association with problem alcohol use.
161-1	26366-26368	In	_	
161-2	26369-26379	conclusion	_	
161-3	26379-26380	,	_	
161-4	26381-26386	women	_	
161-5	26387-26389	as	_	
161-6	26390-26398	compared	_	
161-7	26399-26401	to	_	
161-8	26402-26405	men	_	
161-9	26406-26412	showed	_	
161-10	26413-26419	higher	_	
161-11	26420-26428	thalamic	_	
161-12	26429-26437	cortical	_	
161-13	26438-26447	responses	_	
161-14	26448-26450	to	_	
161-15	26451-26457	errors	_	
161-16	26458-26461	and	_	
161-17	26462-26471	reduction	_	
161-18	26472-26474	in	_	
161-19	26475-26478	the	_	
161-20	26479-26484	error	_	
161-21	26485-26494	responses	_	
161-22	26495-26497	in	_	
161-23	26498-26509	association	_	
161-24	26510-26514	with	_	
161-25	26515-26522	problem	_	
161-26	26523-26530	alcohol	_	
161-27	26531-26534	use	_	
161-28	26534-26535	.	_	

#Text=The findings suggested sex differences in arousal elicited by salient events.
162-1	26536-26539	The	_	
162-2	26540-26548	findings	_	
162-3	26549-26558	suggested	_	
162-4	26559-26562	sex	_	
162-5	26563-26574	differences	_	
162-6	26575-26577	in	_	
162-7	26578-26585	arousal	_	
162-8	26586-26594	elicited	_	
162-9	26595-26597	by	_	
162-10	26598-26605	salient	_	
162-11	26606-26612	events	_	
162-12	26612-26613	.	_	

#Text=More studies are required to determine whether this phenotype reflect sex differences in the influence of alcohol or in the neural processes disposing individuals to problem drinking.
163-1	26614-26618	More	_	
163-2	26619-26626	studies	_	
163-3	26627-26630	are	_	
163-4	26631-26639	required	_	
163-5	26640-26642	to	_	
163-6	26643-26652	determine	_	
163-7	26653-26660	whether	_	
163-8	26661-26665	this	_	
163-9	26666-26675	phenotype	_	
163-10	26676-26683	reflect	_	
163-11	26684-26687	sex	_	
163-12	26688-26699	differences	_	
163-13	26700-26702	in	_	
163-14	26703-26706	the	_	
163-15	26707-26716	influence	_	
163-16	26717-26719	of	_	
163-17	26720-26727	alcohol	_	
163-18	26728-26730	or	_	
163-19	26731-26733	in	_	
163-20	26734-26737	the	_	
163-21	26738-26744	neural	_	
163-22	26745-26754	processes	_	
163-23	26755-26764	disposing	_	
163-24	26765-26776	individuals	_	
163-25	26777-26779	to	_	
163-26	26780-26787	problem	_	
163-27	26788-26796	drinking	_	
163-28	26796-26797	.	_	

#Text=Financial Disclosures: JHK is cosponsor of a patent for the intranasal administration of ketamine for the treatment of depression that was licensed by Janssen Pharmaceuticals, the maker of S-ketamine.
164-1	26798-26807	Financial	_	
164-2	26808-26819	Disclosures	_	
164-3	26819-26820	:	_	
164-4	26821-26824	JHK	_	
164-5	26825-26827	is	_	
164-6	26828-26837	cosponsor	_	
164-7	26838-26840	of	_	
164-8	26841-26842	a	_	
164-9	26843-26849	patent	_	
164-10	26850-26853	for	_	
164-11	26854-26857	the	_	
164-12	26858-26868	intranasal	_	
164-13	26869-26883	administration	_	
164-14	26884-26886	of	_	
164-15	26887-26895	ketamine	_	
164-16	26896-26899	for	_	
164-17	26900-26903	the	_	
164-18	26904-26913	treatment	_	
164-19	26914-26916	of	_	
164-20	26917-26927	depression	_	
164-21	26928-26932	that	_	
164-22	26933-26936	was	_	
164-23	26937-26945	licensed	_	
164-24	26946-26948	by	_	
164-25	26949-26956	Janssen	_	
164-26	26957-26972	Pharmaceuticals	_	
164-27	26972-26973	,	_	
164-28	26974-26977	the	_	
164-29	26978-26983	maker	_	
164-30	26984-26986	of	_	
164-31	26987-26997	S-ketamine	_	
164-32	26997-26998	.	_	

#Text=JHK has a patent related to the use of riluzole to treat anxiety disorders that was licensed by Biohaven Medical Sciences.
165-1	26999-27002	JHK	_	
165-2	27003-27006	has	_	
165-3	27007-27008	a	_	
165-4	27009-27015	patent	_	
165-5	27016-27023	related	_	
165-6	27024-27026	to	_	
165-7	27027-27030	the	_	
165-8	27031-27034	use	_	
165-9	27035-27037	of	_	
165-10	27038-27046	riluzole	_	
165-11	27047-27049	to	_	
165-12	27050-27055	treat	_	
165-13	27056-27063	anxiety	_	
165-14	27064-27073	disorders	_	
165-15	27074-27078	that	_	
165-16	27079-27082	was	_	
165-17	27083-27091	licensed	_	
165-18	27092-27094	by	_	
165-19	27095-27103	Biohaven	_	
165-20	27104-27111	Medical	_	
165-21	27112-27120	Sciences	_	
165-22	27120-27121	.	_	

#Text=JHK has stock or stock options in Biohaven Medical Sciences, ARett Pharmaceuticals, Blackthorn Therapeutics, Spring Health, and Luc Therapeutics.
166-1	27122-27125	JHK	_	
166-2	27126-27129	has	_	
166-3	27130-27135	stock	_	
166-4	27136-27138	or	_	
166-5	27139-27144	stock	_	
166-6	27145-27152	options	_	
166-7	27153-27155	in	_	
166-8	27156-27164	Biohaven	_	
166-9	27165-27172	Medical	_	
166-10	27173-27181	Sciences	_	
166-11	27181-27182	,	_	
166-12	27183-27188	ARett	_	
166-13	27189-27204	Pharmaceuticals	_	
166-14	27204-27205	,	_	
166-15	27206-27216	Blackthorn	_	
166-16	27217-27229	Therapeutics	_	
166-17	27229-27230	,	_	
166-18	27231-27237	Spring	_	
166-19	27238-27244	Health	_	
166-20	27244-27245	,	_	
166-21	27246-27249	and	_	
166-22	27250-27253	Luc	_	
166-23	27254-27266	Therapeutics	_	
166-24	27266-27267	.	_	

#Text=JHK consults broadly to the pharmaceutical industry, but his annual income over the past year did not exceed $5000 for any organization.
167-1	27268-27271	JHK	_	
167-2	27272-27280	consults	_	
167-3	27281-27288	broadly	_	
167-4	27289-27291	to	_	
167-5	27292-27295	the	_	
167-6	27296-27310	pharmaceutical	_	
167-7	27311-27319	industry	_	
167-8	27319-27320	,	_	
167-9	27321-27324	but	_	
167-10	27325-27328	his	_	
167-11	27329-27335	annual	_	
167-12	27336-27342	income	_	
167-13	27343-27347	over	_	
167-14	27348-27351	the	_	
167-15	27352-27356	past	_	
167-16	27357-27361	year	_	
167-17	27362-27365	did	_	
167-18	27366-27369	not	_	
167-19	27370-27376	exceed	_	
167-20	27377-27382	$5000	_	
167-21	27383-27386	for	_	
167-22	27387-27390	any	_	
167-23	27391-27403	organization	_	
167-24	27403-27404	.	_	

#Text=JHK receives more than $5000 in income from the Society of Biological Psychiatry for editing Biological Psychiatry.
168-1	27405-27408	JHK	_	
168-2	27409-27417	receives	_	
168-3	27418-27422	more	_	
168-4	27423-27427	than	_	
168-5	27428-27433	$5000	_	
168-6	27434-27436	in	_	
168-7	27437-27443	income	_	
168-8	27444-27448	from	_	
168-9	27449-27452	the	_	
168-10	27453-27460	Society	_	
168-11	27461-27463	of	_	
168-12	27464-27474	Biological	_	
168-13	27475-27485	Psychiatry	_	
168-14	27486-27489	for	_	
168-15	27490-27497	editing	_	
168-16	27498-27508	Biological	_	
168-17	27509-27519	Psychiatry	_	
168-18	27519-27520	.	_	

#Text=The other authors report no biomedical financial interests or potential conflicts of interest.
169-1	27521-27524	The	_	
169-2	27525-27530	other	_	
169-3	27531-27538	authors	_	
169-4	27539-27545	report	_	
169-5	27546-27548	no	_	
169-6	27549-27559	biomedical	_	
169-7	27560-27569	financial	_	
169-8	27570-27579	interests	_	
169-9	27580-27582	or	_	
169-10	27583-27592	potential	_	
169-11	27593-27602	conflicts	_	
169-12	27603-27605	of	_	
169-13	27606-27614	interest	_	
169-14	27614-27615	.	_	

#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
170-1	27616-27620	This	_	
170-2	27621-27623	is	_	
170-3	27624-27625	a	_	
170-4	27626-27629	PDF	_	
170-5	27630-27634	file	_	
170-6	27635-27637	of	_	
170-7	27638-27640	an	_	
170-8	27641-27649	unedited	_	
170-9	27650-27660	manuscript	_	
170-10	27661-27665	that	_	
170-11	27666-27669	has	_	
170-12	27670-27674	been	_	
170-13	27675-27683	accepted	_	
170-14	27684-27687	for	_	
170-15	27688-27699	publication	_	
170-16	27699-27700	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
171-1	27701-27703	As	_	
171-2	27704-27705	a	_	
171-3	27706-27713	service	_	
171-4	27714-27716	to	_	
171-5	27717-27720	our	_	
171-6	27721-27730	customers	_	
171-7	27731-27733	we	_	
171-8	27734-27737	are	_	
171-9	27738-27747	providing	_	
171-10	27748-27752	this	_	
171-11	27753-27758	early	_	
171-12	27759-27766	version	_	
171-13	27767-27769	of	_	
171-14	27770-27773	the	_	
171-15	27774-27784	manuscript	_	
171-16	27784-27785	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
172-1	27786-27789	The	_	
172-2	27790-27800	manuscript	_	
172-3	27801-27805	will	_	
172-4	27806-27813	undergo	_	
172-5	27814-27825	copyediting	_	
172-6	27825-27826	,	_	
172-7	27827-27838	typesetting	_	
172-8	27838-27839	,	_	
172-9	27840-27843	and	_	
172-10	27844-27850	review	_	
172-11	27851-27853	of	_	
172-12	27854-27857	the	_	
172-13	27858-27867	resulting	_	
172-14	27868-27873	proof	_	
172-15	27874-27880	before	_	
172-16	27881-27883	it	_	
172-17	27884-27886	is	_	
172-18	27887-27896	published	_	
172-19	27897-27899	in	_	
172-20	27900-27903	its	_	
172-21	27904-27909	final	_	
172-22	27910-27917	citable	_	
172-23	27918-27922	form	_	
172-24	27922-27923	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
173-1	27924-27930	Please	_	
173-2	27931-27935	note	_	
173-3	27936-27940	that	_	
173-4	27941-27947	during	_	
173-5	27948-27951	the	_	
173-6	27952-27962	production	_	
173-7	27963-27970	process	_	
173-8	27971-27977	errors	_	
173-9	27978-27981	may	_	
173-10	27982-27984	be	_	
173-11	27985-27995	discovered	_	
173-12	27996-28001	which	_	
173-13	28002-28007	could	_	
173-14	28008-28014	affect	_	
173-15	28015-28018	the	_	
173-16	28019-28026	content	_	
173-17	28026-28027	,	_	
173-18	28028-28031	and	_	
173-19	28032-28035	all	_	
173-20	28036-28041	legal	_	
173-21	28042-28053	disclaimers	_	
173-22	28054-28058	that	_	
173-23	28059-28064	apply	_	
173-24	28065-28067	to	_	
173-25	28068-28071	the	_	
173-26	28072-28079	journal	_	
173-27	28080-28087	pertain	_	
173-28	28087-28088	.	_	

#Text=Neural markers of errors as endophenotypes in neuropsychiatric disorders
#Text=Impaired learning from errors in cannabis users: Dorsal anterior cingulate cortex and hippocampus hypoactivity
#Text=The influence of monetary punishment on cognitive control in abstinent onetary punishment on cognitive control in abstinent cocaine-users
#Text=Power spectrum scale invariance as a neural marker of cocaine misuse and altered cognitive control
#Text=Impaired Bayesian learning for cognitive control in cocaine dependence
#Text=Left middle frontal gyrus response to inhibitory errors in children prospectively predicts early problem substance use
#Text=Neural correlates of correct and failed response inhibition in heavy versus light social drinkers: an fMRI study during a go/no-go task by healthy participants
#Text=Inhibitory control and response monitoring are not systematically related to weekly alcohol consumption in the general population
#Text=Impulsivity and response inhibition in alcohol dependence and problem gambling
#Text=Error detection and behavioural inhibition in young heavy drinkers
#Text=Altered Impulse Control in Alcohol Dependence: Neural Measures of Stop Signal Performance
#Text=Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions
#Text=Cognitive control in alcohol use disorder: deficits and clinical relevance
#Text=Social context and sensation seeking: gender differences in college student drinking motivations
#Text=Gender differences in substance use disorders
#Text=Modeling the impact of age and sex on a dimension of poly-substance use in adolescence: a longitudinal study from 11- to 17-years-old
#Text=Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study
#Text=Introduction: gendering socio cultural alcohol and drug research
#Text=Sweet liking, novelty seeking, and gender predict alcoholic status
#Text=Personality and substance use disorders: I.
174-1	28089-28095	Neural	_	
174-2	28096-28103	markers	_	
174-3	28104-28106	of	_	
174-4	28107-28113	errors	_	
174-5	28114-28116	as	_	
174-6	28117-28131	endophenotypes	_	
174-7	28132-28134	in	_	
174-8	28135-28151	neuropsychiatric	_	
174-9	28152-28161	disorders	_	
174-10	28162-28170	Impaired	_	
174-11	28171-28179	learning	_	
174-12	28180-28184	from	_	
174-13	28185-28191	errors	_	
174-14	28192-28194	in	_	
174-15	28195-28203	cannabis	_	
174-16	28204-28209	users	_	
174-17	28209-28210	:	_	
174-18	28211-28217	Dorsal	_	
174-19	28218-28226	anterior	_	
174-20	28227-28236	cingulate	_	
174-21	28237-28243	cortex	_	
174-22	28244-28247	and	_	
174-23	28248-28259	hippocampus	_	
174-24	28260-28272	hypoactivity	_	
174-25	28273-28276	The	_	
174-26	28277-28286	influence	_	
174-27	28287-28289	of	_	
174-28	28290-28298	monetary	_	
174-29	28299-28309	punishment	_	
174-30	28310-28312	on	_	
174-31	28313-28322	cognitive	_	
174-32	28323-28330	control	_	
174-33	28331-28333	in	_	
174-34	28334-28343	abstinent	_	
174-35	28344-28351	onetary	_	
174-36	28352-28362	punishment	_	
174-37	28363-28365	on	_	
174-38	28366-28375	cognitive	_	
174-39	28376-28383	control	_	
174-40	28384-28386	in	_	
174-41	28387-28396	abstinent	_	
174-42	28397-28410	cocaine-users	_	
174-43	28411-28416	Power	_	
174-44	28417-28425	spectrum	_	
174-45	28426-28431	scale	_	
174-46	28432-28442	invariance	_	
174-47	28443-28445	as	_	
174-48	28446-28447	a	_	
174-49	28448-28454	neural	_	
174-50	28455-28461	marker	_	
174-51	28462-28464	of	_	
174-52	28465-28472	cocaine	_	
174-53	28473-28479	misuse	_	
174-54	28480-28483	and	_	
174-55	28484-28491	altered	_	
174-56	28492-28501	cognitive	_	
174-57	28502-28509	control	_	
174-58	28510-28518	Impaired	_	
174-59	28519-28527	Bayesian	_	
174-60	28528-28536	learning	_	
174-61	28537-28540	for	_	
174-62	28541-28550	cognitive	_	
174-63	28551-28558	control	_	
174-64	28559-28561	in	_	
174-65	28562-28569	cocaine	_	
174-66	28570-28580	dependence	_	
174-67	28581-28585	Left	_	
174-68	28586-28592	middle	_	
174-69	28593-28600	frontal	_	
174-70	28601-28606	gyrus	_	
174-71	28607-28615	response	_	
174-72	28616-28618	to	_	
174-73	28619-28629	inhibitory	_	
174-74	28630-28636	errors	_	
174-75	28637-28639	in	_	
174-76	28640-28648	children	_	
174-77	28649-28662	prospectively	_	
174-78	28663-28671	predicts	_	
174-79	28672-28677	early	_	
174-80	28678-28685	problem	_	
174-81	28686-28695	substance	_	
174-82	28696-28699	use	_	
174-83	28700-28706	Neural	_	
174-84	28707-28717	correlates	_	
174-85	28718-28720	of	_	
174-86	28721-28728	correct	_	
174-87	28729-28732	and	_	
174-88	28733-28739	failed	_	
174-89	28740-28748	response	_	
174-90	28749-28759	inhibition	_	
174-91	28760-28762	in	_	
174-92	28763-28768	heavy	_	
174-93	28769-28775	versus	_	
174-94	28776-28781	light	_	
174-95	28782-28788	social	_	
174-96	28789-28797	drinkers	_	
174-97	28797-28798	:	_	
174-98	28799-28801	an	_	
174-99	28802-28806	fMRI	_	
174-100	28807-28812	study	_	
174-101	28813-28819	during	_	
174-102	28820-28821	a	_	
174-103	28822-28824	go	_	
174-104	28824-28825	/	_	
174-105	28825-28830	no-go	_	
174-106	28831-28835	task	_	
174-107	28836-28838	by	_	
174-108	28839-28846	healthy	_	
174-109	28847-28859	participants	_	
174-110	28860-28870	Inhibitory	_	
174-111	28871-28878	control	_	
174-112	28879-28882	and	_	
174-113	28883-28891	response	_	
174-114	28892-28902	monitoring	_	
174-115	28903-28906	are	_	
174-116	28907-28910	not	_	
174-117	28911-28925	systematically	_	
174-118	28926-28933	related	_	
174-119	28934-28936	to	_	
174-120	28937-28943	weekly	_	
174-121	28944-28951	alcohol	_	
174-122	28952-28963	consumption	_	
174-123	28964-28966	in	_	
174-124	28967-28970	the	_	
174-125	28971-28978	general	_	
174-126	28979-28989	population	_	
174-127	28990-29001	Impulsivity	_	
174-128	29002-29005	and	_	
174-129	29006-29014	response	_	
174-130	29015-29025	inhibition	_	
174-131	29026-29028	in	_	
174-132	29029-29036	alcohol	_	
174-133	29037-29047	dependence	_	
174-134	29048-29051	and	_	
174-135	29052-29059	problem	_	
174-136	29060-29068	gambling	_	
174-137	29069-29074	Error	_	
174-138	29075-29084	detection	_	
174-139	29085-29088	and	_	
174-140	29089-29100	behavioural	_	
174-141	29101-29111	inhibition	_	
174-142	29112-29114	in	_	
174-143	29115-29120	young	_	
174-144	29121-29126	heavy	_	
174-145	29127-29135	drinkers	_	
174-146	29136-29143	Altered	_	
174-147	29144-29151	Impulse	_	
174-148	29152-29159	Control	_	
174-149	29160-29162	in	_	
174-150	29163-29170	Alcohol	_	
174-151	29171-29181	Dependence	_	
174-152	29181-29182	:	_	
174-153	29183-29189	Neural	_	
174-154	29190-29198	Measures	_	
174-155	29199-29201	of	_	
174-156	29202-29206	Stop	_	
174-157	29207-29213	Signal	_	
174-158	29214-29225	Performance	_	
174-159	29226-29236	Systematic	_	
174-160	29237-29243	review	_	
174-161	29244-29246	of	_	
174-162	29247-29250	ERP	_	
174-163	29251-29254	and	_	
174-164	29255-29259	fMRI	_	
174-165	29260-29267	studies	_	
174-166	29268-29281	investigating	_	
174-167	29282-29292	inhibitory	_	
174-168	29293-29300	control	_	
174-169	29301-29304	and	_	
174-170	29305-29310	error	_	
174-171	29311-29321	processing	_	
174-172	29322-29324	in	_	
174-173	29325-29331	people	_	
174-174	29332-29336	with	_	
174-175	29337-29346	substance	_	
174-176	29347-29357	dependence	_	
174-177	29358-29361	and	_	
174-178	29362-29373	behavioural	_	
174-179	29374-29384	addictions	_	
174-180	29385-29394	Cognitive	_	
174-181	29395-29402	control	_	
174-182	29403-29405	in	_	
174-183	29406-29413	alcohol	_	
174-184	29414-29417	use	_	
174-185	29418-29426	disorder	_	
174-186	29426-29427	:	_	
174-187	29428-29436	deficits	_	
174-188	29437-29440	and	_	
174-189	29441-29449	clinical	_	
174-190	29450-29459	relevance	_	
174-191	29460-29466	Social	_	
174-192	29467-29474	context	_	
174-193	29475-29478	and	_	
174-194	29479-29488	sensation	_	
174-195	29489-29496	seeking	_	
174-196	29496-29497	:	_	
174-197	29498-29504	gender	_	
174-198	29505-29516	differences	_	
174-199	29517-29519	in	_	
174-200	29520-29527	college	_	
174-201	29528-29535	student	_	
174-202	29536-29544	drinking	_	
174-203	29545-29556	motivations	_	
174-204	29557-29563	Gender	_	
174-205	29564-29575	differences	_	
174-206	29576-29578	in	_	
174-207	29579-29588	substance	_	
174-208	29589-29592	use	_	
174-209	29593-29602	disorders	_	
174-210	29603-29611	Modeling	_	
174-211	29612-29615	the	_	
174-212	29616-29622	impact	_	
174-213	29623-29625	of	_	
174-214	29626-29629	age	_	
174-215	29630-29633	and	_	
174-216	29634-29637	sex	_	
174-217	29638-29640	on	_	
174-218	29641-29642	a	_	
174-219	29643-29652	dimension	_	
174-220	29653-29655	of	_	
174-221	29656-29670	poly-substance	_	
174-222	29671-29674	use	_	
174-223	29675-29677	in	_	
174-224	29678-29689	adolescence	_	
174-225	29689-29690	:	_	
174-226	29691-29692	a	_	
174-227	29693-29705	longitudinal	_	
174-228	29706-29711	study	_	
174-229	29712-29716	from	_	
174-230	29717-29719	11	_	
174-231	29719-29720	-	_	
174-232	29721-29723	to	_	
174-233	29724-29726	17	_	
174-234	29726-29727	-	_	
174-235	29727-29736	years-old	_	
174-236	29737-29743	Gender	_	
174-237	29744-29755	differences	_	
174-238	29756-29758	in	_	
174-239	29759-29766	alcohol	_	
174-240	29767-29776	treatment	_	
174-241	29776-29777	:	_	
174-242	29778-29780	an	_	
174-243	29781-29789	analysis	_	
174-244	29790-29792	of	_	
174-245	29793-29800	outcome	_	
174-246	29801-29805	from	_	
174-247	29806-29809	the	_	
174-248	29810-29817	COMBINE	_	
174-249	29818-29823	study	_	
174-250	29824-29836	Introduction	_	
174-251	29836-29837	:	_	
174-252	29838-29847	gendering	_	
174-253	29848-29853	socio	_	
174-254	29854-29862	cultural	_	
174-255	29863-29870	alcohol	_	
174-256	29871-29874	and	_	
174-257	29875-29879	drug	_	
174-258	29880-29888	research	_	
174-259	29889-29894	Sweet	_	
174-260	29895-29901	liking	_	
174-261	29901-29902	,	_	
174-262	29903-29910	novelty	_	
174-263	29911-29918	seeking	_	
174-264	29918-29919	,	_	
174-265	29920-29923	and	_	
174-266	29924-29930	gender	_	
174-267	29931-29938	predict	_	
174-268	29939-29948	alcoholic	_	
174-269	29949-29955	status	_	
174-270	29956-29967	Personality	_	
174-271	29968-29971	and	_	
174-272	29972-29981	substance	_	
174-273	29982-29985	use	_	
174-274	29986-29995	disorders	_	
174-275	29995-29996	:	_	
174-276	29997-29998	I	_	
174-277	29998-29999	.	_	

#Text=Effects of gender and alcoholism subtype
#Text=Gender differences in factors influencing alcohol use and drinking progression among adolescents
#Text=Gender differences in risk factors and consequences for alcohol use and problems
#Text=Sex differences in guanfacine effects on drug craving and stress arousal in cocaine-dependent individuals
#Text=Gender differences in craving and cue reactivity to smoking and negative affect/stress cues
#Text=Gender differences in alcohol and substance use relapse
#Text=Gender differences in neural correlates of stress-induced anxiety
#Text=Neuroimaging study of sex differences in the neuropathology of cocaine abuse
#Text=Sex differences in brain activation to emotional stimuli: a meta-analysis of neuroimaging studies
#Text=Gender differences in brain activity toward unpleasant linguistic stimuli concerning interpersonal relationships: an fMRI study
#Text=Gender Influences on Brain Responses to Errors and Post-Error Adjustments
#Text=Sex moderates the relationship between worry and performance monitoring brain activity in undergraduates
#Text=Gender Differences in Cognitive Control: an Extended Investigation of the Stop Signal Task
#Text=Sex dependency of inhibitory control functions
#Text=Cerebral correlates of skin conductance responses in a cognitive task
#Text=Barratt Impulsivity and Neural Regulation of Physiological Arousal
#Text=Dissociable processes of cognitive control during error and non-error conflicts: a study of the stop signal task
#Text=A cerebellar thalamic cortical circuit for error-related cognitive control
#Text=Distinct neural processes support post-success and post-error slowing in the stop signal task
#Text=
#Text=Sex differences in the interacting roles of impulsivity and positive alcohol expectancy in problem drinking: A structural brain imaging study
#Text=
#Text=Estimating risk of alcohol dependence using alcohol screening scores
#Text=Factor structure of the Barratt impulsiveness scale
#Text=A revised Alcohol Expectancy Questionnaire: factor structure confirmation, and invariance in a general population sample
#Text=Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing
#Text=On the ability to inhibit simple and choice reaction time responses: a model and a method
#Text=Decreased saliency processing as a neural measure of Barratt impulsivity in healthy adults
#Text=Error-Related Functional Connectivity of the Habenula in Humans
#Text=Increased error-related thalamic activity during early compared to late cocaine abstinence
#Text=The influence of risky and conservative mental sets on cerebral activations of cognitive control
#Text=Neural bases of individual variation in decision time
#Text=Transformed up-down methods in psychoacoustics
#Text=Sequential estimation of quantal response curves: A new method of estimation
#Text=On the ability to inhibit thought and action: A user's guide to the stop signal paradigm
#Text=Unified segmentation
#Text=The effects of age on cerebral activations: internally versus externally driven processes
#Text=Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates
#Text=
#Text=Sex moderates the association between symptoms of anxiety, but not obsessive compulsive disorder, and error-monitoring brain activity: A meta-analytic review
#Text=Spontaneous pupil dilations during the resting state are associated with activation of the salience network
#Text=The Brainstem in Emotion: A Review
#Text=Anxiety and error monitoring: increased error sensitivity or altered expectations?
175-1	30000-30007	Effects	_	
175-2	30008-30010	of	_	
175-3	30011-30017	gender	_	
175-4	30018-30021	and	_	
175-5	30022-30032	alcoholism	_	
175-6	30033-30040	subtype	_	
175-7	30041-30047	Gender	_	
175-8	30048-30059	differences	_	
175-9	30060-30062	in	_	
175-10	30063-30070	factors	_	
175-11	30071-30082	influencing	_	
175-12	30083-30090	alcohol	_	
175-13	30091-30094	use	_	
175-14	30095-30098	and	_	
175-15	30099-30107	drinking	_	
175-16	30108-30119	progression	_	
175-17	30120-30125	among	_	
175-18	30126-30137	adolescents	_	
175-19	30138-30144	Gender	_	
175-20	30145-30156	differences	_	
175-21	30157-30159	in	_	
175-22	30160-30164	risk	_	
175-23	30165-30172	factors	_	
175-24	30173-30176	and	_	
175-25	30177-30189	consequences	_	
175-26	30190-30193	for	_	
175-27	30194-30201	alcohol	_	
175-28	30202-30205	use	_	
175-29	30206-30209	and	_	
175-30	30210-30218	problems	_	
175-31	30219-30222	Sex	_	
175-32	30223-30234	differences	_	
175-33	30235-30237	in	_	
175-34	30238-30248	guanfacine	_	
175-35	30249-30256	effects	_	
175-36	30257-30259	on	_	
175-37	30260-30264	drug	_	
175-38	30265-30272	craving	_	
175-39	30273-30276	and	_	
175-40	30277-30283	stress	_	
175-41	30284-30291	arousal	_	
175-42	30292-30294	in	_	
175-43	30295-30312	cocaine-dependent	_	
175-44	30313-30324	individuals	_	
175-45	30325-30331	Gender	_	
175-46	30332-30343	differences	_	
175-47	30344-30346	in	_	
175-48	30347-30354	craving	_	
175-49	30355-30358	and	_	
175-50	30359-30362	cue	_	
175-51	30363-30373	reactivity	_	
175-52	30374-30376	to	_	
175-53	30377-30384	smoking	_	
175-54	30385-30388	and	_	
175-55	30389-30397	negative	_	
175-56	30398-30404	affect	_	
175-57	30404-30405	/	_	
175-58	30405-30411	stress	_	
175-59	30412-30416	cues	_	
175-60	30417-30423	Gender	_	
175-61	30424-30435	differences	_	
175-62	30436-30438	in	_	
175-63	30439-30446	alcohol	_	
175-64	30447-30450	and	_	
175-65	30451-30460	substance	_	
175-66	30461-30464	use	_	
175-67	30465-30472	relapse	_	
175-68	30473-30479	Gender	_	
175-69	30480-30491	differences	_	
175-70	30492-30494	in	_	
175-71	30495-30501	neural	_	
175-72	30502-30512	correlates	_	
175-73	30513-30515	of	_	
175-74	30516-30530	stress-induced	_	
175-75	30531-30538	anxiety	_	
175-76	30539-30551	Neuroimaging	_	
175-77	30552-30557	study	_	
175-78	30558-30560	of	_	
175-79	30561-30564	sex	_	
175-80	30565-30576	differences	_	
175-81	30577-30579	in	_	
175-82	30580-30583	the	_	
175-83	30584-30598	neuropathology	_	
175-84	30599-30601	of	_	
175-85	30602-30609	cocaine	_	
175-86	30610-30615	abuse	_	
175-87	30616-30619	Sex	_	
175-88	30620-30631	differences	_	
175-89	30632-30634	in	_	
175-90	30635-30640	brain	_	
175-91	30641-30651	activation	_	
175-92	30652-30654	to	_	
175-93	30655-30664	emotional	_	
175-94	30665-30672	stimuli	_	
175-95	30672-30673	:	_	
175-96	30674-30675	a	_	
175-97	30676-30689	meta-analysis	_	
175-98	30690-30692	of	_	
175-99	30693-30705	neuroimaging	_	
175-100	30706-30713	studies	_	
175-101	30714-30720	Gender	_	
175-102	30721-30732	differences	_	
175-103	30733-30735	in	_	
175-104	30736-30741	brain	_	
175-105	30742-30750	activity	_	
175-106	30751-30757	toward	_	
175-107	30758-30768	unpleasant	_	
175-108	30769-30779	linguistic	_	
175-109	30780-30787	stimuli	_	
175-110	30788-30798	concerning	_	
175-111	30799-30812	interpersonal	_	
175-112	30813-30826	relationships	_	
175-113	30826-30827	:	_	
175-114	30828-30830	an	_	
175-115	30831-30835	fMRI	_	
175-116	30836-30841	study	_	
175-117	30842-30848	Gender	_	
175-118	30849-30859	Influences	_	
175-119	30860-30862	on	_	
175-120	30863-30868	Brain	_	
175-121	30869-30878	Responses	_	
175-122	30879-30881	to	_	
175-123	30882-30888	Errors	_	
175-124	30889-30892	and	_	
175-125	30893-30903	Post-Error	_	
175-126	30904-30915	Adjustments	_	
175-127	30916-30919	Sex	_	
175-128	30920-30929	moderates	_	
175-129	30930-30933	the	_	
175-130	30934-30946	relationship	_	
175-131	30947-30954	between	_	
175-132	30955-30960	worry	_	
175-133	30961-30964	and	_	
175-134	30965-30976	performance	_	
175-135	30977-30987	monitoring	_	
175-136	30988-30993	brain	_	
175-137	30994-31002	activity	_	
175-138	31003-31005	in	_	
175-139	31006-31020	undergraduates	_	
175-140	31021-31027	Gender	_	
175-141	31028-31039	Differences	_	
175-142	31040-31042	in	_	
175-143	31043-31052	Cognitive	_	
175-144	31053-31060	Control	_	
175-145	31060-31061	:	_	
175-146	31062-31064	an	_	
175-147	31065-31073	Extended	_	
175-148	31074-31087	Investigation	_	
175-149	31088-31090	of	_	
175-150	31091-31094	the	_	
175-151	31095-31099	Stop	_	
175-152	31100-31106	Signal	_	
175-153	31107-31111	Task	_	
175-154	31112-31115	Sex	_	
175-155	31116-31126	dependency	_	
175-156	31127-31129	of	_	
175-157	31130-31140	inhibitory	_	
175-158	31141-31148	control	_	
175-159	31149-31158	functions	_	
175-160	31159-31167	Cerebral	_	
175-161	31168-31178	correlates	_	
175-162	31179-31181	of	_	
175-163	31182-31186	skin	_	
175-164	31187-31198	conductance	_	
175-165	31199-31208	responses	_	
175-166	31209-31211	in	_	
175-167	31212-31213	a	_	
175-168	31214-31223	cognitive	_	
175-169	31224-31228	task	_	
175-170	31229-31236	Barratt	_	
175-171	31237-31248	Impulsivity	_	
175-172	31249-31252	and	_	
175-173	31253-31259	Neural	_	
175-174	31260-31270	Regulation	_	
175-175	31271-31273	of	_	
175-176	31274-31287	Physiological	_	
175-177	31288-31295	Arousal	_	
175-178	31296-31307	Dissociable	_	
175-179	31308-31317	processes	_	
175-180	31318-31320	of	_	
175-181	31321-31330	cognitive	_	
175-182	31331-31338	control	_	
175-183	31339-31345	during	_	
175-184	31346-31351	error	_	
175-185	31352-31355	and	_	
175-186	31356-31365	non-error	_	
175-187	31366-31375	conflicts	_	
175-188	31375-31376	:	_	
175-189	31377-31378	a	_	
175-190	31379-31384	study	_	
175-191	31385-31387	of	_	
175-192	31388-31391	the	_	
175-193	31392-31396	stop	_	
175-194	31397-31403	signal	_	
175-195	31404-31408	task	_	
175-196	31409-31410	A	_	
175-197	31411-31421	cerebellar	_	
175-198	31422-31430	thalamic	_	
175-199	31431-31439	cortical	_	
175-200	31440-31447	circuit	_	
175-201	31448-31451	for	_	
175-202	31452-31465	error-related	_	
175-203	31466-31475	cognitive	_	
175-204	31476-31483	control	_	
175-205	31484-31492	Distinct	_	
175-206	31493-31499	neural	_	
175-207	31500-31509	processes	_	
175-208	31510-31517	support	_	
175-209	31518-31530	post-success	_	
175-210	31531-31534	and	_	
175-211	31535-31545	post-error	_	
175-212	31546-31553	slowing	_	
175-213	31554-31556	in	_	
175-214	31557-31560	the	_	
175-215	31561-31565	stop	_	
175-216	31566-31572	signal	_	
175-217	31573-31577	task	_	
175-218	31579-31582	Sex	_	
175-219	31583-31594	differences	_	
175-220	31595-31597	in	_	
175-221	31598-31601	the	_	
175-222	31602-31613	interacting	_	
175-223	31614-31619	roles	_	
175-224	31620-31622	of	_	
175-225	31623-31634	impulsivity	_	
175-226	31635-31638	and	_	
175-227	31639-31647	positive	_	
175-228	31648-31655	alcohol	_	
175-229	31656-31666	expectancy	_	
175-230	31667-31669	in	_	
175-231	31670-31677	problem	_	
175-232	31678-31686	drinking	_	
175-233	31686-31687	:	_	
175-234	31688-31689	A	_	
175-235	31690-31700	structural	_	
175-236	31701-31706	brain	_	
175-237	31707-31714	imaging	_	
175-238	31715-31720	study	_	
175-239	31722-31732	Estimating	_	
175-240	31733-31737	risk	_	
175-241	31738-31740	of	_	
175-242	31741-31748	alcohol	_	
175-243	31749-31759	dependence	_	
175-244	31760-31765	using	_	
175-245	31766-31773	alcohol	_	
175-246	31774-31783	screening	_	
175-247	31784-31790	scores	_	
175-248	31791-31797	Factor	_	
175-249	31798-31807	structure	_	
175-250	31808-31810	of	_	
175-251	31811-31814	the	_	
175-252	31815-31822	Barratt	_	
175-253	31823-31836	impulsiveness	_	
175-254	31837-31842	scale	_	
175-255	31843-31844	A	_	
175-256	31845-31852	revised	_	
175-257	31853-31860	Alcohol	_	
175-258	31861-31871	Expectancy	_	
175-259	31872-31885	Questionnaire	_	
175-260	31885-31886	:	_	
175-261	31887-31893	factor	_	
175-262	31894-31903	structure	_	
175-263	31904-31916	confirmation	_	
175-264	31916-31917	,	_	
175-265	31918-31921	and	_	
175-266	31922-31932	invariance	_	
175-267	31933-31935	in	_	
175-268	31936-31937	a	_	
175-269	31938-31945	general	_	
175-270	31946-31956	population	_	
175-271	31957-31963	sample	_	
175-272	31964-31971	Imaging	_	
175-273	31972-31980	response	_	
175-274	31981-31991	inhibition	_	
175-275	31992-31994	in	_	
175-276	31995-31996	a	_	
175-277	31997-32008	stop-signal	_	
175-278	32009-32013	task	_	
175-279	32013-32014	:	_	
175-280	32015-32021	neural	_	
175-281	32022-32032	correlates	_	
175-282	32033-32044	independent	_	
175-283	32045-32047	of	_	
175-284	32048-32054	signal	_	
175-285	32055-32065	monitoring	_	
175-286	32066-32069	and	_	
175-287	32070-32083	post-response	_	
175-288	32084-32094	processing	_	
175-289	32095-32097	On	_	
175-290	32098-32101	the	_	
175-291	32102-32109	ability	_	
175-292	32110-32112	to	_	
175-293	32113-32120	inhibit	_	
175-294	32121-32127	simple	_	
175-295	32128-32131	and	_	
175-296	32132-32138	choice	_	
175-297	32139-32147	reaction	_	
175-298	32148-32152	time	_	
175-299	32153-32162	responses	_	
175-300	32162-32163	:	_	
175-301	32164-32165	a	_	
175-302	32166-32171	model	_	
175-303	32172-32175	and	_	
175-304	32176-32177	a	_	
175-305	32178-32184	method	_	
175-306	32185-32194	Decreased	_	
175-307	32195-32203	saliency	_	
175-308	32204-32214	processing	_	
175-309	32215-32217	as	_	
175-310	32218-32219	a	_	
175-311	32220-32226	neural	_	
175-312	32227-32234	measure	_	
175-313	32235-32237	of	_	
175-314	32238-32245	Barratt	_	
175-315	32246-32257	impulsivity	_	
175-316	32258-32260	in	_	
175-317	32261-32268	healthy	_	
175-318	32269-32275	adults	_	
175-319	32276-32289	Error-Related	_	
175-320	32290-32300	Functional	_	
175-321	32301-32313	Connectivity	_	
175-322	32314-32316	of	_	
175-323	32317-32320	the	_	
175-324	32321-32329	Habenula	_	
175-325	32330-32332	in	_	
175-326	32333-32339	Humans	_	
175-327	32340-32349	Increased	_	
175-328	32350-32363	error-related	_	
175-329	32364-32372	thalamic	_	
175-330	32373-32381	activity	_	
175-331	32382-32388	during	_	
175-332	32389-32394	early	_	
175-333	32395-32403	compared	_	
175-334	32404-32406	to	_	
175-335	32407-32411	late	_	
175-336	32412-32419	cocaine	_	
175-337	32420-32430	abstinence	_	
175-338	32431-32434	The	_	
175-339	32435-32444	influence	_	
175-340	32445-32447	of	_	
175-341	32448-32453	risky	_	
175-342	32454-32457	and	_	
175-343	32458-32470	conservative	_	
175-344	32471-32477	mental	_	
175-345	32478-32482	sets	_	
175-346	32483-32485	on	_	
175-347	32486-32494	cerebral	_	
175-348	32495-32506	activations	_	
175-349	32507-32509	of	_	
175-350	32510-32519	cognitive	_	
175-351	32520-32527	control	_	
175-352	32528-32534	Neural	_	
175-353	32535-32540	bases	_	
175-354	32541-32543	of	_	
175-355	32544-32554	individual	_	
175-356	32555-32564	variation	_	
175-357	32565-32567	in	_	
175-358	32568-32576	decision	_	
175-359	32577-32581	time	_	
175-360	32582-32593	Transformed	_	
175-361	32594-32601	up-down	_	
175-362	32602-32609	methods	_	
175-363	32610-32612	in	_	
175-364	32613-32628	psychoacoustics	_	
175-365	32629-32639	Sequential	_	
175-366	32640-32650	estimation	_	
175-367	32651-32653	of	_	
175-368	32654-32661	quantal	_	
175-369	32662-32670	response	_	
175-370	32671-32677	curves	_	
175-371	32677-32678	:	_	
175-372	32679-32680	A	_	
175-373	32681-32684	new	_	
175-374	32685-32691	method	_	
175-375	32692-32694	of	_	
175-376	32695-32705	estimation	_	
175-377	32706-32708	On	_	
175-378	32709-32712	the	_	
175-379	32713-32720	ability	_	
175-380	32721-32723	to	_	
175-381	32724-32731	inhibit	_	
175-382	32732-32739	thought	_	
175-383	32740-32743	and	_	
175-384	32744-32750	action	_	
175-385	32750-32751	:	_	
175-386	32752-32753	A	_	
175-387	32754-32760	user's	_	
175-388	32761-32766	guide	_	
175-389	32767-32769	to	_	
175-390	32770-32773	the	_	
175-391	32774-32778	stop	_	
175-392	32779-32785	signal	_	
175-393	32786-32794	paradigm	_	
175-394	32795-32802	Unified	_	
175-395	32803-32815	segmentation	_	
175-396	32816-32819	The	_	
175-397	32820-32827	effects	_	
175-398	32828-32830	of	_	
175-399	32831-32834	age	_	
175-400	32835-32837	on	_	
175-401	32838-32846	cerebral	_	
175-402	32847-32858	activations	_	
175-403	32858-32859	:	_	
175-404	32860-32870	internally	_	
175-405	32871-32877	versus	_	
175-406	32878-32888	externally	_	
175-407	32889-32895	driven	_	
175-408	32896-32905	processes	_	
175-409	32906-32913	Cluster	_	
175-410	32914-32921	failure	_	
175-411	32921-32922	:	_	
175-412	32923-32926	Why	_	
175-413	32927-32931	fMRI	_	
175-414	32932-32942	inferences	_	
175-415	32943-32946	for	_	
175-416	32947-32954	spatial	_	
175-417	32955-32961	extent	_	
175-418	32962-32966	have	_	
175-419	32967-32975	inflated	_	
175-420	32976-32990	false-positive	_	
175-421	32991-32996	rates	_	
175-422	32998-33001	Sex	_	
175-423	33002-33011	moderates	_	
175-424	33012-33015	the	_	
175-425	33016-33027	association	_	
175-426	33028-33035	between	_	
175-427	33036-33044	symptoms	_	
175-428	33045-33047	of	_	
175-429	33048-33055	anxiety	_	
175-430	33055-33056	,	_	
175-431	33057-33060	but	_	
175-432	33061-33064	not	_	
175-433	33065-33074	obsessive	_	
175-434	33075-33085	compulsive	_	
175-435	33086-33094	disorder	_	
175-436	33094-33095	,	_	
175-437	33096-33099	and	_	
175-438	33100-33116	error-monitoring	_	
175-439	33117-33122	brain	_	
175-440	33123-33131	activity	_	
175-441	33131-33132	:	_	
175-442	33133-33134	A	_	
175-443	33135-33148	meta-analytic	_	
175-444	33149-33155	review	_	
175-445	33156-33167	Spontaneous	_	
175-446	33168-33173	pupil	_	
175-447	33174-33183	dilations	_	
175-448	33184-33190	during	_	
175-449	33191-33194	the	_	
175-450	33195-33202	resting	_	
175-451	33203-33208	state	_	
175-452	33209-33212	are	_	
175-453	33213-33223	associated	_	
175-454	33224-33228	with	_	
175-455	33229-33239	activation	_	
175-456	33240-33242	of	_	
175-457	33243-33246	the	_	
175-458	33247-33255	salience	_	
175-459	33256-33263	network	_	
175-460	33264-33267	The	_	
175-461	33268-33277	Brainstem	_	
175-462	33278-33280	in	_	
175-463	33281-33288	Emotion	_	
175-464	33288-33289	:	_	
175-465	33290-33291	A	_	
175-466	33292-33298	Review	_	
175-467	33299-33306	Anxiety	_	
175-468	33307-33310	and	_	
175-469	33311-33316	error	_	
175-470	33317-33327	monitoring	_	
175-471	33327-33328	:	_	
175-472	33329-33338	increased	_	
175-473	33339-33344	error	_	
175-474	33345-33356	sensitivity	_	
175-475	33357-33359	or	_	
175-476	33360-33367	altered	_	
175-477	33368-33380	expectations	_	
175-478	33380-33381	?	_	

#Text=Altered brain responses in subjects with irritable bowel syndrome during cued and uncued pain expectation
#Text=Towards understanding sex differences in visceral pain: enhanced reactivation of classically-conditioned fear in healthy women
#Text=Sex differences in functional brain activation during noxious visceral stimulation in rats
#Text=Investigating the impact of sex and cortisol on implicit fear conditioning with fMRI
#Text=Hemispheric Lateralization of Resting-State Functional Connectivity of the Anterior Insula: Association with Age, Gender, and a Novelty-Seeking Trait
#Text=Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression
#Text=Molecular and cellular sex differences at the intersection of stress and arousal
#Text=Oestrogen receptor beta contributes to the transient sex difference in tyrosine hydroxylase expression in the mouse locus coeruleus
#Text=Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice
#Text=Alcohol consumption impairs detection of performance errors in mediofrontal cortex
#Text=Dissociable patterns in the control of emotional interference in adults with attention-deficit/hyperactivity disorder (ADHD) and in adults with alcohol dependence
#Text=Acute calming effects of alcohol are associated with disruption of the salience network
#Text=Thalamocingulate interactions in performance monitoring
#Text=Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
#Text=Sex differences in the relationship between heavy alcohol use, inhibition and performance monitoring: Disconnect between behavioural and brain functional measures
#Text=Sex as a Biological Variable: Who, What, When, Why, and How
#Text=Why sex hormones matter for neuroscience: A very short review on sex, sex hormones, and functional brain asymmetries
#Text=Family history of alcoholism interacts with alcohol to affect brain regions involved in behavioral inhibition
#Text=(A) Brain regions responding to error: stop error > go success (p<0.05, FWE corrected).
176-1	33382-33389	Altered	_	
176-2	33390-33395	brain	_	
176-3	33396-33405	responses	_	
176-4	33406-33408	in	_	
176-5	33409-33417	subjects	_	
176-6	33418-33422	with	_	
176-7	33423-33432	irritable	_	
176-8	33433-33438	bowel	_	
176-9	33439-33447	syndrome	_	
176-10	33448-33454	during	_	
176-11	33455-33459	cued	_	
176-12	33460-33463	and	_	
176-13	33464-33470	uncued	_	
176-14	33471-33475	pain	_	
176-15	33476-33487	expectation	_	
176-16	33488-33495	Towards	_	
176-17	33496-33509	understanding	_	
176-18	33510-33513	sex	_	
176-19	33514-33525	differences	_	
176-20	33526-33528	in	_	
176-21	33529-33537	visceral	_	
176-22	33538-33542	pain	_	
176-23	33542-33543	:	_	
176-24	33544-33552	enhanced	_	
176-25	33553-33565	reactivation	_	
176-26	33566-33568	of	_	
176-27	33569-33592	classically-conditioned	_	
176-28	33593-33597	fear	_	
176-29	33598-33600	in	_	
176-30	33601-33608	healthy	_	
176-31	33609-33614	women	_	
176-32	33615-33618	Sex	_	
176-33	33619-33630	differences	_	
176-34	33631-33633	in	_	
176-35	33634-33644	functional	_	
176-36	33645-33650	brain	_	
176-37	33651-33661	activation	_	
176-38	33662-33668	during	_	
176-39	33669-33676	noxious	_	
176-40	33677-33685	visceral	_	
176-41	33686-33697	stimulation	_	
176-42	33698-33700	in	_	
176-43	33701-33705	rats	_	
176-44	33706-33719	Investigating	_	
176-45	33720-33723	the	_	
176-46	33724-33730	impact	_	
176-47	33731-33733	of	_	
176-48	33734-33737	sex	_	
176-49	33738-33741	and	_	
176-50	33742-33750	cortisol	_	
176-51	33751-33753	on	_	
176-52	33754-33762	implicit	_	
176-53	33763-33767	fear	_	
176-54	33768-33780	conditioning	_	
176-55	33781-33785	with	_	
176-56	33786-33790	fMRI	_	
176-57	33791-33802	Hemispheric	_	
176-58	33803-33817	Lateralization	_	
176-59	33818-33820	of	_	
176-60	33821-33834	Resting-State	_	
176-61	33835-33845	Functional	_	
176-62	33846-33858	Connectivity	_	
176-63	33859-33861	of	_	
176-64	33862-33865	the	_	
176-65	33866-33874	Anterior	_	
176-66	33875-33881	Insula	_	
176-67	33881-33882	:	_	
176-68	33883-33894	Association	_	
176-69	33895-33899	with	_	
176-70	33900-33903	Age	_	
176-71	33903-33904	,	_	
176-72	33905-33911	Gender	_	
176-73	33911-33912	,	_	
176-74	33913-33916	and	_	
176-75	33917-33918	a	_	
176-76	33919-33934	Novelty-Seeking	_	
176-77	33935-33940	Trait	_	
176-78	33941-33950	Increased	_	
176-79	33951-33964	vulnerability	_	
176-80	33965-33967	of	_	
176-81	33968-33971	the	_	
176-82	33972-33977	brain	_	
176-83	33978-33992	norepinephrine	_	
176-84	33993-33999	system	_	
176-85	34000-34002	of	_	
176-86	34003-34010	females	_	
176-87	34011-34013	to	_	
176-88	34014-34037	corticotropin-releasing	_	
176-89	34038-34044	factor	_	
176-90	34045-34059	overexpression	_	
176-91	34060-34069	Molecular	_	
176-92	34070-34073	and	_	
176-93	34074-34082	cellular	_	
176-94	34083-34086	sex	_	
176-95	34087-34098	differences	_	
176-96	34099-34101	at	_	
176-97	34102-34105	the	_	
176-98	34106-34118	intersection	_	
176-99	34119-34121	of	_	
176-100	34122-34128	stress	_	
176-101	34129-34132	and	_	
176-102	34133-34140	arousal	_	
176-103	34141-34150	Oestrogen	_	
176-104	34151-34159	receptor	_	
176-105	34160-34164	beta	_	
176-106	34165-34176	contributes	_	
176-107	34177-34179	to	_	
176-108	34180-34183	the	_	
176-109	34184-34193	transient	_	
176-110	34194-34197	sex	_	
176-111	34198-34208	difference	_	
176-112	34209-34211	in	_	
176-113	34212-34220	tyrosine	_	
176-114	34221-34232	hydroxylase	_	
176-115	34233-34243	expression	_	
176-116	34244-34246	in	_	
176-117	34247-34250	the	_	
176-118	34251-34256	mouse	_	
176-119	34257-34262	locus	_	
176-120	34263-34272	coeruleus	_	
176-121	34273-34276	Sex	_	
176-122	34277-34288	differences	_	
176-123	34289-34291	in	_	
176-124	34292-34295	the	_	
176-125	34296-34306	regulation	_	
176-126	34307-34309	of	_	
176-127	34310-34318	tyrosine	_	
176-128	34319-34330	hydroxylase	_	
176-129	34331-34335	gene	_	
176-130	34336-34349	transcription	_	
176-131	34350-34352	by	_	
176-132	34353-34361	estrogen	_	
176-133	34362-34364	in	_	
176-134	34365-34368	the	_	
176-135	34369-34374	locus	_	
176-136	34375-34384	coeruleus	_	
176-137	34385-34387	of	_	
176-138	34388-34391	TH9	_	
176-139	34391-34392	-	_	
176-140	34392-34396	LacZ	_	
176-141	34397-34407	transgenic	_	
176-142	34408-34412	mice	_	
176-143	34413-34420	Alcohol	_	
176-144	34421-34432	consumption	_	
176-145	34433-34440	impairs	_	
176-146	34441-34450	detection	_	
176-147	34451-34453	of	_	
176-148	34454-34465	performance	_	
176-149	34466-34472	errors	_	
176-150	34473-34475	in	_	
176-151	34476-34488	mediofrontal	_	
176-152	34489-34495	cortex	_	
176-153	34496-34507	Dissociable	_	
176-154	34508-34516	patterns	_	
176-155	34517-34519	in	_	
176-156	34520-34523	the	_	
176-157	34524-34531	control	_	
176-158	34532-34534	of	_	
176-159	34535-34544	emotional	_	
176-160	34545-34557	interference	_	
176-161	34558-34560	in	_	
176-162	34561-34567	adults	_	
176-163	34568-34572	with	_	
176-164	34573-34590	attention-deficit	_	
176-165	34590-34591	/	_	
176-166	34591-34604	hyperactivity	_	
176-167	34605-34613	disorder	_	
176-168	34614-34615	(	_	
176-169	34615-34619	ADHD	_	
176-170	34619-34620	)	_	
176-171	34621-34624	and	_	
176-172	34625-34627	in	_	
176-173	34628-34634	adults	_	
176-174	34635-34639	with	_	
176-175	34640-34647	alcohol	_	
176-176	34648-34658	dependence	_	
176-177	34659-34664	Acute	_	
176-178	34665-34672	calming	_	
176-179	34673-34680	effects	_	
176-180	34681-34683	of	_	
176-181	34684-34691	alcohol	_	
176-182	34692-34695	are	_	
176-183	34696-34706	associated	_	
176-184	34707-34711	with	_	
176-185	34712-34722	disruption	_	
176-186	34723-34725	of	_	
176-187	34726-34729	the	_	
176-188	34730-34738	salience	_	
176-189	34739-34746	network	_	
176-190	34747-34763	Thalamocingulate	_	
176-191	34764-34776	interactions	_	
176-192	34777-34779	in	_	
176-193	34780-34791	performance	_	
176-194	34792-34802	monitoring	_	
176-195	34803-34815	Non-invasive	_	
176-196	34816-34823	mapping	_	
176-197	34824-34826	of	_	
176-198	34827-34838	connections	_	
176-199	34839-34846	between	_	
176-200	34847-34852	human	_	
176-201	34853-34861	thalamus	_	
176-202	34862-34865	and	_	
176-203	34866-34872	cortex	_	
176-204	34873-34878	using	_	
176-205	34879-34888	diffusion	_	
176-206	34889-34896	imaging	_	
176-207	34897-34900	Sex	_	
176-208	34901-34912	differences	_	
176-209	34913-34915	in	_	
176-210	34916-34919	the	_	
176-211	34920-34932	relationship	_	
176-212	34933-34940	between	_	
176-213	34941-34946	heavy	_	
176-214	34947-34954	alcohol	_	
176-215	34955-34958	use	_	
176-216	34958-34959	,	_	
176-217	34960-34970	inhibition	_	
176-218	34971-34974	and	_	
176-219	34975-34986	performance	_	
176-220	34987-34997	monitoring	_	
176-221	34997-34998	:	_	
176-222	34999-35009	Disconnect	_	
176-223	35010-35017	between	_	
176-224	35018-35029	behavioural	_	
176-225	35030-35033	and	_	
176-226	35034-35039	brain	_	
176-227	35040-35050	functional	_	
176-228	35051-35059	measures	_	
176-229	35060-35063	Sex	_	
176-230	35064-35066	as	_	
176-231	35067-35068	a	_	
176-232	35069-35079	Biological	_	
176-233	35080-35088	Variable	_	
176-234	35088-35089	:	_	
176-235	35090-35093	Who	_	
176-236	35093-35094	,	_	
176-237	35095-35099	What	_	
176-238	35099-35100	,	_	
176-239	35101-35105	When	_	
176-240	35105-35106	,	_	
176-241	35107-35110	Why	_	
176-242	35110-35111	,	_	
176-243	35112-35115	and	_	
176-244	35116-35119	How	_	
176-245	35120-35123	Why	_	
176-246	35124-35127	sex	_	
176-247	35128-35136	hormones	_	
176-248	35137-35143	matter	_	
176-249	35144-35147	for	_	
176-250	35148-35160	neuroscience	_	
176-251	35160-35161	:	_	
176-252	35162-35163	A	_	
176-253	35164-35168	very	_	
176-254	35169-35174	short	_	
176-255	35175-35181	review	_	
176-256	35182-35184	on	_	
176-257	35185-35188	sex	_	
176-258	35188-35189	,	_	
176-259	35190-35193	sex	_	
176-260	35194-35202	hormones	_	
176-261	35202-35203	,	_	
176-262	35204-35207	and	_	
176-263	35208-35218	functional	_	
176-264	35219-35224	brain	_	
176-265	35225-35236	asymmetries	_	
176-266	35237-35243	Family	_	
176-267	35244-35251	history	_	
176-268	35252-35254	of	_	
176-269	35255-35265	alcoholism	_	
176-270	35266-35275	interacts	_	
176-271	35276-35280	with	_	
176-272	35281-35288	alcohol	_	
176-273	35289-35291	to	_	
176-274	35292-35298	affect	_	
176-275	35299-35304	brain	_	
176-276	35305-35312	regions	_	
176-277	35313-35321	involved	_	
176-278	35322-35324	in	_	
176-279	35325-35335	behavioral	_	
176-280	35336-35346	inhibition	_	
176-281	35347-35348	(	_	
176-282	35348-35349	A	_	
176-283	35349-35350	)	_	
176-284	35351-35356	Brain	_	
176-285	35357-35364	regions	_	
176-286	35365-35375	responding	_	
176-287	35376-35378	to	_	
176-288	35379-35384	error	_	
176-289	35384-35385	:	_	
176-290	35386-35390	stop	_	
176-291	35391-35396	error	_	
176-292	35397-35398	>	_	
176-293	35399-35401	go	_	
176-294	35402-35409	success	_	
176-295	35410-35411	(	_	
176-296	35411-35412	p	_	
176-297	35412-35413	<	_	
176-298	35413-35417	0.05	_	
176-299	35417-35418	,	_	
176-300	35419-35422	FWE	_	
176-301	35423-35432	corrected	_	
176-302	35432-35433	)	_	
176-303	35433-35434	.	_	

#Text=(B) Regions showing greater error-related activations in women as compared to men (p<0.001, uncorrected).
177-1	35435-35436	(	_	
177-2	35436-35437	B	_	
177-3	35437-35438	)	_	
177-4	35439-35446	Regions	_	
177-5	35447-35454	showing	_	
177-6	35455-35462	greater	_	
177-7	35463-35476	error-related	_	
177-8	35477-35488	activations	_	
177-9	35489-35491	in	_	
177-10	35492-35497	women	_	
177-11	35498-35500	as	_	
177-12	35501-35509	compared	_	
177-13	35510-35512	to	_	
177-14	35513-35516	men	_	
177-15	35517-35518	(	_	
177-16	35518-35519	p	_	
177-17	35519-35520	<	_	
177-18	35520-35525	0.001	_	
177-19	35525-35526	,	_	
177-20	35527-35538	uncorrected	_	
177-21	35538-35539	)	_	
177-22	35539-35540	.	_	

#Text=The inset highlights the bilateral thalamus clusters.
178-1	35541-35544	The	_	
178-2	35545-35550	inset	_	
178-3	35551-35561	highlights	_	
178-4	35562-35565	the	_	
178-5	35566-35575	bilateral	_	
178-6	35576-35584	thalamus	_	
178-7	35585-35593	clusters	_	
178-8	35593-35594	.	_	

#Text=Clusters that met the corrected extent threshold p<0.05 FWE are shown in Tables 3 and 4.
179-1	35595-35603	Clusters	_	
179-2	35604-35608	that	_	
179-3	35609-35612	met	_	
179-4	35613-35616	the	_	
179-5	35617-35626	corrected	_	
179-6	35627-35633	extent	_	
179-7	35634-35643	threshold	_	
179-8	35644-35645	p	_	
179-9	35645-35646	<	_	
179-10	35646-35650	0.05	_	
179-11	35651-35654	FWE	_	
179-12	35655-35658	are	_	
179-13	35659-35664	shown	_	
179-14	35665-35667	in	_	
179-15	35668-35674	Tables	_	
179-16	35675-35676	3	_	
179-17	35677-35680	and	_	
179-18	35681-35682	4	_	
179-19	35682-35683	.	_	

#Text=Error-related regional activations in correlation with AUDIT score in (A) men and (B) women (p<0.001, uncorrected).
180-1	35684-35697	Error-related	_	
180-2	35698-35706	regional	_	
180-3	35707-35718	activations	_	
180-4	35719-35721	in	_	
180-5	35722-35733	correlation	_	
180-6	35734-35738	with	_	
180-7	35739-35744	AUDIT	_	
180-8	35745-35750	score	_	
180-9	35751-35753	in	_	
180-10	35754-35755	(	_	
180-11	35755-35756	A	_	
180-12	35756-35757	)	_	
180-13	35758-35761	men	_	
180-14	35762-35765	and	_	
180-15	35766-35767	(	_	
180-16	35767-35768	B	_	
180-17	35768-35769	)	_	
180-18	35770-35775	women	_	
180-19	35776-35777	(	_	
180-20	35777-35778	p	_	
180-21	35778-35779	<	_	
180-22	35779-35784	0.001	_	
180-23	35784-35785	,	_	
180-24	35786-35797	uncorrected	_	
180-25	35797-35798	)	_	
180-26	35798-35799	.	_	

#Text=Clusters that met the corrected extent threshold are shown in Table 5.
181-1	35800-35808	Clusters	_	
181-2	35809-35813	that	_	
181-3	35814-35817	met	_	
181-4	35818-35821	the	_	
181-5	35822-35831	corrected	_	
181-6	35832-35838	extent	_	
181-7	35839-35848	threshold	_	
181-8	35849-35852	are	_	
181-9	35853-35858	shown	_	
181-10	35859-35861	in	_	
181-11	35862-35867	Table	_	
181-12	35868-35869	5	_	
181-13	35869-35870	.	_	

#Text=Slope tests confirmed sex differences in the correlation of thalamic error-related response and drinking variables.
182-1	35871-35876	Slope	_	
182-2	35877-35882	tests	_	
182-3	35883-35892	confirmed	_	
182-4	35893-35896	sex	_	
182-5	35897-35908	differences	_	
182-6	35909-35911	in	_	
182-7	35912-35915	the	_	
182-8	35916-35927	correlation	_	
182-9	35928-35930	of	_	
182-10	35931-35939	thalamic	_	
182-11	35940-35953	error-related	_	
182-12	35954-35962	response	_	
182-13	35963-35966	and	_	
182-14	35967-35975	drinking	_	
182-15	35976-35985	variables	_	
182-16	35985-35986	.	_	

#Text=(A) Effect size vs.
183-1	35987-35988	(	_	
183-2	35988-35989	A	_	
183-3	35989-35990	)	_	
183-4	35991-35997	Effect	_	
183-5	35998-36002	size	_	
183-6	36003-36005	vs	_	
183-7	36005-36006	.	_	

#Text=AUDIT (men: r=0.20 and p=0.1091, women: r=-0.43, p=0.0001; slope test: t=4.05; p=8.3e-05).
184-1	36007-36012	AUDIT	_	
184-2	36013-36014	(	_	
184-3	36014-36017	men	_	
184-4	36017-36018	:	_	
184-5	36019-36020	r	_	
184-6	36020-36021	=	_	
184-7	36021-36025	0.20	_	
184-8	36026-36029	and	_	
184-9	36030-36031	p	_	
184-10	36031-36032	=	_	
184-11	36032-36038	0.1091	_	
184-12	36038-36039	,	_	
184-13	36040-36045	women	_	
184-14	36045-36046	:	_	
184-15	36047-36048	r	_	
184-16	36048-36049	=	_	
184-17	36049-36050	-	_	
184-18	36050-36054	0.43	_	
184-19	36054-36055	,	_	
184-20	36056-36057	p	_	
184-21	36057-36058	=	_	
184-22	36058-36064	0.0001	_	
184-23	36064-36065	;	_	
184-24	36066-36071	slope	_	
184-25	36072-36076	test	_	
184-26	36076-36077	:	_	
184-27	36078-36079	t	_	
184-28	36079-36080	=	_	
184-29	36080-36084	4.05	_	
184-30	36084-36085	;	_	
184-31	36086-36087	p	_	
184-32	36087-36088	=	_	
184-33	36088-36092	8.3e	_	
184-34	36092-36093	-	_	
184-35	36093-36095	05	_	
184-36	36095-36096	)	_	
184-37	36096-36097	.	_	

#Text=(B) Effect size vs. average monthly number of drinks (men: r=0.11 and p=0.3781, women: r=-0.30, p=0.0071; slope test: t=2.64; p=0.0092).
185-1	36098-36099	(	_	
185-2	36099-36100	B	_	
185-3	36100-36101	)	_	
185-4	36102-36108	Effect	_	
185-5	36109-36113	size	_	
185-6	36114-36116	vs	_	
185-7	36116-36117	.	_	
185-8	36118-36125	average	_	
185-9	36126-36133	monthly	_	
185-10	36134-36140	number	_	
185-11	36141-36143	of	_	
185-12	36144-36150	drinks	_	
185-13	36151-36152	(	_	
185-14	36152-36155	men	_	
185-15	36155-36156	:	_	
185-16	36157-36158	r	_	
185-17	36158-36159	=	_	
185-18	36159-36163	0.11	_	
185-19	36164-36167	and	_	
185-20	36168-36169	p	_	
185-21	36169-36170	=	_	
185-22	36170-36176	0.3781	_	
185-23	36176-36177	,	_	
185-24	36178-36183	women	_	
185-25	36183-36184	:	_	
185-26	36185-36186	r	_	
185-27	36186-36187	=	_	
185-28	36187-36188	-	_	
185-29	36188-36192	0.30	_	
185-30	36192-36193	,	_	
185-31	36194-36195	p	_	
185-32	36195-36196	=	_	
185-33	36196-36202	0.0071	_	
185-34	36202-36203	;	_	
185-35	36204-36209	slope	_	
185-36	36210-36214	test	_	
185-37	36214-36215	:	_	
185-38	36216-36217	t	_	
185-39	36217-36218	=	_	
185-40	36218-36222	2.64	_	
185-41	36222-36223	;	_	
185-42	36224-36225	p	_	
185-43	36225-36226	=	_	
185-44	36226-36232	0.0092	_	
185-45	36232-36233	)	_	
185-46	36233-36234	.	_	

#Text=Demographics and drinking measures.
186-1	36235-36247	Demographics	_	
186-2	36248-36251	and	_	
186-3	36252-36260	drinking	_	
186-4	36261-36269	measures	_	
186-5	36269-36270	.	_	

#Text=Age (years)\tAUDIT score\tYears drinking\t#Drinks /month\tAE score\tBIS score\t \tAll (n = 145)\t31.5 ± 12.5\t5.1 ± 4.2\t13.6±11.6\t16.9 ± 17.9\t10.9 ± 4.1\t60.7±9.0\t \tWomen (n = 77)\t30.0 ± 11.6\t4.2 ± 3.6\t11.8±10.8\t13.4 ± 15.0\t10.6 ± 4.1\t59.1±9.2\t \tMen (n = 68)\t33.1 ± 13.4\t6.1 ± 4.6\t15.6±12.3\t20.9 ± 20.1\t11.2 ± 4.2\t62.5±8.4\t \tp-value *\t0.1437\t0.0061\t0.0508\t0.0122\t0.4348\t0.0221\t \t
#Text=Note:
#Text=two-tailed two-sample t test; AUDIT: Alcohol Use Disorder Identification Test; AE: alcohol expectancy (global positive); BIS: Barratt Impulsivity Scale.
187-1	36272-36275	Age	_	
187-2	36276-36277	(	_	
187-3	36277-36282	years	_	
187-4	36282-36283	)	_	
187-5	36284-36289	AUDIT	_	
187-6	36290-36295	score	_	
187-7	36296-36301	Years	_	
187-8	36302-36310	drinking	_	
187-9	36311-36312	#	_	
187-10	36312-36318	Drinks	_	
187-11	36319-36320	/	_	
187-12	36320-36325	month	_	
187-13	36326-36328	AE	_	
187-14	36329-36334	score	_	
187-15	36335-36338	BIS	_	
187-16	36339-36344	score	_	
187-17	36347-36350	All	_	
187-18	36351-36352	(	_	
187-19	36352-36353	n	_	
187-20	36354-36355	=	_	
187-21	36356-36359	145	_	
187-22	36359-36360	)	_	
187-23	36361-36365	31.5	_	
187-24	36366-36367	±	_	
187-25	36368-36372	12.5	_	
187-26	36373-36376	5.1	_	
187-27	36377-36378	±	_	
187-28	36379-36382	4.2	_	
187-29	36383-36387	13.6	_	
187-30	36387-36388	±	_	
187-31	36388-36392	11.6	_	
187-32	36393-36397	16.9	_	
187-33	36398-36399	±	_	
187-34	36400-36404	17.9	_	
187-35	36405-36409	10.9	_	
187-36	36410-36411	±	_	
187-37	36412-36415	4.1	_	
187-38	36416-36420	60.7	_	
187-39	36420-36421	±	_	
187-40	36421-36424	9.0	_	
187-41	36427-36432	Women	_	
187-42	36433-36434	(	_	
187-43	36434-36435	n	_	
187-44	36436-36437	=	_	
187-45	36438-36440	77	_	
187-46	36440-36441	)	_	
187-47	36442-36446	30.0	_	
187-48	36447-36448	±	_	
187-49	36449-36453	11.6	_	
187-50	36454-36457	4.2	_	
187-51	36458-36459	±	_	
187-52	36460-36463	3.6	_	
187-53	36464-36468	11.8	_	
187-54	36468-36469	±	_	
187-55	36469-36473	10.8	_	
187-56	36474-36478	13.4	_	
187-57	36479-36480	±	_	
187-58	36481-36485	15.0	_	
187-59	36486-36490	10.6	_	
187-60	36491-36492	±	_	
187-61	36493-36496	4.1	_	
187-62	36497-36501	59.1	_	
187-63	36501-36502	±	_	
187-64	36502-36505	9.2	_	
187-65	36508-36511	Men	_	
187-66	36512-36513	(	_	
187-67	36513-36514	n	_	
187-68	36515-36516	=	_	
187-69	36517-36519	68	_	
187-70	36519-36520	)	_	
187-71	36521-36525	33.1	_	
187-72	36526-36527	±	_	
187-73	36528-36532	13.4	_	
187-74	36533-36536	6.1	_	
187-75	36537-36538	±	_	
187-76	36539-36542	4.6	_	
187-77	36543-36547	15.6	_	
187-78	36547-36548	±	_	
187-79	36548-36552	12.3	_	
187-80	36553-36557	20.9	_	
187-81	36558-36559	±	_	
187-82	36560-36564	20.1	_	
187-83	36565-36569	11.2	_	
187-84	36570-36571	±	_	
187-85	36572-36575	4.2	_	
187-86	36576-36580	62.5	_	
187-87	36580-36581	±	_	
187-88	36581-36584	8.4	_	
187-89	36587-36594	p-value	_	
187-90	36595-36596	*	_	
187-91	36597-36603	0.1437	_	
187-92	36604-36610	0.0061	_	
187-93	36611-36617	0.0508	_	
187-94	36618-36624	0.0122	_	
187-95	36625-36631	0.4348	_	
187-96	36632-36638	0.0221	_	
187-97	36642-36646	Note	_	
187-98	36646-36647	:	_	
187-99	36648-36658	two-tailed	_	
187-100	36659-36669	two-sample	_	
187-101	36670-36671	t	_	
187-102	36672-36676	test	_	
187-103	36676-36677	;	_	
187-104	36678-36683	AUDIT	_	
187-105	36683-36684	:	_	
187-106	36685-36692	Alcohol	_	
187-107	36693-36696	Use	_	
187-108	36697-36705	Disorder	_	
187-109	36706-36720	Identification	_	
187-110	36721-36725	Test	_	
187-111	36725-36726	;	_	
187-112	36727-36729	AE	_	
187-113	36729-36730	:	_	
187-114	36731-36738	alcohol	_	
187-115	36739-36749	expectancy	_	
187-116	36750-36751	(	_	
187-117	36751-36757	global	_	
187-118	36758-36766	positive	_	
187-119	36766-36767	)	_	
187-120	36767-36768	;	_	
187-121	36769-36772	BIS	_	
187-122	36772-36773	:	_	
187-123	36774-36781	Barratt	_	
187-124	36782-36793	Impulsivity	_	
187-125	36794-36799	Scale	_	
187-126	36799-36800	.	_	

#Text=Performance in the stop signal task.
188-1	36801-36812	Performance	_	
188-2	36813-36815	in	_	
188-3	36816-36819	the	_	
188-4	36820-36824	stop	_	
188-5	36825-36831	signal	_	
188-6	36832-36836	task	_	
188-7	36836-36837	.	_	

#Text=SSRT (ms)\tMedian go RT (ms)\t% GS\t% SS\tPES (effect size)\t \tWomen (n = 77)\t217 ± 47\t629 ± 89\t91.1 ± 9.4\t52.3 ± 3.9\t2.2 ± 1.4\t \tMen (n = 68)\t224 ± 38\t648 ± 97\t90.2 ± 9.3\t52.5 ± 4.0\t1.9 ± 1.2\t \tp-value *\t0.34\t0.21\t0.54\t0.66\t0.16\t \t
#Text=Note: All values are mean ± standard deviation; SSRT: stop signal reaction time; RT: reaction time; % GS: percentage of go success trials (RT < 1 s); % SS: percentage of stop success trials; PES: post-error slowing.
#Text=p-value based on 2-tailed 2-sample t-test.
189-1	36839-36843	SSRT	_	
189-2	36844-36845	(	_	
189-3	36845-36847	ms	_	
189-4	36847-36848	)	_	
189-5	36849-36855	Median	_	
189-6	36856-36858	go	_	
189-7	36859-36861	RT	_	
189-8	36862-36863	(	_	
189-9	36863-36865	ms	_	
189-10	36865-36866	)	_	
189-11	36867-36868	%	_	
189-12	36869-36871	GS	_	
189-13	36872-36873	%	_	
189-14	36874-36876	SS	_	
189-15	36877-36880	PES	_	
189-16	36881-36882	(	_	
189-17	36882-36888	effect	_	
189-18	36889-36893	size	_	
189-19	36893-36894	)	_	
189-20	36897-36902	Women	_	
189-21	36903-36904	(	_	
189-22	36904-36905	n	_	
189-23	36906-36907	=	_	
189-24	36908-36910	77	_	
189-25	36910-36911	)	_	
189-26	36912-36915	217	_	
189-27	36916-36917	±	_	
189-28	36918-36920	47	_	
189-29	36921-36924	629	_	
189-30	36925-36926	±	_	
189-31	36927-36929	89	_	
189-32	36930-36934	91.1	_	
189-33	36935-36936	±	_	
189-34	36937-36940	9.4	_	
189-35	36941-36945	52.3	_	
189-36	36946-36947	±	_	
189-37	36948-36951	3.9	_	
189-38	36952-36955	2.2	_	
189-39	36956-36957	±	_	
189-40	36958-36961	1.4	_	
189-41	36964-36967	Men	_	
189-42	36968-36969	(	_	
189-43	36969-36970	n	_	
189-44	36971-36972	=	_	
189-45	36973-36975	68	_	
189-46	36975-36976	)	_	
189-47	36977-36980	224	_	
189-48	36981-36982	±	_	
189-49	36983-36985	38	_	
189-50	36986-36989	648	_	
189-51	36990-36991	±	_	
189-52	36992-36994	97	_	
189-53	36995-36999	90.2	_	
189-54	37000-37001	±	_	
189-55	37002-37005	9.3	_	
189-56	37006-37010	52.5	_	
189-57	37011-37012	±	_	
189-58	37013-37016	4.0	_	
189-59	37017-37020	1.9	_	
189-60	37021-37022	±	_	
189-61	37023-37026	1.2	_	
189-62	37029-37036	p-value	_	
189-63	37037-37038	*	_	
189-64	37039-37043	0.34	_	
189-65	37044-37048	0.21	_	
189-66	37049-37053	0.54	_	
189-67	37054-37058	0.66	_	
189-68	37059-37063	0.16	_	
189-69	37067-37071	Note	_	
189-70	37071-37072	:	_	
189-71	37073-37076	All	_	
189-72	37077-37083	values	_	
189-73	37084-37087	are	_	
189-74	37088-37092	mean	_	
189-75	37093-37094	±	_	
189-76	37095-37103	standard	_	
189-77	37104-37113	deviation	_	
189-78	37113-37114	;	_	
189-79	37115-37119	SSRT	_	
189-80	37119-37120	:	_	
189-81	37121-37125	stop	_	
189-82	37126-37132	signal	_	
189-83	37133-37141	reaction	_	
189-84	37142-37146	time	_	
189-85	37146-37147	;	_	
189-86	37148-37150	RT	_	
189-87	37150-37151	:	_	
189-88	37152-37160	reaction	_	
189-89	37161-37165	time	_	
189-90	37165-37166	;	_	
189-91	37167-37168	%	_	
189-92	37169-37171	GS	_	
189-93	37171-37172	:	_	
189-94	37173-37183	percentage	_	
189-95	37184-37186	of	_	
189-96	37187-37189	go	_	
189-97	37190-37197	success	_	
189-98	37198-37204	trials	_	
189-99	37205-37206	(	_	
189-100	37206-37208	RT	_	
189-101	37209-37210	<	_	
189-102	37211-37212	1	_	
189-103	37213-37214	s	_	
189-104	37214-37215	)	_	
189-105	37215-37216	;	_	
189-106	37217-37218	%	_	
189-107	37219-37221	SS	_	
189-108	37221-37222	:	_	
189-109	37223-37233	percentage	_	
189-110	37234-37236	of	_	
189-111	37237-37241	stop	_	
189-112	37242-37249	success	_	
189-113	37250-37256	trials	_	
189-114	37256-37257	;	_	
189-115	37258-37261	PES	_	
189-116	37261-37262	:	_	
189-117	37263-37273	post-error	_	
189-118	37274-37281	slowing	_	
189-119	37281-37282	.	_	
189-120	37283-37290	p-value	_	
189-121	37291-37296	based	_	
189-122	37297-37299	on	_	
189-123	37300-37301	2	_	
189-124	37301-37302	-	_	
189-125	37302-37308	tailed	_	
189-126	37309-37310	2	_	
189-127	37310-37311	-	_	
189-128	37311-37317	sample	_	
189-129	37318-37324	t-test	_	
189-130	37324-37325	.	_	

#Text=Brain regions showing error-related activations in the stop signal task.
190-1	37326-37331	Brain	_	
190-2	37332-37339	regions	_	
190-3	37340-37347	showing	_	
190-4	37348-37361	error-related	_	
190-5	37362-37373	activations	_	
190-6	37374-37376	in	_	
190-7	37377-37380	the	_	
190-8	37381-37385	stop	_	
190-9	37386-37392	signal	_	
190-10	37393-37397	task	_	
190-11	37397-37398	.	_	

#Text=One sample t-test, p<0.05, FWE corrected.
191-1	37399-37402	One	_	
191-2	37403-37409	sample	_	
191-3	37410-37416	t-test	_	
191-4	37416-37417	,	_	
191-5	37418-37419	p	_	
191-6	37419-37420	<	_	
191-7	37420-37424	0.05	_	
191-8	37424-37425	,	_	
191-9	37426-37429	FWE	_	
191-10	37430-37439	corrected	_	
191-11	37439-37440	.	_	

#Text=Cluster k>100.
192-1	37441-37448	Cluster	_	
192-2	37449-37450	k	_	
192-3	37450-37451	>	_	
192-4	37451-37454	100	_	
192-5	37454-37455	.	_	

#Text=All peak voxels 8 mm apart are identified.
193-1	37456-37459	All	_	
193-2	37460-37464	peak	_	
193-3	37465-37471	voxels	_	
193-4	37472-37473	8	_	
193-5	37474-37476	mm	_	
193-6	37477-37482	apart	_	
193-7	37483-37486	are	_	
193-8	37487-37497	identified	_	
193-9	37497-37498	.	_	

#Text=Volume voxels (k)\tPeak voxel Z\tMNI coordinate\tSide\tIdentified brain region\t \t\t\tx\ty\tz\t\t\t \t3898\t17.03\t-40\t18\t0\tL\tInsula\t \t15.74\t-32\t20\t-8\tL\tInsula\t \t10.76\t-50\t10\t4\tL\tInferior frontal cortex\t \t\t \t4786\t15.46\t40\t20\t-2\tR\tInsula/ Inferior frontal cortex\t \t15.15\t32\t24\t-6\tR\tInsula/ Inferior frontal cortex\t \t11.71\t48\t4\t42\tR\tPrecentral gyrus\t \t\t \t7040\t13.48\t60\t-42\t22\tR\tSuperior temporal gyrus\t \t11.60\t52\t-42\t34\tR\tSupramarginal gyrus\t \t11.60\t50\t-28\t-4\tR\tMiddle temporal gyrus\t \t\t \t7481\t13.46\t-4\t24\t32\tL\tACC/preSMA\t \t13.19\t6\t22\t36\tR\tACC/preSMA\t \t13.05\t4\t32\t26\tR\tACC/preSMA\t \t\t \t6136\t11.82\t-6\t-26\t-4\tL\tThalamus\t \t11.30\t8\t-24\t-12\tR\tThalamus\t \t11.22\t10\t-12\t6\tR\tThalamus\t \t\t \t6341\t11.40\t-56\t-46\t34\tL\tSupramarginal gyrus\t \t11.40\t-32\t-90\t-2\tL\tMiddle occipital cortex\t \t10.90\t-28\t-54\t44\tL\tInferior parietal cortex\t \t
#Text=ACC: anterior cingulate cortex; preSMA: pre-supplementary motor area
#Text=Regions with higher error-related responses in women as compared to men (p<0.001, uncorrected, k>100 voxels).
194-1	37499-37505	Volume	_	
194-2	37506-37512	voxels	_	
194-3	37513-37514	(	_	
194-4	37514-37515	k	_	
194-5	37515-37516	)	_	
194-6	37517-37521	Peak	_	
194-7	37522-37527	voxel	_	
194-8	37528-37529	Z	_	
194-9	37530-37533	MNI	_	
194-10	37534-37544	coordinate	_	
194-11	37545-37549	Side	_	
194-12	37550-37560	Identified	_	
194-13	37561-37566	brain	_	
194-14	37567-37573	region	_	
194-15	37578-37579	x	_	
194-16	37580-37581	y	_	
194-17	37582-37583	z	_	
194-18	37588-37592	3898	_	
194-19	37593-37598	17.03	_	
194-20	37599-37600	-	_	
194-21	37600-37602	40	_	
194-22	37603-37605	18	_	
194-23	37606-37607	0	_	
194-24	37608-37609	L	_	
194-25	37610-37616	Insula	_	
194-26	37619-37624	15.74	_	
194-27	37625-37626	-	_	
194-28	37626-37628	32	_	
194-29	37629-37631	20	_	
194-30	37632-37633	-	_	
194-31	37633-37634	8	_	
194-32	37635-37636	L	_	
194-33	37637-37643	Insula	_	
194-34	37646-37651	10.76	_	
194-35	37652-37653	-	_	
194-36	37653-37655	50	_	
194-37	37656-37658	10	_	
194-38	37659-37660	4	_	
194-39	37661-37662	L	_	
194-40	37663-37671	Inferior	_	
194-41	37672-37679	frontal	_	
194-42	37680-37686	cortex	_	
194-43	37692-37696	4786	_	
194-44	37697-37702	15.46	_	
194-45	37703-37705	40	_	
194-46	37706-37708	20	_	
194-47	37709-37710	-	_	
194-48	37710-37711	2	_	
194-49	37712-37713	R	_	
194-50	37714-37720	Insula	_	
194-51	37720-37721	/	_	
194-52	37722-37730	Inferior	_	
194-53	37731-37738	frontal	_	
194-54	37739-37745	cortex	_	
194-55	37748-37753	15.15	_	
194-56	37754-37756	32	_	
194-57	37757-37759	24	_	
194-58	37760-37761	-	_	
194-59	37761-37762	6	_	
194-60	37763-37764	R	_	
194-61	37765-37771	Insula	_	
194-62	37771-37772	/	_	
194-63	37773-37781	Inferior	_	
194-64	37782-37789	frontal	_	
194-65	37790-37796	cortex	_	
194-66	37799-37804	11.71	_	
194-67	37805-37807	48	_	
194-68	37808-37809	4	_	
194-69	37810-37812	42	_	
194-70	37813-37814	R	_	
194-71	37815-37825	Precentral	_	
194-72	37826-37831	gyrus	_	
194-73	37837-37841	7040	_	
194-74	37842-37847	13.48	_	
194-75	37848-37850	60	_	
194-76	37851-37852	-	_	
194-77	37852-37854	42	_	
194-78	37855-37857	22	_	
194-79	37858-37859	R	_	
194-80	37860-37868	Superior	_	
194-81	37869-37877	temporal	_	
194-82	37878-37883	gyrus	_	
194-83	37886-37891	11.60	_	
194-84	37892-37894	52	_	
194-85	37895-37896	-	_	
194-86	37896-37898	42	_	
194-87	37899-37901	34	_	
194-88	37902-37903	R	_	
194-89	37904-37917	Supramarginal	_	
194-90	37918-37923	gyrus	_	
194-91	37926-37931	11.60	_	
194-92	37932-37934	50	_	
194-93	37935-37936	-	_	
194-94	37936-37938	28	_	
194-95	37939-37940	-	_	
194-96	37940-37941	4	_	
194-97	37942-37943	R	_	
194-98	37944-37950	Middle	_	
194-99	37951-37959	temporal	_	
194-100	37960-37965	gyrus	_	
194-101	37971-37975	7481	_	
194-102	37976-37981	13.46	_	
194-103	37982-37983	-	_	
194-104	37983-37984	4	_	
194-105	37985-37987	24	_	
194-106	37988-37990	32	_	
194-107	37991-37992	L	_	
194-108	37993-37996	ACC	_	
194-109	37996-37997	/	_	
194-110	37997-38003	preSMA	_	
194-111	38006-38011	13.19	_	
194-112	38012-38013	6	_	
194-113	38014-38016	22	_	
194-114	38017-38019	36	_	
194-115	38020-38021	R	_	
194-116	38022-38025	ACC	_	
194-117	38025-38026	/	_	
194-118	38026-38032	preSMA	_	
194-119	38035-38040	13.05	_	
194-120	38041-38042	4	_	
194-121	38043-38045	32	_	
194-122	38046-38048	26	_	
194-123	38049-38050	R	_	
194-124	38051-38054	ACC	_	
194-125	38054-38055	/	_	
194-126	38055-38061	preSMA	_	
194-127	38067-38071	6136	_	
194-128	38072-38077	11.82	_	
194-129	38078-38079	-	_	
194-130	38079-38080	6	_	
194-131	38081-38082	-	_	
194-132	38082-38084	26	_	
194-133	38085-38086	-	_	
194-134	38086-38087	4	_	
194-135	38088-38089	L	_	
194-136	38090-38098	Thalamus	_	
194-137	38101-38106	11.30	_	
194-138	38107-38108	8	_	
194-139	38109-38110	-	_	
194-140	38110-38112	24	_	
194-141	38113-38114	-	_	
194-142	38114-38116	12	_	
194-143	38117-38118	R	_	
194-144	38119-38127	Thalamus	_	
194-145	38130-38135	11.22	_	
194-146	38136-38138	10	_	
194-147	38139-38140	-	_	
194-148	38140-38142	12	_	
194-149	38143-38144	6	_	
194-150	38145-38146	R	_	
194-151	38147-38155	Thalamus	_	
194-152	38161-38165	6341	_	
194-153	38166-38171	11.40	_	
194-154	38172-38173	-	_	
194-155	38173-38175	56	_	
194-156	38176-38177	-	_	
194-157	38177-38179	46	_	
194-158	38180-38182	34	_	
194-159	38183-38184	L	_	
194-160	38185-38198	Supramarginal	_	
194-161	38199-38204	gyrus	_	
194-162	38207-38212	11.40	_	
194-163	38213-38214	-	_	
194-164	38214-38216	32	_	
194-165	38217-38218	-	_	
194-166	38218-38220	90	_	
194-167	38221-38222	-	_	
194-168	38222-38223	2	_	
194-169	38224-38225	L	_	
194-170	38226-38232	Middle	_	
194-171	38233-38242	occipital	_	
194-172	38243-38249	cortex	_	
194-173	38252-38257	10.90	_	
194-174	38258-38259	-	_	
194-175	38259-38261	28	_	
194-176	38262-38263	-	_	
194-177	38263-38265	54	_	
194-178	38266-38268	44	_	
194-179	38269-38270	L	_	
194-180	38271-38279	Inferior	_	
194-181	38280-38288	parietal	_	
194-182	38289-38295	cortex	_	
194-183	38299-38302	ACC	_	
194-184	38302-38303	:	_	
194-185	38304-38312	anterior	_	
194-186	38313-38322	cingulate	_	
194-187	38323-38329	cortex	_	
194-188	38329-38330	;	_	
194-189	38331-38337	preSMA	_	
194-190	38337-38338	:	_	
194-191	38339-38356	pre-supplementary	_	
194-192	38357-38362	motor	_	
194-193	38363-38367	area	_	
194-194	38368-38375	Regions	_	
194-195	38376-38380	with	_	
194-196	38381-38387	higher	_	
194-197	38388-38401	error-related	_	
194-198	38402-38411	responses	_	
194-199	38412-38414	in	_	
194-200	38415-38420	women	_	
194-201	38421-38423	as	_	
194-202	38424-38432	compared	_	
194-203	38433-38435	to	_	
194-204	38436-38439	men	_	
194-205	38440-38441	(	_	
194-206	38441-38442	p	_	
194-207	38442-38443	<	_	
194-208	38443-38448	0.001	_	
194-209	38448-38449	,	_	
194-210	38450-38461	uncorrected	_	
194-211	38461-38462	,	_	
194-212	38463-38464	k	_	
194-213	38464-38465	>	_	
194-214	38465-38468	100	_	
194-215	38469-38475	voxels	_	
194-216	38475-38476	)	_	
194-217	38476-38477	.	_	

#Text=All voxel peaks 8mm apart are shown.
195-1	38478-38481	All	_	
195-2	38482-38487	voxel	_	
195-3	38488-38493	peaks	_	
195-4	38494-38497	8mm	_	
195-5	38498-38503	apart	_	
195-6	38504-38507	are	_	
195-7	38508-38513	shown	_	
195-8	38513-38514	.	_	

#Text=Volume voxels (k)\tPeak voxel Z\tMNI coordinate\tSide\tIdentified brain region\t \t\t\tx\ty\tz\t\t\t \t951\t4.72\t-16\t-20\t10\tL\tThalamus*\t \t4.15\t-10\t-14\t-2\tL\tThalamus*\t \t4.13\t18\t-18\t8\tR\tThalamus*\t \t\t \t947\t4.45\t48\t-48\t14\tR\tMiddle temporal cortex*\t \t3.47\t44\t-40\t4\tR\tMiddle temporal cortex*\t \t3.27\t46\t-28\t2\tR\tSuperior temporal cortex*\t \t\t \t114\t3.89\t2\t18\t40\tR\tdACC\t \t3.36\t-8\t6\t44\tL\tdACC\t \t
#Text=Note:
#Text=indicates clusters with a significant voxel p<0.05, FWE corrected. dACC: dorsal anterior cingulate cortex.
196-1	38515-38521	Volume	_	
196-2	38522-38528	voxels	_	
196-3	38529-38530	(	_	
196-4	38530-38531	k	_	
196-5	38531-38532	)	_	
196-6	38533-38537	Peak	_	
196-7	38538-38543	voxel	_	
196-8	38544-38545	Z	_	
196-9	38546-38549	MNI	_	
196-10	38550-38560	coordinate	_	
196-11	38561-38565	Side	_	
196-12	38566-38576	Identified	_	
196-13	38577-38582	brain	_	
196-14	38583-38589	region	_	
196-15	38594-38595	x	_	
196-16	38596-38597	y	_	
196-17	38598-38599	z	_	
196-18	38604-38607	951	_	
196-19	38608-38612	4.72	_	
196-20	38613-38614	-	_	
196-21	38614-38616	16	_	
196-22	38617-38618	-	_	
196-23	38618-38620	20	_	
196-24	38621-38623	10	_	
196-25	38624-38625	L	_	
196-26	38626-38634	Thalamus	_	
196-27	38634-38635	*	_	
196-28	38638-38642	4.15	_	
196-29	38643-38644	-	_	
196-30	38644-38646	10	_	
196-31	38647-38648	-	_	
196-32	38648-38650	14	_	
196-33	38651-38652	-	_	
196-34	38652-38653	2	_	
196-35	38654-38655	L	_	
196-36	38656-38664	Thalamus	_	
196-37	38664-38665	*	_	
196-38	38668-38672	4.13	_	
196-39	38673-38675	18	_	
196-40	38676-38677	-	_	
196-41	38677-38679	18	_	
196-42	38680-38681	8	_	
196-43	38682-38683	R	_	
196-44	38684-38692	Thalamus	_	
196-45	38692-38693	*	_	
196-46	38699-38702	947	_	
196-47	38703-38707	4.45	_	
196-48	38708-38710	48	_	
196-49	38711-38712	-	_	
196-50	38712-38714	48	_	
196-51	38715-38717	14	_	
196-52	38718-38719	R	_	
196-53	38720-38726	Middle	_	
196-54	38727-38735	temporal	_	
196-55	38736-38742	cortex	_	
196-56	38742-38743	*	_	
196-57	38746-38750	3.47	_	
196-58	38751-38753	44	_	
196-59	38754-38755	-	_	
196-60	38755-38757	40	_	
196-61	38758-38759	4	_	
196-62	38760-38761	R	_	
196-63	38762-38768	Middle	_	
196-64	38769-38777	temporal	_	
196-65	38778-38784	cortex	_	
196-66	38784-38785	*	_	
196-67	38788-38792	3.27	_	
196-68	38793-38795	46	_	
196-69	38796-38797	-	_	
196-70	38797-38799	28	_	
196-71	38800-38801	2	_	
196-72	38802-38803	R	_	
196-73	38804-38812	Superior	_	
196-74	38813-38821	temporal	_	
196-75	38822-38828	cortex	_	
196-76	38828-38829	*	_	
196-77	38835-38838	114	_	
196-78	38839-38843	3.89	_	
196-79	38844-38845	2	_	
196-80	38846-38848	18	_	
196-81	38849-38851	40	_	
196-82	38852-38853	R	_	
196-83	38854-38858	dACC	_	
196-84	38861-38865	3.36	_	
196-85	38866-38867	-	_	
196-86	38867-38868	8	_	
196-87	38869-38870	6	_	
196-88	38871-38873	44	_	
196-89	38874-38875	L	_	
196-90	38876-38880	dACC	_	
196-91	38884-38888	Note	_	
196-92	38888-38889	:	_	
196-93	38890-38899	indicates	_	
196-94	38900-38908	clusters	_	
196-95	38909-38913	with	_	
196-96	38914-38915	a	_	
196-97	38916-38927	significant	_	
196-98	38928-38933	voxel	_	
196-99	38934-38935	p	_	
196-100	38935-38936	<	_	
196-101	38936-38940	0.05	_	
196-102	38940-38941	,	_	
196-103	38942-38945	FWE	_	
196-104	38946-38955	corrected	_	
196-105	38955-38956	.	_	
196-106	38957-38961	dACC	_	
196-107	38961-38962	:	_	
196-108	38963-38969	dorsal	_	
196-109	38970-38978	anterior	_	
196-110	38979-38988	cingulate	_	
196-111	38989-38995	cortex	_	
196-112	38995-38996	.	_	

#Text=Brain regions showing error-related response in correlation with AUDIT score in women.
197-1	38997-39002	Brain	_	
197-2	39003-39010	regions	_	
197-3	39011-39018	showing	_	
197-4	39019-39032	error-related	_	
197-5	39033-39041	response	_	
197-6	39042-39044	in	_	
197-7	39045-39056	correlation	_	
197-8	39057-39061	with	_	
197-9	39062-39067	AUDIT	_	
197-10	39068-39073	score	_	
197-11	39074-39076	in	_	
197-12	39077-39082	women	_	
197-13	39082-39083	.	_	

#Text=Multiple regression, p<0.001, uncorrected in combination with cluster p<0.05 FWE corrected (k>100).
198-1	39084-39092	Multiple	_	
198-2	39093-39103	regression	_	
198-3	39103-39104	,	_	
198-4	39105-39106	p	_	
198-5	39106-39107	<	_	
198-6	39107-39112	0.001	_	
198-7	39112-39113	,	_	
198-8	39114-39125	uncorrected	_	
198-9	39126-39128	in	_	
198-10	39129-39140	combination	_	
198-11	39141-39145	with	_	
198-12	39146-39153	cluster	_	
198-13	39154-39155	p	_	
198-14	39155-39156	<	_	
198-15	39156-39160	0.05	_	
198-16	39161-39164	FWE	_	
198-17	39165-39174	corrected	_	
198-18	39175-39176	(	_	
198-19	39176-39177	k	_	
198-20	39177-39178	>	_	
198-21	39178-39181	100	_	
198-22	39181-39182	)	_	
198-23	39182-39183	.	_	

#Text=All peak voxels 8 mm apart are identified.
199-1	39184-39187	All	_	
199-2	39188-39192	peak	_	
199-3	39193-39199	voxels	_	
199-4	39200-39201	8	_	
199-5	39202-39204	mm	_	
199-6	39205-39210	apart	_	
199-7	39211-39214	are	_	
199-8	39215-39225	identified	_	
199-9	39225-39226	.	_	

#Text=Volume voxels (k)\tPeak voxel Z\tMNI coordinate\tSide\tIdentified brain region\t \t\t\tx\ty\tz\t \t192\t4.73\t28\t-44\t-24\tR\tFusiform gyrus\t \t3.56\t40\t-48\t-16\tR\tFusiform gyrus\t \t3.46\t20\t-42\t-16\tR\tLingual gyrus\t \t\t \t225\t4.62\t44\t-18\t36\tR\tPostcentral gyrus\t \t4.07\t40\t-4\t52\tR\tPrecentral gyrus\t \t3.64\t46\t-16\t48\tR\tPostcentral/precentral gyrus\t \t\t \t889\t4.41\t-26\t-82\t20\tL\tMiddle occipital gyrus\t \t4.31\t-20\t-82\t32\tL\tSuperior occipital gyrus\t \t4.23\t-6\t-78\t24\tL\tCuneus\t \t\t \t650\t4.41\t22\t10\t16\tR\tCaudate, putamen\t \t4.21\t-12\t-4\t14\tL\tThalamus, caudate\t \t3.97\t12\t-2\t12\tR\tThalamus, caudate\t \t\t \t245\t4.06\t-22\t-66\t-12\tL\tLingual gyrus\t \t3.99\t-20\t-74\t-12\tL\tLingual gyrus\t \t3.66\t-26\t-58\t-12\tL\tFusiform gyrus\t \t\t \t191\t3.96\t36\t-28\t-14\tR\tHippocampus, fusiform gyrus\t \t3.83\t34\t-18\t-4\tR\tInsula, putamen\t \t3.72\t40\t-32\t-4\tR\tMiddle temporal gyrus\t \t\t \t192\t3.88\t2\t-10\t56\tR\tSupplementary motor area\t \t3.62\t6\t0\t46\tR\tAnterior cingulate cortex\t \t3.46\t0\t10\t46\tR/L\tPre-supplementary motor area
200-1	39227-39233	Volume	_	
200-2	39234-39240	voxels	_	
200-3	39241-39242	(	_	
200-4	39242-39243	k	_	
200-5	39243-39244	)	_	
200-6	39245-39249	Peak	_	
200-7	39250-39255	voxel	_	
200-8	39256-39257	Z	_	
200-9	39258-39261	MNI	_	
200-10	39262-39272	coordinate	_	
200-11	39273-39277	Side	_	
200-12	39278-39288	Identified	_	
200-13	39289-39294	brain	_	
200-14	39295-39301	region	_	
200-15	39306-39307	x	_	
200-16	39308-39309	y	_	
200-17	39310-39311	z	_	
200-18	39314-39317	192	_	
200-19	39318-39322	4.73	_	
200-20	39323-39325	28	_	
200-21	39326-39327	-	_	
200-22	39327-39329	44	_	
200-23	39330-39331	-	_	
200-24	39331-39333	24	_	
200-25	39334-39335	R	_	
200-26	39336-39344	Fusiform	_	
200-27	39345-39350	gyrus	_	
200-28	39353-39357	3.56	_	
200-29	39358-39360	40	_	
200-30	39361-39362	-	_	
200-31	39362-39364	48	_	
200-32	39365-39366	-	_	
200-33	39366-39368	16	_	
200-34	39369-39370	R	_	
200-35	39371-39379	Fusiform	_	
200-36	39380-39385	gyrus	_	
200-37	39388-39392	3.46	_	
200-38	39393-39395	20	_	
200-39	39396-39397	-	_	
200-40	39397-39399	42	_	
200-41	39400-39401	-	_	
200-42	39401-39403	16	_	
200-43	39404-39405	R	_	
200-44	39406-39413	Lingual	_	
200-45	39414-39419	gyrus	_	
200-46	39425-39428	225	_	
200-47	39429-39433	4.62	_	
200-48	39434-39436	44	_	
200-49	39437-39438	-	_	
200-50	39438-39440	18	_	
200-51	39441-39443	36	_	
200-52	39444-39445	R	_	
200-53	39446-39457	Postcentral	_	
200-54	39458-39463	gyrus	_	
200-55	39466-39470	4.07	_	
200-56	39471-39473	40	_	
200-57	39474-39475	-	_	
200-58	39475-39476	4	_	
200-59	39477-39479	52	_	
200-60	39480-39481	R	_	
200-61	39482-39492	Precentral	_	
200-62	39493-39498	gyrus	_	
200-63	39501-39505	3.64	_	
200-64	39506-39508	46	_	
200-65	39509-39510	-	_	
200-66	39510-39512	16	_	
200-67	39513-39515	48	_	
200-68	39516-39517	R	_	
200-69	39518-39529	Postcentral	_	
200-70	39529-39530	/	_	
200-71	39530-39540	precentral	_	
200-72	39541-39546	gyrus	_	
200-73	39552-39555	889	_	
200-74	39556-39560	4.41	_	
200-75	39561-39562	-	_	
200-76	39562-39564	26	_	
200-77	39565-39566	-	_	
200-78	39566-39568	82	_	
200-79	39569-39571	20	_	
200-80	39572-39573	L	_	
200-81	39574-39580	Middle	_	
200-82	39581-39590	occipital	_	
200-83	39591-39596	gyrus	_	
200-84	39599-39603	4.31	_	
200-85	39604-39605	-	_	
200-86	39605-39607	20	_	
200-87	39608-39609	-	_	
200-88	39609-39611	82	_	
200-89	39612-39614	32	_	
200-90	39615-39616	L	_	
200-91	39617-39625	Superior	_	
200-92	39626-39635	occipital	_	
200-93	39636-39641	gyrus	_	
200-94	39644-39648	4.23	_	
200-95	39649-39650	-	_	
200-96	39650-39651	6	_	
200-97	39652-39653	-	_	
200-98	39653-39655	78	_	
200-99	39656-39658	24	_	
200-100	39659-39660	L	_	
200-101	39661-39667	Cuneus	_	
200-102	39673-39676	650	_	
200-103	39677-39681	4.41	_	
200-104	39682-39684	22	_	
200-105	39685-39687	10	_	
200-106	39688-39690	16	_	
200-107	39691-39692	R	_	
200-108	39693-39700	Caudate	_	
200-109	39700-39701	,	_	
200-110	39702-39709	putamen	_	
200-111	39712-39716	4.21	_	
200-112	39717-39718	-	_	
200-113	39718-39720	12	_	
200-114	39721-39722	-	_	
200-115	39722-39723	4	_	
200-116	39724-39726	14	_	
200-117	39727-39728	L	_	
200-118	39729-39737	Thalamus	_	
200-119	39737-39738	,	_	
200-120	39739-39746	caudate	_	
200-121	39749-39753	3.97	_	
200-122	39754-39756	12	_	
200-123	39757-39758	-	_	
200-124	39758-39759	2	_	
200-125	39760-39762	12	_	
200-126	39763-39764	R	_	
200-127	39765-39773	Thalamus	_	
200-128	39773-39774	,	_	
200-129	39775-39782	caudate	_	
200-130	39788-39791	245	_	
200-131	39792-39796	4.06	_	
200-132	39797-39798	-	_	
200-133	39798-39800	22	_	
200-134	39801-39802	-	_	
200-135	39802-39804	66	_	
200-136	39805-39806	-	_	
200-137	39806-39808	12	_	
200-138	39809-39810	L	_	
200-139	39811-39818	Lingual	_	
200-140	39819-39824	gyrus	_	
200-141	39827-39831	3.99	_	
200-142	39832-39833	-	_	
200-143	39833-39835	20	_	
200-144	39836-39837	-	_	
200-145	39837-39839	74	_	
200-146	39840-39841	-	_	
200-147	39841-39843	12	_	
200-148	39844-39845	L	_	
200-149	39846-39853	Lingual	_	
200-150	39854-39859	gyrus	_	
200-151	39862-39866	3.66	_	
200-152	39867-39868	-	_	
200-153	39868-39870	26	_	
200-154	39871-39872	-	_	
200-155	39872-39874	58	_	
200-156	39875-39876	-	_	
200-157	39876-39878	12	_	
200-158	39879-39880	L	_	
200-159	39881-39889	Fusiform	_	
200-160	39890-39895	gyrus	_	
200-161	39901-39904	191	_	
200-162	39905-39909	3.96	_	
200-163	39910-39912	36	_	
200-164	39913-39914	-	_	
200-165	39914-39916	28	_	
200-166	39917-39918	-	_	
200-167	39918-39920	14	_	
200-168	39921-39922	R	_	
200-169	39923-39934	Hippocampus	_	
200-170	39934-39935	,	_	
200-171	39936-39944	fusiform	_	
200-172	39945-39950	gyrus	_	
200-173	39953-39957	3.83	_	
200-174	39958-39960	34	_	
200-175	39961-39962	-	_	
200-176	39962-39964	18	_	
200-177	39965-39966	-	_	
200-178	39966-39967	4	_	
200-179	39968-39969	R	_	
200-180	39970-39976	Insula	_	
200-181	39976-39977	,	_	
200-182	39978-39985	putamen	_	
200-183	39988-39992	3.72	_	
200-184	39993-39995	40	_	
200-185	39996-39997	-	_	
200-186	39997-39999	32	_	
200-187	40000-40001	-	_	
200-188	40001-40002	4	_	
200-189	40003-40004	R	_	
200-190	40005-40011	Middle	_	
200-191	40012-40020	temporal	_	
200-192	40021-40026	gyrus	_	
200-193	40032-40035	192	_	
200-194	40036-40040	3.88	_	
200-195	40041-40042	2	_	
200-196	40043-40044	-	_	
200-197	40044-40046	10	_	
200-198	40047-40049	56	_	
200-199	40050-40051	R	_	
200-200	40052-40065	Supplementary	_	
200-201	40066-40071	motor	_	
200-202	40072-40076	area	_	
200-203	40079-40083	3.62	_	
200-204	40084-40085	6	_	
200-205	40086-40087	0	_	
200-206	40088-40090	46	_	
200-207	40091-40092	R	_	
200-208	40093-40101	Anterior	_	
200-209	40102-40111	cingulate	_	
200-210	40112-40118	cortex	_	
200-211	40121-40125	3.46	_	
200-212	40126-40127	0	_	
200-213	40128-40130	10	_	
200-214	40131-40133	46	_	
200-215	40134-40135	R	_	
200-216	40135-40136	/	_	
200-217	40136-40137	L	_	
200-218	40138-40155	Pre-supplementary	_	
200-219	40156-40161	motor	_	
200-220	40162-40166	area	_	
